University of Arkansas, Fayetteville

ScholarWorks@UARK
Graduate Theses and Dissertations
5-2022

Investigating Molecular Mechanisms behind Bacterial
Chondronecrosis with Osteomyelitis (BCO) Pathogenesis in
Modern Broilers
Alison Ramser
University of Arkansas, Fayetteville

Follow this and additional works at: https://scholarworks.uark.edu/etd
Part of the Animal Diseases Commons, Animal Experimentation and Research Commons, Molecular
Biology Commons, and the Poultry or Avian Science Commons

Citation
Ramser, A. (2022). Investigating Molecular Mechanisms behind Bacterial Chondronecrosis with
Osteomyelitis (BCO) Pathogenesis in Modern Broilers. Graduate Theses and Dissertations Retrieved from
https://scholarworks.uark.edu/etd/4448

This Dissertation is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for
inclusion in Graduate Theses and Dissertations by an authorized administrator of ScholarWorks@UARK. For more
information, please contact scholar@uark.edu.

Investigating Molecular Mechanisms behind
Bacterial Chondronecrosis with Osteomyelitis (BCO)
Pathogenesis in Modern Broilers

A dissertation submitted in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy in Cell and Molecular Biology

Alison Ramser
The Pennsylvania State University
Bachelor of Science in Animal Science, 2019

May 2022
University of Arkansas

This dissertation is approved for recommendation to the Graduate Council.

________________________________
Sami Dridi, Ph.D.
Dissertation Committee Chair

________________________________
Robert Wideman, Ph.D.
Committee Member

_____________________________
Rachel Hawken, Ph.D.
Committee Member

________________________________
Adnan Alrubaye, Ph.D.
Committee Member

________________________________
Nicholas P. Greene, Ph.D.
Committee Member

Abstract
Bacterial chondronecrosis with osteomyelitis (BCO), a leading cause of lameness in broiler
chickens, is characterized by infection, inflammation, and bone attrition. There are currently no
effective treatments and positive diagnosis is only possible through necropsy evaluations.
Lameness is also a rising animal welfare and economic concern, making prevention and
detection of BCO all the more critical. These challenges are exacerbated by a lack of mechanistic
understanding of BCO’s etiology. The question I asked during my dissertation was how bacteria
induce bone attrition in BCO pathology. My research has shown that mitochondrial dysfunction
is characteristic of BCO conditions along with autophagy machinery dysregulation. This
autophagy dysregulation is also seen to a result of in vitro infection with known BCO-isolates
and affecting bone cell viability. The local bone and systemic blood profile of cytokines,
chemokines, inflammasomes, and relevant FGFs were also evaluated. This revealed a unique
signature of BCO detectable within circulation and in local bone. Additionally, this signature
was made up of factors which negatively affect bone cell viability. It was also shown that
primary avian chondrocytes exhibiting optimal phenotypes could be successfully isolated form
chicks. These primary cells could provide an improved, highly relevant model for in vitro
analysis of avian bone diseases and infections. Finally, the potential roles of two factors
regulating energy and lipid metabolism were preliminarily explored as a future target for BCO
research. These findings provide novel insight into mechanisms of etiology and means of noninvasive detection while also improving upon current methods of avian growth-plate research.
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Chapter 1 – Introduction
The modern broiler is a prodigy of genetic investigation, a beneficiary of nutritional and
husbandry innovations, and a cornucopia of scientific intrigue. Never has a bird grown as fast
and produced as much yield while improving its feed efficiency and resisting disease, infection,
and disorders. There is much to celebrate about the efficient animal that globally provides one of
the most popular animal protein options. However, the broiler is not finished with its work.
While much has been achieved, more needs to be attained. As global population rises and more
individuals crave affordable quality animal protein grown with less resources and better
conditions, the broiler will need help [1, 2].
One challenge is the maintenance of the broiler’s welfare and bodily integrity so that it can
continue to perform at its peak. Lameness and skeletal disorders have become an increasingly
concerning obstacle to broiler welfare and performance. Specifically, bacterial chondronecrosis
with osteomyelitis (BCO), also known as femur head necrosis (FHN) and tibial head necrosis
(THN), is a leading cause of lameness with multiple factors at play. BCO primarily affects the
proximal growth plates of the long bones, areas within the skeletal system that undergo
additional stress and dynamic remodeling during fast growth [3, 4]. These areas are also highly
vascularized leading to potential exposure to opportunistic bacteria within the blood stream to
weakened or damaged sites within the growth plate [5]. Once infection occurs, inflammatory
immune responses and necrosis sets in leading to bone attrition and often lameness [6, 7]. While
lameness is a major animal welfare and performance concern as lame birds feel more pain and
access less feed and water, the true danger behind BCO is its subclinical persistence [5, 8, 9]. To
date, BCO is only diagnosable through necropsy and inspection of the proximal femur and tibial
heads [5]. Without lameness, BCO birds may go undetected in breeding programs and
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production. Therefore, defining the molecular mechanisms involved in this disorder is critical to
improving prevention, detection, and potentially treatment of BCO.
Researchers have successfully demonstrated spontaneous induction of BCO in broilers reared on
wire flooring [10, 11]. This model has become the foundation for studying BCO. It works on the
principal of increased mechanical stress in addition to a more stressful environment conditions
that are optimal for decreased bone integrity and increased bacterial load. Indeed, there is a fairly
agreed upon mechanism in which BCO occurs within the long bones, however what is yet to be
understood is how bacterial infection creates the symptoms and bone condition seen and what the
systemic immune and metabolic factors are that contribute to or are the result of BCO. Recently,
it was shown that DICER1 dysregulation coupled with double stranded ribonucleic acid
(dsRNA) accumulation led to NLRP3 inflammasome activation in BCO bone and human bone
affected by osteomyelitis [12]. This is the first research to implicate a cellular process in the
pathogenicity of BCO and set the stage for further in-depth molecular analysis to reveal
pathways and processes involved in BCO. In continuum to the above-mentioned study, I
demonstrated the presence of mitochondrial dysfunction in BCO (Chapter 3) and outlined its
involvement in bacterial infection and cell survival (Chapter 2). Additionally, I evaluated the role
of autophagy machinery manipulation in BCO etiology (Chapter 5). It was demonstrated that this
dysregulation seen in tissue was also seen under challenge with known BCO-isolates. This
dysregulation was sufficient to affect bone cell viability and therefore could be contributing to
bone attrition and lack of healing. The systemic effects of BCO were investigated by defining the
cytokine, chemokine, inflammasome, and FGF profiles in bone and blood of BCO-affected birds
compared to their healthy counterparts (Chapter 7). BCO was shown to have a unique signature
of cytokines, including TNFα, and chemokines, such as IL-8, contributing to the systemic
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inflammatory state. This signature could be used as a non-invasive detection and could also
contribute to inflammatory bone loss through affecting bone cell viability.
One of the limiting factors in the study of BCO is the lack of an avian bone cell line for in vitro
analysis. To address this limitation, I successfully isolated, cultured, and characterized primary
growth plate chondrocytes from chicks (Chapter 8). These cells showed optimal phenotype for
mimicking avian growth-plate tissue by day 3 in culture and proven secretion of collagen type II
by day 7. Finally, the roles of two regulators of lipid metabolism and energy homeostasis was
preliminarily investigated. First, the regulation of visfatin were evaluated within hepatic cells in
order to better understand its role in avian systems (Chapter 10). Avian-uncoupling protein (avUCP) and its regulation by growth factors, hormones, and pro-inflammatory markers, was
evaluated in avian muscle cells (Chapter 11). These factors could be essential to understanding
the systemic effect and causes of BCO and have shown to be regulated through several means in
their major cell types.
Taken as a whole, these novel findings demonstrate complex molecular networks involved in cell
stress response, cell survival, bone homeostasis, and systemic inflammation to be implicated in
BCO etiology. These pathways and their outcomes create the unique systemic effects seen in
BCO and provide a basis for non-invasive markers, potential targets for treatment or selection,
and a foundation for future research to better understand BCO in the broiler.
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Chapter 2 –
Title: Bacterial chondronecrosis with osteomyelitis (BCO) in modern broilers: impacts,
mechanisms, and perspectives
Authors: Alison Ferver and Sami Dridi
Center of Excellence for Poultry Science, University of Arkansas, 1260 W. Maple Street,
Fayetteville, AR, 72701, USA.
Correspondence: Sami Dridi. Email: dridi@uark.edu
Abstract: Bacterial chondronecrosis with osteomyelitis (BCO) is one of the leading causes of
lameness and welfare concerns in the modern broiler. The avian bone physiology and remodeling
process is complex and dependent on numerous bone and vascular cell types and pathways
working harmoniously. The rapid growth rate of the leg bones in the modern broiler coupled
with high body weight gain and high metabolic demands have predisposed the broiler to damage
within the bone, opportunistic bacterial infection, and subsequent BCO. The maturation and
ossification of chondrocytes at the growth plate epiphyseal cartilage junction is critical for leg
soundness and defense against mechanical stressors and is ongoing throughout a broiler’s life
span. The mitochondria play a critical role in stem cell maturation and differentiation in bone and
their dysfunction has been implicated in numerous diseases, including type 2 diabetic
osteomyelitis and osteoporosis. An understanding of the dynamics between bone physiology and
bacterial infection along with mitochondrial dynamics and function in disease states could give
more insights into the etiology of BCO and subsequent development of effective strategies to
preventing/treating BCO pathology. This review will address the impacts of BCO as well as the
physiology involved while highlighting the need for mechanistic understanding of BCO at the
5

cellular level which could address the potential role of mitochondrial dysfunction and BCO
pathogenicity.
Keywords: broilers, lameness, osteomyelitis, osteochondrosis, mitochondria, mitochondrial
dysfunction, avian bone physiology
Review Methodology: Data for this review were compiled using databases such as NCBI
PubMed, University of Arkansas Library Quick Search, run by WorldCat, Science Direct, and
JSTOR. Search terms used included “bacterial chondronecrosis with osteomyelitis (BCO)”,
“broilers”, “femur head necrosis”, “femur head separation”, “lameness in broilers”, “avian bone
physiology”, “avian anatomy”, “avian bone remodeling”, “endocrinology of bone remodeling”,
“causative agents of BCO”, “S. aureus infection”, “mitochondrial dysfunction”, “mitochondrial
function”, “mitochondrial dysfunction and bone”, “mitochondrial dysfunction and disease”, and
“mitochondria and bacterial infections”. Manual of Ornithology, by Noble Proctor and Patrick
Lynch, was sourced from the author’s personal library.
Introduction: In order to address lameness in modern broilers, a basic understanding of bone
physiology is necessary. Although genetics has successfully selected for a faster growing bird,
selection for leg health traits such as gait scores is novel, and the avian bone consists of
numerous cell types and structures that genetic selection has yet to explore. In the case of BCO,
there are numerous hypotheses surrounding the involvement of the skeletal system and the
ultimate bacterial infection of the femur head. This review will explore not only the impact of
BCO on the poultry industry in terms of production losses due to lameness, but also the
increasingly more pressing loss in animal welfare. The physiology behind BCO will be reviewed
before exploring the causative agents and current theories on BCO pathogenicity. In this review,
we will summarize recent evidence supporting the pivotal role of mitochondria in bone disease
6

and highlighting the need of further in depth mechanistic studies delineating mitochondria
dysfunction and BCO development, which might allow the discovery of new metabolic and
signaling pathways as effective preventive/therapeutic targets.
Impacts of BCO on the poultry industry
The modern broiler is the most efficient meat bird in history in terms of feed conversion and
muscle development. This has been achieved through not only improved husbandry and
nutrition, but also intense genetic selection for performance traits. The success of the broiler in
performance is marred by numerous health and welfare disorders. Recent studies put the
prevalence of birds with severe gait impairment anywhere from 5.5 to 48.8%. BCO is the most
common cause of severe leg disorders in broilers and a 2017 study found 28% of necropsied
birds from 20 commercial farms exhibited BCO lesions [1, 2]. Although lameness has shown to
be associated with BCO, it has also shown to not be a sufficient indicator of BCO as numerous
studies show incidence of BCO in sound/normal gait, unchallenged birds [3–6]. The greatest
threat of BCO is the subclinical birds. Currently, there is no method for diagnosing BCO in live
birds. Therefore, BCO has persisted in breeding programs and a portion of BCO affected birds
go undetected in commercial flocks. BCO has also become a serious welfare concern as it is
considered painful for the bird even when subclinical but especially when lameness is exhibited
[7, 8]. This concern is not only for the betterment of the birds, but also the success of producers
as lameness has increasingly become a measurement of welfare in audits of poultry producers
[9]. A better understanding of the mechanism behind BCO could provide targets for treatment
and prevention to improve overall production and welfare of the broiler.
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Overview of avian physiology involved in BCO
Bone structure/anatomy
Avian bone is a dynamic and complex tissue essential for not only overall growth of the bird, but
also for immune health, reproductive effectiveness, and proficient movement. The avian leg
consists of four bones, not including the metatarsals of the foot, and demonstrates avian skeletal
evolution. In birds, the tibia and tarsals have fused forming a tibiotarsus joined at the distal end
of the femur along with the fibula forming the knee joint. This fusion is also seen below the
ankle or “heel” joint where the tarsometatarsus is the result of fusion between tarsals and
metatarsals [10]. This fusion of the lower bones within the leg is what makes birds digitigrade,
meaning they walk on their toes. Fusion of bones is seen throughout the avian skeletal system
and aids in shock absorption from flight takeoff, landing, and running in the legs [10, 11]. The
proximal end of the femur joins the pelvic girdle at the acetabulum in an area known as the
trochanter of the femur. The distal end joins the patella and cnemial crest of the tibiotarsus
(hereafter referred to as the tibia) to form the knee joint [12].
The structure of the avian bone starts with an outer shell of cortical bone which surrounds the
marrow space and trabecular or cancellous bone. The trabecular bones have higher turnover rates
due to the increased surface area of their lattice-like organization [13]. Bone can either be
lamellar or woven, with lamellar being a combination of corticoid and cancellous bones. As a
mature form of bone, lamellar bone is deposited more slowly than woven bones, which is
deposited during healing processes and intramembranous ossification [14–16]. A single leg bone
has several regions starting with the largest section, the diaphysis which spans the center of the
bone and multiple bone sections. Within the diaphysis region, there is a medullary cavity which
develops from trabecular bone thinning and resorbing [3, 4]. Surrounding the medullary cavity is
8

endosteal bone leading into the metaphysis region above the diaphysis shaft of the bone toward
the proximal and distal ends. Here, the resorptive zone is where the trabecular bone is resorbed
and is surrounded by periosteal bone. The metaphysis region continues through a bone cell
calcifying zone until the growth plate or physis, where elongation of the bone occurs due to cell
division and maturation. Within the growth plate, the hypertrophic zone is followed by a
prehypertrophic zone, a proliferating zone and ends at a resting zone up against the epiphyseal
region consisting of a hyaline zone and articular cartilage cap [3, 4].
These zones and regions are often delineated by the vascular structures within them (Figure 1).
Unlike mammals, avian growth plates are highly vascularized and are primarily supplied by the
ischiadic artery and partly by the external iliac artery [10, 22]. Blood enters the bone in two
regions, the epiphysis and the diaphysis. In the epiphysis, the epiphyseal vascular supply travels
through epiphyseal canals through the hyaline zone or junctional canals through the hyaline zone
and down toward the growth plate. The terminal branches of this vasculature form epiphyseal
vascular capillary complexes if they terminate within the hyaline zone or penetrating vascular
capillary plexus if they are penetrating epiphyseal vessels traveling through junctional canals
ending at the growth plate. The penetrating vascular capillary plexus brings blood to the resting,
proliferating, and prehypertrophic zone within the growth plate and serve as direct physiological
links between the ever-shifting growth plate and the harder articular cartilage cap. In the
diaphysis region, the nutrient artery enters at the nutrient foramen and splits into ascending and
descending branches that continue to divide inside the diaphysis forming metaphyseal vessels
that penetrate the metaphysis (Figure 1). These vessels terminate as metaphyseal vascular
capillary plexus and bring blood to the calcifying zone. In addition to the vasculature terminating
in specific regions, there is some evidence that occasional or even putative transphyseal vessels

9

penetrate through both the hyaline cartilage and the entire growth plate although it also
resembles scar tissue left by retreating penetrating epiphyseal vessels. These conflicting
observations warrant further investigation into communication between arterioles and veins
within the physeal-metaphyseal interface [17–20].
Cell types and functions
The regions of the bone also correlate with differing cell types and stages of cellular maturation.
The major cell types that make up the mineralized connective tissue that is bone are osteoblasts,
lining cells, osteoclasts, and osteocytes [23–25].
On the surface of the bone, cuboidal cells, mature osteoblasts, derive from mesenchymal stem
cells of the bone marrow in which the commitment toward osteoprogenitor cell lineage requires
specific gene expression and synchronized synthesis of specific proteins [24, 25]. Osteoblasts are
primarily found in the areas of active bone formation as their primary function is to synthesize
components of the extracellular matrix in bone. To accomplish this, a complex arrangement of
osteoblasts in contact via adherens and gap junctions connect to microfilaments and enzymes
involved in intracellular secondary messenger systems [24]. Along with numerous secretory
vesicles, osteoblasts contain abundant rough endoplasmic reticulum and Golgi apparatus for the
purposes of protein synthesis, modification, and transportation during bone matrix formation
[25].
Osteoclasts differ from osteoblasts in several ways. Foremost, osteoblasts’ main function is of
bone resorption for the purpose of bone remodeling in times of growth or mechanical stressors
[24]. Additionally, osteoclasts are terminally differentiated multinucleated cells with origins
from mononuclear cells in the hematopoietic stem cell lineage [25]. The commitment of
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hematopoietic stem cells is influenced by multiple factors, some of which are secreted by
osteoblast and osteoprogenitor mesenchymal cells. This relationship to osteoblasts, as well as
others, constitutes the balance of bone resorption and formation needed for effective remodeling
of the skeletal structure due to growth, metabolic needs, or in response to mechanical stressors.
Osteoclasts are also highly secretory cells which form either denovo multinucleated osteoclasts
through fusing together or a precursor pool by remaining mononuclear cells for future
recruitment. During bone remodeling, osteoclasts polarize and have four distinct membrane
domains, two of which are in contact with the bone matrix, the sealing zone, and ruffled border.
These domains only form when osteoclasts are in direct contact with extracellular mineralized
matrix and result in depressions known as Howship’s lacunae due to resorption [24, 25].
When neither bone resorption nor formation is occurring, flat, elongated cells called lining cells
cover the surface of bone and are considered post proliferative osteoblasts. The lining cells act as
a barrier preventing osteoclasts from contacting bone matrix and beginning resorption. Within
the bone, osteocytes make up most of the cells found in bone and are defined by their location in
the bone and morphology. Their dendritic morphology is elongated in cortical bone and rounded
in trabecular bone. Osteocytes are “entrapped osteoblasts” incorporated in the matrix. These cells
make up the majority of the diaphysis region in the bone and contribute to the remodeling of
bone within the shaft.
The metaphysis and growth plate regions contain cellular structure and cell types responsible for
longitudinal growth. Longitudinal growth is accomplished through endochondral ossification
which involves the replacement of the cartilage within the growth plate with bone tissue.
Chondrocyte cells are the most prominent cell within cartilage and secrete most of the
components in the cartilage extracellular matrix. Cartilage extracellular matrix consists primarily
11

of aggregates of aggrecan and glycosaminoglycan hyaluronan all packed among collagen type II
fibrils [26, 27]. These components contribute greatly to growth through not only mechanical
stability, but also the ability of the growth plate to withstand compression [28]. The zones within
the growth plate and metaphysis region correspond to the stages of chondrocyte hypertrophy, cell
growth, and proliferation, cellular division. Immature chondrocytes make up the resting zone of
the growth plate directly beneath the epiphyseal region. Below the resting zone is the
proliferating zone were post-hypertrophic chondrocytes proliferate before entering the prehypertrophic layer. After prehypertrophic, enlarged chondrocytes, hypertrophic chondrocytes
make up the hypertrophic zone which is nonvascular. The calcifying zone consists of
chondrocytes organized in columns in numerous cellular states. Within the calcifying zone,
chondrocytes become degenerative before undergoing apoptosis and subsequent calcification.
Also within the calcifying zone, metaphyseal vascular capillary plexus and metaphyseal vessels
run along either side of the chondrocyte columns. Once in the hypertrophic zone, extracellular
matrix separates the chondrocytes before they undergo ossification. Chondrocytes can also be
found in small amounts the hyaline cartilage of the epiphyseal region which is primarily
comprised of dense cartilage extracellular matrix [29]. The function for the articular cartilage,
found at the most proximal or distal end of the long bone, is to provide lubrication and decreased
friction for articulation of the joint and aid in transmission of weight [30].
Bone remodeling
The fast growth and abundant meat yield seen in the modern broiler may be the focus of
performance, but it is the rapid remodeling of skeletal structures that most contributes to growth
in any organism. In birds, bone remodeling is best known to occur in the medullary cavity to
provide calcium needed for eggshell formation [31]. However, in the modern broiler, selective
12

breeding has resulted in an accelerated early skeletal development along with rapid muscle
growth and weight gain. As early as 1950, researchers established the relationship between
weight gain and skeletal development with over 98% of the variability in femur length
attributable to weight [32]. In 1997, it was determined that as weight increases, bone remodeling
escalates leading to thicker bone [33]. In particular, the modern broiler’s leg bones have a
distinctly rapid rate of elongation via growth plates and expansion via remodeling of the cortical
bone. The long bones in the modern broiler increase four-fold in length and three- to five-fold in
mid shaft diameter within 6 weeks of age [34].
In addition to the rapid growth, longitudinal bone growth continues in broiler breeders until 25
weeks of age and broilers reach market weight within 5–8 weeks [16]. This indicates that broilers
do not reach a stage of homeostasis and remodeling but instead undergo development of bone
through endochondral ossification while simultaneously reaching peak muscular growth within
their short lifespan. Bone elongation and endochondral ossification occur due to chondrocyte
proliferation and hypertrophy along with extracellular matrix secretion [28]. Proliferating
chondrocytes are responsible for new growth and secrete large aggregating sulfated
proteoglycans, including aggrecan, and become embedded in fibers consisting of primarily type
II collagen [35–37]. These components, along with many other, including growth factors,
cytokines, and prostaglandins, make up the extra cellular matrix which encases proliferating
chondrocytes. As they mature, the secretions and morphologies of the chondrocytes change and
become hypertrophic chondrocytes, enlarging and eventually undergoing terminal differentiation
[38, 39]. Secretions of collagen type X, in addition to type II, along with fibronectin, annexin,
and small molecular proteoglycan components such as decorin and byglycan are produced by
chondrocytes within the hypertrophic zone [40–42]. There is also a high level of alkaline
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phosphatase activity within this zone that is associated with mineralization. Mineralization
occurs in the epiphyseal plates and is regulated spatially and temporally [35]. Aging
chondrocytes that have used up all remaining glycogen begin to concentrate calcium via their
mitochondria. The mitochondria simultaneously shift to anaerobic metabolism along with
changes in oxygen tension and glycolytic enzymes [43]. Matrix vesicles containing alkaline
phosphatase, phosphatidyl serine, a complex of calcium and phosphorus, and annexins II, V, and
VI are shed by the hypertrophic chondrocytes [44–46]. The complex acts as the nucleation site
for calcification, while annexins are collagen binding, acting as anchors to the extra cellular
matrix and mediating calcium influx into the vesicles [45, 47]. The inclusion of zinc and copper
into the matrix vesicles is thought to aid in maintaining an undefined shape of the mineral until
hydroxyapatite crystallization is initiated [45, 48]. The initiation occurs within the vesicles and
ultimately ruptures the vesicle to begin growth along the collagen type I fibers that were
previously synthesized by the hypertrophic chondrocytes [39]. Studies have shown that some
chondrocytes secrete angiogenic factors like vascular endothelial growth factor and stimulate
invasion of the vascular system into the cartilage matrix [49, 50]. The vasculature that invades
the cartilage simultaneously brings osteoblasts to initiate bone formation through binding to the
mineralized cartilage matrix and secretion of components of osteoid which provides the
crosslinking for hydroxyapatite crystals to grow along [25, 51]. As the osteoid is laid and bone
forms, vessels which previously supplied areas of new growth must retreat timely to allow the
transition of tissue within the bone and maintain blood supply to the new regions of growth. The
retreat of epiphyseal vessels from the growth plate during growth results in eosinophilic streaks
which were once thought to be means of communication between epiphyseal and metaphyseal
vessels across the growth plate [20].
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Physiologically, bone remodeling is regulated and influenced by several growth and metabolic
pathways related to nutritional state, weight, and age. Growth hormones are some of the key
factors influencing proliferation of chondrocyte cells in the proliferation zone of the growth
plate. Thyroid hormones regulate fibroblast growth factor receptor signaling during
chondrogenesis [52]. Endochondral ossification is regulated by several transcription factors
including runt-related transcription factor 2 (RUNX2) and Osterix (SP7) [53]. RUNX2 has a
connection with chordate, channel-forming protein known as Pannexin 3 (PANX3) in osteoblasts
and chondrocytes. Pannexins are homologous to invertebrate gap junction proteins known as
Innexins [54–58]. PANX3 has been shown to form hemichannels that may be required for the
differentiation of hypertrophic chondrocytes to osteoblasts in late stage bone growth [59].
Fibroblast growth factor receptors (Cek1, Cek2, Cek3, and FREK) are present in proliferating
chondrocytes and known to be key regulators of endochondral bone growth. Fibroblast growth
factor ligands (FGF-2 and FGF-4) are present in the epiphyseal growth plate and have been
shown to stimulate chondrocyte proliferation [60]. Nutritionally, polyunsaturated fatty acids of
the n-3 series (n-3 PUFAs) have shown beneficial effects on bone formation such as stimulation
of osteoblast function in cell-culture studies and fish oil is often fed to improve bone growth and
as a preventative to certain leg disorders. Calcium, phosphorus, and vitamin D are also fed to
broilers to improve and aid in bone formation since both minerals are needed in abundance and
vitamin D3 acts on both osteoblasts and chondrocytes and stimulates production of osteoclasts
all for bone remodeling [61, 62].
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Current theories on the pathogenesis of BCO and modeling BCO
Tissue damage and bacteria infection
The BCO pathogenicity has been extensively studied, starting in the 1930s with hypotheses
surrounding routes of infection by bacteria [63]. The causative route of infection that leads to the
bacterial colonization of BCO has been the focal point for many studies and been hypothesized
to be through wounds and abrasions on the feet and skin, insect bites, nasal cavity adhesion of
particular Staphylococcus strains, latent staphylococci being triggered by stressful rearing
conditions, the blood, and mechanical damage or a disease state that favors bacterial colonization
[63–71]. The use of “floor eggs” has also been implicated in the development of BCO through
exposure to feces in the litter resulting in increased bacterial infection of staphylococcal strains
compared to chicks hatched from eggs in the nest boxes. This coincided with increased incidence
of BCO in floor-egg-hatched birds [72].
In an attempt to develop an experimental model of BCO, these potential routes of infection were
further investigated and utilized. In the case of respiratory transmission, aerosol inoculation with
causative bacteria was investigated as a model for BCO. Aerosol inoculation has been both
successful and unsuccessful at inducing osteomyelitis, but has proven to be dependent on other
factors such as simultaneous viral infection and virulence factors of bacterial strains used [68,
70]. However, a successful model using aerosol found that slow-growing genotypes were
unaffected by aerosol inoculation [72].
In 1973, it was shown that intravenous injections of Staphylococcus aureus resulted in
osteomyelitis lesions matching the spontaneous disease in turkeys [73]. In the continued search
for an effective experimental model, this method was used in broilers, first as a model of
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osteomyelitis in infants, and later for BCO [74–76]. The success of this model indicates that
BCO is a result of bacterial infection via the growing ends of metaphyseal blood vessels within
the growth plate in the hypertrophic region responsible for longitudinal growth of the bone. The
attenuated endothelium of the capillary tips of these blood vessels are known to be fenestrated
and often discontinuous and believed to provide the contact point between bacteria in the blood
stream and the cartilage matrix [20, 77]. Spread of bacterial infection has been hypothesized to
be due to transphyseal blood vessels which connect the metaphyseal and physeal vessels to the
epiphyseal vessels within growing broilers [75].
An immunosuppression and stress-mediated model for inducing BCO has also been investigated
and shown successful. Immunosuppression has been implicated in commercial outbreaks of BCO
[68, 70, 72, 78–82]. In 2012, Wideman and Pevzner successfully induced spontaneous BCO
through dexamethasone injections, a synthetic glucocorticoid, and a model already proven to
induce turkey osteomyelitis complex. Also, in 2012, Wideman developed a wire flooring model
for spontaneously inducing BCO in boilers without the use of bacterial or glucocorticoid
injection. This model works under the hypothesis that fundamental weakness at the
cartilagegrowth plate junction, coupled with mechanical stressors, in the form of unstable footing
on wire floors, leads to chondrotic cleft formation, or “wound sites” [3, 4]. These wound sites
expose the cartilage matrix to opportunistic, collagen binding bacteria and often intersect blood
vessels within the growth plate leading to exposure to circulating bacteria and areas of decreased
blood flow [3, 4]. This model also is believed to spontaneously induce immunosuppression
through stimulating chronic stress by depriving birds’ access to floor liter [4, 83]. The ability to
spontaneously induce BCO without introducing a specific bacterium gives the wire-flooring
model better mimics commercial environments as numerous opportunistic bacteria have been

17

identified in BCO affected tissue, which will be discussed in more detail in the proceeding
section. The efficacy of this model is further supported by physiological studies of broiler bone
remodeling and growth rates.
In the modern broilers, bone remodeling, as previously described, occurs at a rapid rate.
Applegate and Lilburn demonstrated how the length of the femur and tibia in the modern broilers
increases approximately four-fold along with the diameter of the mid-shaft increasing anywhere
from three- to five-fold within the first 6 weeks post-hatch [34]. Broiler’s rapid growth has been
extensively documented. Along with the proclivity of broilers to develop lameness when
compared to egg laying breeds [21, 84–89]. A recent RNASeq study sampled 42-day-old male
broilers with separation of the articular cartilage cap from the growth plate and “initial,” nonnecrotic BCO lesions in both tibias as an affected group and attached cartilage cap and absence
of lesions as unaffected. The results showed osteochondral genes downregulated in BCO
affected tibia compared to unaffected bone. One-twenty nine downregulated genes were
investigated and found to be associated with nine biological processes involving skeletal system,
connective tissue and cartilage development along with organ and skeletal system
morphogenesis [90]. Similar findings were found in a RNASeq study of the femur head,
specifically femur head separation (FHS). With similar sampling parameters, 160 downregulated
and 154 upregulated genes were found in FHS affected birds and associated with biological
processes such as cell adhesion, extracellular matrix, bone development, blood circulation, lipid
metabolism, cell death, and immune response [91]. These findings further support the hypothesis
that a structural weakness at the growth plate epiphyseal cartilage junction leads to a
predisposition to wound sites and bacterial infection seen in BCO. This would suggest that
bacterial infection is secondary and corresponds with a late, necrotic stage of BCO.
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Current identified causative agents and potential underlying mechanisms in BCO
The bacterial component of BCO has been associated with development of necrotic bone and
subsequent lameness in the modern broilers. The most commonly found bacterium associated
with BCO is Staphylococcus aureus. However, numerous opportunistic bacteria have been
identified including Staphylococcus hyicus, Staphylococcus xylosus, Staphylococcus simulans,
Staphylococcus agnetis, Mycobacterium avium, Salmonella spp., E. coli, and Enterococcus [82,
92–94]. These bacteria are often in mixed cultures and form complex microbial communities in
bone, including bone that appears to be normal [4, 95]. Studies of these communities have found
that microbial communities differ from the tibia to the femur as well as among severity of
lesions. In the presence of BCO lesions, the microbial community is comprised of primarily
Staphylococcus, Enterobacter, and Serrotia indicating that BCO is associated with decreased
microbial diversity in the bone [4, 95].
The genus Staphylococcus is a Gram-positive, halotolerant bacteria that are prevalent on skin and
mucosal surfaces [96]. Staphylococcus aureus is the most pathogenic species within the genus
and is the only species that produces a protein called coagulases which affect fibrinogen [96]. S.
aureus has been well studied in the case of osteomyelitis and has been found to be one of the
most prevalent in avian BCO. Another member for the Staphylococcus genus that has been
associated with BCO is Staphylococcus agnetis. The S. agnetis 908 strain was successfully
isolated from BCO affected birds, and its genome has been investigated for virulence factors
affecting its pathogenicity [97, 98]. S. agnetis 908 has also been used in in vitro models for BCO
using bone cells [99]. Staphylococcus species are known to incite bone destruction, soft tissue
inflammation in the surrounding area, and spread throughout the bloodstream. S. aureus invades
and persists within osteoblasts causing physiological changes that promote bone resorption. Bone
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resorption is promoted through increased expression of the osteoclast-activating molecule
receptor activator of NF-KB ligand (RANK-L) and pro-inflammatory cytokines. In a second
mode of favoring bone resorption, S. aureus within osteoblasts results in cell death. The specific
mechanism for cell death is not fully understood; however, microcomputed tomography of BCO
affected femurs showed that the bacterial regulatory locus of S. aureus Sae was critical to
pathogenesis. Sae-regulated factors not only favor bacterial survival within the bone, but also
promote pathological bone remodeling [100]. Osteoblast cell death and bone destruction are
triggered by aureolysin, which is a Sae-regulated secreted protease that self-activates when
secreted and initiates the proteolytic activation cascade [100, 101]. S. aureus also produces
toxins such as poreforming toxins (PFTs), α-toxins, and leukotoxins designed to avoid
elimination by host defense using different mechanisms [102,103]. Leukotoxins act in both a
receptormediated and receptor-independent manner to target white blood cell lysis [102]. PFTs
not only disrupt membrane barriers of eukaryotic cells to cause host cell lysis, but also exert
subtle changes to cell activity and physiology through toxin receptors [103].
The role of the bacterial communities in the pathogenicity of BCO in the avian species is
unclear. The presence of communities in healthy bone as well as the spontaneous development of
BCO on wire flooring, as well as RNASeq showing differentially expressed genes involved in
cartilaginous and skeletal development, point to a need for bone abnormalities to be present for
the bacterial effects to take hold. Regardless of the specific role bacteria play on BCO of the
modern broiler, opportunistic bacteria overwhelm the mechanically and/or metabolically stressed
femoral head of the growth plate leading to decreased bacterial diversity and severe necrosis of
the bone.
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Mitochondrial dysfunction and disease
The mitochondria are organelles found in almost every eukaryotic cell and are responsible for
not only energy production, but also a cell death regulator [104], with some of the key pathways
illustrated in Figure 2. Functioning mitochondria can change their shape, position, and number
within the cell in order to facilitate numerous cellular processes including calcium signaling,
cellular proliferation and differentiation, thermogenesis, and cell death [105, 106]. This is done
through three major facets of mitochondria: mitochondrial biogenesis, function, and dynamics
(fission or fusion) [107]. These three facets work harmoniously in healthy cells and their
dysregulation has been implicated in numerous diseases and disorders and termed mitochondrial
dysfunction.
Mitochondrial dysfunction can be defined as alterations in the function of the electron transport
chain, the maintenance of the electrical and chemical transmembrane potential or a decrease in
the transport of metabolites into the mitochondria [108]. This dysfunction leads to reduced
oxidative phosphorylation efficiency and subsequently reduced adenosine-5′-triphosphate (ATP)
(Figure 2). Mitochondrial efficiency and function are dependent on a balance of mitophagy and
biogenesis [107, 109]. Biogenesis and other mitochondrial processes are controlled and
conducted by proteins encoded by both nuclear and mitochondrial genomes [109]. Proteomic and
genomic analysis has shown that the mitochondria are comprised of over 1,000 proteins with the
number varying between species [110, 111]. Mitochondrial biogenesis not only results in
variations in mitochondrial number but also size and mass [109]. The transcription cascade of
mitochondrial biogenesis is regulated by numerous transcription factors including PGC-1α
(peroxisome proliferator-activated receptor-γ coactivator-1α), nuclear respiratory factors (NRF1
and NRF2), and mitochondrial transcription factor A (Tfam). Biogenesis is stimulated through
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PGC-1α through cold exposure and exercise and its dysregulation has been shown in disease
states [112–114].
Mitochondria are dynamic organelles that divide and fuse to meet the metabolic and stress needs
of the cell. Mitochondrial fusing (fusion) and division (fission) counteract aging through
completion of gene products after fusion of impaired mitochondria and acts as organelle quality
control by dividing and removing damaged mitochondria and is also a step in apoptosis [115,
116]. Fusion of mitochondria mitigates stress through mixing damaged components as a form of
complementation and fission enables removal of damaged mitochondria as well as apoptosis at
high levels of cellular stress [116]. Fission is mediated by cytosolic dynamin family member
(Drp1/ Dnm1) which is recruited by MFF1 (mitochondrial fission factor) and then fission is
supported by mitochondrial fission process 1 (MTFP1), a protein found of the inner membrane
[117–119]. Mitochondrial fission regulator 1 protein (MTFR1) not only regulates fission, but
also been shown to regulate antioxidant activity in vivo [120,121].
Mitochondrial function involves the efficiency of oxidative phosphorylation, through
maintenance of mitochondrial membrane potential and ATP-producing machinery, and the
absence of mitochondrial DNA (mtDNA) damage. Dysfunction of oxidative phosphorylation
leads to oxidative stress as reactive oxidative species accumulates which can lead to mtDNA
damage and dysfunction, as well as apoptosis [122, 123]. Decreased production of ATP through
loss of mitochondrial basic functions leads to activation of AMP-activated protein kinase
(AMPK) signaling which stimulates biogenesis through PGC-1α [124]. All mitochondrial
processes work cooperatively to meat metabolic demands and adapt or respond to environmental
stressors and without this cooperation and function, disease states can be reached.
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Mitochondrial dysfunction has been found to underly more than 50 inborn errors of metabolism
[125, 126]. In the broiler, mitochondrial dysfunction has been implicated in pulmonary
hypertension syndrome (ascites), heat stress effects, high dietary copper effects, and ammonia
inhalation damage to the bursa of fabricius [127–132]. Growing evidence of its implications in
the etiologies of several diverse diseases, including type 2 diabetes, neurodegenerative diseases
such as Alzheimer’s, and cancer, point to the farreaching effects of the mitochondria on cellular
processes in all tissues [133–135]. Type 2 diabetes is one of the most common conditions
associated with osteomyelitis and often occurs in the foot of type 2 diabetes patients [136, 137].
It has also been shown that chronic osteomyelitis increases the incidence of type 2 diabetes and
an estimated 60% of diabetic foot ulcers are infected and more than two thirds of diabetic
patients with foot ulcers have lower limb amputations due to infection [138]. Mitochondria are
key players in bone homeostasis through their involvement in regulation of stem cell
differentiation and maturation which occurs rapidly and in multiple cell types of growing bone.
As previously described, the maturation and ossification of chondrocytes is key to proper
cartilage and bone formation and mitochondrial damage has been linked to osteoporosis [36,
139]. The mechanism behind potential role mitochondrial dysfunction plays in bone related
diseases has not been fully investigated. In BCO, a study has shown ROS accumulation
coinciding with inflammasome activation in BCO affected tissue and in vitro model [92]. As
ROS is a key indicator of mitochondrial dysfunction and modern broiler bones demand
mitochondrial function during rapid growth, further investigation into this disease and
mitochondrial function is warranted. Mitochondrial dysfunction has become a key player in the
etiology of numerous metabolic and physiological diseases with far-reaching implications and
dynamic mechanisms.
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Conclusions and perspectives
The modern broiler’s high performance of growth and muscle development has pushed the
bounds of physiology to a point that is vulnerable to environmental stressors and disease. A
fundamental weakness in growth plate and cartilage junctions in fast-growing bone predisposes
broilers to circulating opportunistic bacteria and subsequent necrosis in what is described as
BCO. The mechanism of BCO is not yet fully understood although implications of
osteochondrotic genes in the pathogenicity of BCO coupled with mitochondrial involvement in
stem cell maturation warrants investigation into the potential role mitochondria play in BCO in
the modern broiler.
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Figure 1. Proximal head of growing bone. Epiphyseal vascular supply (ev); epiphyseal vascular
canals (ec); hyaline zone (hy); epiphysis (e); junctional canals (jc); growth plate (gp) or physis;
epiphyseal vascular capillary complexes (evc); penetrating epiphyseal vessels (pev) that terminate as
a penetrating vascular capillary plexus (pvp) supplying the resting zone (rz), proliferating zone (pz),
and prehypertrophic zone (phz); nutrient artery (ana) forms metaphyseal vessels (mv) within the
metaphysis (m) which then terminate as the metaphyseal vascular capillary plexus (mvp) supplying
the calcifying zone (cz); the diaphysis (d); hypertrophic zone (hz); transphyseal vessels (tp). This
figure was first published in Wideman RF, Prisby RD “Bone circulatory disturbances in the
development of spontaneous bacterial chondronecrosis with osteomyelitis: a translational model for
the pathogenesis of femoral head necrosis” in Frontiers Endocrinology, 2012 and was made through
references of original sources [17–21] (Wise and Jennings, 1973; Howlett, 1979, 1980; Duff, 1984;
Thorp, 1986; Ali, 1992; Farquharson and Jefferies, 2000).
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Figure 2. Mitochondrial dysfunction and its affects. Mitochondrial dysfunction in relation to
environmental and foreign stimuli resulting in numerous effects such as gene regulation, ATP
production, and cell survival. DAMP, damage-associated molecular partners; DRP1, dynaminrelated protein 1; Foxo, forkhead box O; NLRP3, NLR family pyrin domain containing 3; ROS,
reactive oxygen species
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Abstract: A leading cause of lameness in modern broilers is bacterial chondronecrosis with osteomyelitis
(BCO). While it is known that the components of BCO are bacterial infection, necrosis, and
inflammation, the mechanism behind BCO etiology is not yet fully understood. In numerous species,
including chicken, mitochondrial dysfunction has been shown to have a role in the pathogenicity of
numerous diseases. The mitochondria is a known target for intracellular bacterial infections, similar to
that of common causative agents in BCO, as well as a known regulator of cellular metabolism, stress
response, and certain types of cell death. This study aimed to determine the expression profile of genes
involved in mitochondrial biogenesis, dynamics and function. RNA was isolated form the tibias from
BCO-affected and healthy broilers and used to measure target gene expression via real-time qPCR.
Mitochondrial biogenesis factors PGC-1α and PGC-1β were both significantly upregulated in BCO along
with mitochondrial fission factors OMA1, MTFR1, MTFP1, and MFF1 as well as cellular respiration
related genes FOXO3 and FOXO4 and av-UCP. Conversely, genes involved in mitochondrial function,
ANT, COXIV and COX5A showed decreased mRNA expression in BCO affected tibia. This study is the
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first to provide evidence of potential mitochondrial dysfunction in BCO bone and warrants further
mechanistic investigation into how this dysfunction contributes to BCO etiology.

Key words: mitochondrial dysfunction, lameness, broilers, chondronecrosis, osteomyelitis, BCO
Introduction
Bacterial chondronecrosis with osteomyelitis (BCO) is a prominent cause of lameness in the
poultry industry which predominantly affects fast growing, large broilers. Lameness in modern
broilers poses both an animal welfare and a production concern as it has been shown that higher
incidence of lameness is associated with suboptimal environments leading to other associated
economic and health concerns including condemnations postmortem and footpad dermatitis [1].
In the case of BCO related lameness, points of high mechanical stress within the avian skeletal
system include the proximal femur head and are the most common areas for BCO to occur [2,3].
Histological changes in the proximal head of femurs affected by BCO show evidence of wound
sites within the epiphyseal region of the growth plate with clear chondronecrosis. These sites
often transect vasculature within the highly vascularized avian growth plate leading to decreased
blood flow to surrounding areas and an entry point for any circulating, collagen-binding bacteria
[2-4]. Numerous opportunistic bacterial species have been identified as causative agents in BCO,
the most common being Staphylococcus aureus [3,4]. It is unclear if wound sights develop
before bacterial infection occurs, but once infected, chondronecrosis is observed at varying
degrees. A study of the microbiome within chicken growth plates showed a decrease in the
diversity of bacterial communities in BCO affected femurs compared to normal with
Staphylococcus species predominating, indicating a shift in the make-up of the microbiome with
tissue damage and inflammation [5]. Research into mitigating BCO in large broilers has
primarily centered around probiotic and feed supplement treatments during production. While
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some of these supplements show to be promising, their proposed mechanisms target the bacterial
load or entry by either improving gut integrity or improving the overall immune system response
without fully investing the etiology of bacterial lead necrosis at the site of infection [6,7]. While
further investigation into management and nutritional preventions are valuable, an understanding
of the molecular mechanisms involved in BCO has yet to be elucidated and would provide
greater insight into treatment and prevention from both a management and potentially genetic
standpoint. Although the exact pathology of BCO is debated, the three major components of
BCO are clear, bacterial infection coinciding with attrition and inflammation of the bone.
The mitochondria play a pivotal role in energy homeostasis, bone growth and remodeling, and
host-cell response to bacterial infection [8]. Mitochondrial dysfunction can be a disruption in
mitochondrial biogenesis, ATP production/bioenergetics, mitochondrial fission and fusion
pathways, or mitochondrial driven cellular responses to stimuli such as environmental stress,
cellular damage, bacterial infection, and inflammation [8]. In the case of intracellular bacterial
infection, like that of S. aureus, the mitochondria is not only a bacterial target, but also a mode of
host-cell defense through accumulation of reactive oxidative species (ROS) [8,9]. Mitochondrial
dysfunction has been reported in neurological degenerative diseases such as Alzheimer’s and
Parkinson’s disease as well as metabolic diseases such as type 2 diabetes and associated
osteomyelitis [8, 11-13]. For these reasons, we sought to investigate the state of mitochondria in
BCO-affected bone of modern broilers. To that end, we assessed the expression of key regulatory
genes for mitochondrial biogenesis, dynamics, and function. Our results show, for the first time,
evidence of mitochondrial dysfunction in the form of increased mitochondrial biogenesis
coactivators and mtDNA, as well as increased expression of known fission regulators and
imbalance of gene expression for genes involved in cellular respiration and antioxidant response.
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Materials and Methods
Collection of BCO and Normal Bone Samples.
All animal experiments were approved by the University of Arkansas (Fayetteville, AR) Animal
Care and Use Committee (protocol number 15043) and were in accordance with
recommendations in NIH’s Guide for the Care and Use of Laboratory Animals. The BCO model
and healthy counterparts were conducted as previously described [3,4]. Cobb 500 males were the
same animals used previously [14]. Briefly, animals had ad libitum access to fresh water and
feed (3.9 Mcal metabolizable energy kg-1and 180 g crude protein kg-1) while the experiment took
place in the Poultry Environmental Research Laboratory at the University of Arkansas Poultry
Research Farm. Ambient temperature was lowered gradually from 32˚C to 25˚C by 21 days of
age. A light cycle of 23 hours light/1 hour dark was maintained along with an approximately
20% relative humidity until 56 days of age. At the end of the 56 days, animals were weighed,
humanely euthanized, and immediately necropsied to determine presence of subclinical lesions
in the proximal heads of both the femora and tibiae. Bone was selected macroscopically based on
previously reported scale (3,4). Normal bone was considered free of any necrosis or lesion and
BCO-affected bone consisted of bone which had either tibial head necrosis (THN) or severe
tibial head necrosis (THNs). Proximal portions of bone, primarily consisting of the growth plate,
from both affected and unaffected animals were snap frozen in liquid nitrogen and stored at 80˚C for later analysis.
Real-Time Quantitative PCR
From the normal and BCO-affected bone samples (N=6), total RNA was isolated in accordance
with the protocol of Carter et al [15]. Cellular RNA was isolated using Trizol reagent (Life
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Technologies, Carlsbad, CA), based on manufacturer’s instructions. RNA concentrations were
determined using Synergy HT multimode microplate reader and total RNA was reverse
transcribed using qScript cDNA SuperMix (Quanta Biosciences, Gaithsburg, MD).
Amplification was achieved using Power SYBRGreen Master Mix (Life Technologies, Carlsbad,
CA) and real-time quantitative PCR (7500 Real Time System; Applied Biosystems, Foster City,
CA). The sequences for oligonucleotide primers for r18s, av-UCP, ANT, NRF1, Ski, FOXO1,
PPARα, PPARγ, PGC-1α, PGC-1β, COXIV, COX5a, D-loop (mtDNA), SSBP1, TFAM, MFN1,
MFN2, DNM1, OPA1, OMA1, MTFR1, MTFP1, and MFF1 were previously published (16).
Novel primers used were FOXO3 (forward, 5’-GCTCCCGGACAAATTCGA-3’; and reverse,
5’-TCGCCAAAATCGGTGACAA-3’), FOXO4 (forward, 5’-CTGGGATACCGGGTCTTGAG3’, and reverse, 5’-GGCTATCTGTCGATTTGAGTAATGAA-3’), Keap1 (forward, 5’CGCCATCTGTTACAACC -3’; and reverse, 5’- GCGTAGATCCCGTCGAT -3’).
Real-time quantitative PCR cycling conditions were 50˚C for 2 minutes, 95˚C for 10 minutes and
40 cycles of a two-step amplification (95˚C for 15 seconds followed by 58˚C for 1 minute). The
dissociation protocol from the sequence detection system was used for melting curve analysis to
exclude potential contamination of non-specific PCR products. Negative controls that were used
as templates contained no reverse transcription products. Relative expression of target genes was
determined using the 2-∆∆CT method and healthy bone tissue or untreated cells were used as
calibrators [16].
Statistical Analysis
Data were analyzed by Student t-test using GraphPad version 7.03 (GraphPad Software, Inc.,
LaJolla, CA). Results are expressed as means ±SEM, with P-value < 0.05 set as statistically
significant.
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Results
Mitochondrial biogenesis-associated genes PGC-1α and PGC-1β were both significantly
upregulated in BCO affected tissue as well as mitochondrial displacement loop (D-loop) (P <
0.05, Figure 1 a, c, d). Mitochondrial transcription factor A (TFAM) and Ski followed a similar
trend although not significantly upregulated (Figure 1e, b). Single-stranded DNA-binding protein
1 (SSBP1) mRNA expression was not significantly different between healthy control and BCOaffected group (Figure 1f). Mitochondrial dynamics indicated several differentially expressed
genes including fusion related gene optic atrophy protein 1 (OPA1) expression being
significantly down regulated (Figure 2a). Mitofusin 2 (MFN2), another fusion regulatory gene,
was significantly upregulated, but MFN1 remained unchanged (P < 0.05, Figure 2b, c). The
fission related genes, including overlapping with the M-AAA protease 1 homolog (OMA1),
mitochondrial fission factor (MFF1) and mitochondrial fission regulator 1 (MTFR1), were not
significantly upregulated in BCO-affected tissue (Figure 2d, g, h). Although mitochondrial
fission process 1 (MTFP1) expression was decreased, it was also not statistically significant
(Figure 2e). Dynamin 1 (DNM1) expression was not affected (Figure 2f).
Gene expression was measured for regulators of mitochondrial function in ATP synthesis and
overall respiratory activity (Figure 3). The gene for adenine nucleotide translocator (ANT) as
well as cytochrome c-oxidase IV and 5A (COXIV, COX5A) were both significantly
downregulated in BCO-affected tibia which coincided with a significant upregulation of avian
uncoupling protein (av-UCP) (P <0.05, Figure 3a, b, c, d). Although Kelch-like ECH-associated
protein 1 (Keap1) and Forkhead box O3 and 4 transcription factors (FOXO3 and FOXO4) were
not significantly upregulated in the case of BCO, they followed a similar positive trend (Figure 3
e, h, i). Peroxisome proliferator activated receptors α and γ (PPARα and PPARγ) as well as
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nuclear factor erythroid 2-related factor 1 (NRF1) were nonsignificant, but upward trending
(Figure 3 f, j, k).
Discussion
The role of mitochondria, its biogenesis, dynamics, and function, in disease states has become
increasingly more poignant in the research community. In human disease, mitochondrial
dysfunction, in the form of mtDNA mutations or disruption in overall mitochondrial biology, has
been implicated in diabetes, Parkinson’s disease, Alzheimer’s disease, dementia, coronary artery
disease, chronic fatigue syndrome, and ataxia [8-13,18]. In broiler (meat-type) chickens, research
has shown evidence of mitochondrial dysfunction related to susceptibility to ascites and to be
influenced by orexin in broiler muscle [19,20]. Mitochondria are also direct targets for some
bacterial infections including Staphylococcus aureus, one of the most common causative agents
in BCO [9, 21]. Mitochondrial dysfunction is believed to be associated with so many disease
states due to its relation to apoptotic and inflammatory pathways [10]. This study found evidence
of mitochondrial dysfunction in the form of biogenesis regulation, fission or fractionation, and
potential disruption of oxidative pathways.
Transcriptional control of mitochondrial biogenesis is heavily regulated via PGC-1α and PGC-1β
[22]. These coactivators both target transcription factors as well as act as targets for gene
expression in mitochondrial biogenesis pathways [23]. Extracellular signals such as metabolic
changes and cell growth are known to modulate their expression, and upregulation of PGC-1α
has been shown to coincide with increased mitochondrial biogenesis and respiration in
inflammatory states [24,25]. In BCO-affected tissue, both PGC-1α and PGC-1β were
significantly upregulated along with a nonsignificant but increased trend of TFAM. This
increased expression suggests potential inflammatory or metabolic stressors influencing
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increased mitochondrial biogenesis to offset deleterious effects of these states. D-Loop, a
measurement of mtDNA, was also significantly upregulated, indicating an increase in
mitochondrial DNA in BCO tissue [26]. Although the state and quality of the mtDNA is not
known, increased expression of key co-activators, along with increased mtDNA, could point to
increased mitochondrial biogenesis in the presence of BCO. Since BCO is a known bacterial
infection, its inflammatory response could be the cause in increased need for mitochondria as
ROS accumulation and metabolic shifts occur. SSBP1 has been shown to regulate mitochondrial
mass in cancer states and to be involved in DNA damage response pathways [27]. SSBP1
expression was not significantly altered in BCO compared to healthy tibia. SSBP1 being not
affected decreases the possibility that DNA damage repair is needed in BCO or that
mitochondrial production is needed not just an increased mass of mitochondria.
Mitochondria are dynamic organelles with their shape and size shifting in response to numerous
stimuli to maintain homeostasis or alter cellular energy states [28]. Mitochondrial fusion is a
state in which separate mitochondrial organelles fuse into a larger network and is often seen
during stress conditions as it has the capacity to partially mix damaged mitochondria for
complementation [28,29]. OPA1 is a key component of mitochondrial fusion found in the inner
mitochondrial membrane and its knock down has resulted in blocked mitochondrial fusion and
cellular defects including decreased cellular respiration and heterogeneity of mitochondrial
membrane [29]. In an ascites susceptible selected line of broilers, OPA1 expression was shown
to decrease under ascites conditions in the lungs, thigh, and breast compared to an ascites
resistant selected line (19). In BCO, significant decrease in OPA1 mRNA expression was
observed although MFN2 was upregulated. Mitofusins (MFN1 and MFN2) are found on the
outer mitochondrial membrane and also are necessary for mitochondrial fusion. However,

45

without OPA1, the inner membrane is unable to fuse and the membrane potential can be
implicated [29]. This demonstrates that there exists a potential pathway of mitochondrial
dysfunction via interruption of inner membrane fusion through OPA1 dysregulation in BCO.
This dysregulation could be due to a shift in cell death pathways in which fracturing of the
mitochondria is a key component, or it could be the result of mitophagy as dysfunctional
mitochondria are processed by the cells via fractionation [30]. The decrease in OPA1 expression
was coupled with a trending increase expression of OMA1, a regulator of mitochondrial fission
via “cutting” OPA1 at specific sites to render it inactive [31,32]. Mitochondrial fission enables
the removal of damaged mitochondria through fragmentation when complementation via fusion
is no longer possible, but also facilitates apoptosis in response to high levels of cellular stress
[32]. Although none were statistically significant, all fission gene expression followed a positive
trend and analysis of protein expression could further elucidate the potential role of these genes.
This increased expression of fission related genes further supports a cellular shift towards fission
of mitochondria rather than fusion and suggests a potential state of mitochondrial turn-over in
response to the high cellular stress during BCO. MTFR1 overexpression has been shown to
promote mitochondrial fission [33]. MTFP1 overexpression has been linked to increased ROS
production and it has been shown to aid in mitochondrial recruitment of DNM1 along with
MFF1 [34-37]. These results show a decreased expression of a significant inner membrane
fission factor OPA1 and point to potential fission/fragmentation of mitochondrial networks in
BCO. Further research is needed to understand the potential impacts of this fission favored state
in relation to BCO pathogenicity and whether it is a response to bacterial infection or a result of
cellular removal and repair of necrotic tissue [37].
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The main function of the mitochondria is to produce ATP for the cell. This is done through
oxidative phosphorylation via the electron transport chain. Mitochondrial membrane potential as
well as function cytochrome-c complexes are necessary for ATP production [38-41]. Key
proteins in this process, including ANT, COXIV, and COX5A, were significantly down
regulated in BCO affected tissue. Conversely, av-UCP, an uncoupler of ATP production via
movement of hydrogen ions across the mitochondrial inner membrane without ATP production,
was significantly upregulated in BCO [42,43]. Av-UCP has been shown to be upregulated by
pro-inflammatory cytokines such as interleukin 6 (IL-6) and tumor necrosis factor α (TNFα) via
the transcription factors PGC-1α and PPARs [42]. This imbalance of gene expression when
compared to unaffected tissue points to potential dysfunction in ATP production in BCO via
uncoupling of ATP production a potential loss of respiratory machinery and transporters such as
COXIV and ANT. Beyond the machinery directly needed for ATP production, increased FOXO3
expression, although not significant, indicates possible reduction of respiratory activity through
its repression of nuclear encoding mitochondrial genes [44]. FOXO4 is a known activator of
antioxidant genes, suggesting potential increased ROS as cellular respiration is impaired [45].
PPARα and PPARγ were slightly upregulated, however not significant. PPARs are involved in
mitochondrial function and have been implicated in diabetes-related mitochondrial dysfunction
[46,47]. Overall, mitochondrial ATP production could be affected in BCO via increased av-UCP
as an inflammatory response and decreased expression of mitochondrial transport proteins. This
decreased in genes needed for proper mitochondrial ATP production could also be the result of
mitochondrial turnover, as indicative of the fission pathways being activated in BCO. Whether a
cause for or result of mitochondrial turnover, gene expression suggests dysregulation of ATP
production pathways in BCO affected tissue.
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Taken together, these results are the first to implicate potential mitochondrial dysfunction with
BCO in modern broilers. Based on the expression of key mitochondrial related genes in BCO
affected bone, upregulation of mitochondrial biogenesis, a known stress response, as well as
mitochondrial fission pathways indicate latent mitochondrial turn over or fractionation coupled
with disruption of ATP production machinery and transporters. More research is needed in order
to elucidate the relationship between mRNA and protein expression in BCO as well as potential
varying gene expressions in the severity of lesions or progression of BCO. In the future, a cell
model of BCO would need to be developed in order to investigate and demonstrate the effects of
differentially expressed genes on the pathogenicity of BCO including mechanisms of cell death
and the extent of bacterial involvement.
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Figure 1. Mitochondrial Biogenesis
RT-qPCR results for a measurement of mitochondrial DNA, D-loop (a) as well as mitochondrial
biogenesis regulators Ski (b), PGC-1α (c), PGC-1β (d), TFAM (e), and SSBP1 (f). Student t-test
was conducted with significance set at p-value < 0.05. * indicates significant differences between
Control and BCO groups.
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Figure 2. Mitochondrial Dynamics
Gene expression for genes regulating mitochondrial fusion, OPA1 (a), MFN1 (b), MFN2 (c), and
fission, OMA1 (d), MTFP1 (e), DNM1 (f), MTFR1 (g), MFF1 (h). Significance was determined
using a student t-test with p-value < 0.05. * indicates significant difference between Control and
BCO expression.
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Figure 3. Mitochondrial Function
Gene expression for genes regulating mitochondrial function, ANT(a), COX5A (b), COXIV (c),
av-UCP (d), Keap1 (e), NRF1 (f), FOXO1 (g), FOXO3 (h), FOXO4 (i), PPARα (j), and PPARγ
(k). Significance was determined using a student t-test with p-value < 0.05. * indicates
significant difference between Control and BCO.
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Methodology: Data for this review was compiled using databases such as NCBI PubMed,
University of Arkansas Library Quick Search, run by WorldCat, Science Direct, and JSTOR.
Search terms used included “autophagy”, “autophagy and bone”, “autophagy stages”, “bacterial
infection and autophagy”, “skeletal diseases and autophagy”, “cell survival and autophagy”,
“macroautophagy”, “autophagy manipulation”, autophagy dysregulation”, “staphylococcus
infection and autophagy” and “skeletal growth and autophagy”.
Abstract: Since its discovery, autophagy has proven to be influential in numerous physiological
processes and states, including growth, stress, disease, and infection, for various cell types. After
decades of research, novel roles for autophagy are still being found as the intricacies of the
autophagy pathway and the balance between degradation and survival are explored. For the
skeletal system, autophagy promotes bone growth through facilitating cell differentiation and
survival within the ossifying bone. Under certain bacterial challenges, cells rely on autophagy for
targeting and degrading pathogens and their secretions. Yet, cells can fall prey to bacterial means
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of autophagy manipulation or hijacking, resulting in persistent infection and potential cell death.
In this review, the molecular mechanisms of autophagy will be explained along with autophagy’s
role in the skeletal system. Furthermore, insights into the role of autophagy in skeletal diseases
and bacterial infections will be explored as well as considerations for future areas of research
where these physiological states overlap.
Introduction
The maintenance of body tissue and organs involves the function and collaboration of several
different cell types along with appropriate response to environmental stimuli such as stress,
disease, and infection. Autophagy is a means of cellular recycling that has a diverse and broad
range of purposes. In bone tissue, autophagy facilitates cell differentiation in order to maintain
the ratios of cell types needed for proper bone growth, healing, and turn-over. Under normal
conditions, it used for the regular maintenance of needed protein turn-over and degradation. In
disease states, or under bacterial challenge, the role of autophagy becomes more complex. If
balanced properly, autophagy promotes cell survival and aids in immune response. However, if
dysregulated, autophagy can be a means of bacterial proliferation and cell death stimulation. It is
for these reasons that investigation into the role of autophagy in bacterial infections of the bone
is worth pursuing.
Overview of Autophagy
Autophagy is a mechanism for the maintenance of cellular homeostasis whose name is derived
from the Greek words “auto”, meaning self, and “phagy”, meaning eating. Through its
involvement in both cell survival and death pathways, autophagy is a key component of a cell’s
reaction to different external and internal environmental stimuli. It was first discovered in 1955
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when biologist Christian de Duve recognized organelles containing hydrolytic enzymes and
dubbed them lysosomes [1 – 2]. Simultaneously, Novikoff and colleagues were capturing
electron microscopy images of dense intracellular bodies containing components of the
cytoplasm [2]. Both researchers had found evidence of a portion of the process now called
autophagy and their findings catalyzed decades of research undertaken to understand and
investigate autophagy. It is now understood that autophagy is a degradation process for cellular
components, organelles, and various molecules. Its function is that of maintaining homeostasis
via endogenous and exogenous waste disposal or the breakdown of entire cellular
organelles/components if damaged or faulty [3].
The autophagy pathway is activated via several stimuli, including, but not limited to, amino acid
starvation, endoplasmic reticulum and heat stress, changes in hormone levels, and infectious
pathogens [4 – 10]. These stimuli involve a variety of autophagy modulators to achieve
activation and therefore result in differing cellular consequences due to the numerous and diverse
signaling pathways involved. For example, in chicken, autophagy is shown to be partially
regulated by leptin signaling in a tissue specific manner [11]. A disruption in the autophagy
mechanism or its modulators has been shown to have pathological consequences which will be
discussed in more detail in this review [3]. A synopsis of the different types of autophagy can be
seen in Figure 1 and will be elaborated on in the proceeding section.
Types of Autophagy
Autophagy can be further defined by the cellular components it targets, or the mechanism by
which it performs membrane development and lysosomal degradation. This characterization
results in the many types of autophagy such as macroautophagy, microautophagy, and chaperone
mediated autophagy.
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Macroautophagy
If large cellular contents and cytoplasm, such as aggregated proteins, damaged organelles, and
intracellular pathogens, need to be degraded, macroautophagy is the major pathway involved
[12]. There are four stages to macroautophagy, initiation, nucleation, elongation, and fusion
(Figure 1a) [12]. During the initiation stage of macroautophagy (Figure 1a), a doublemembraned, crescent-shape phagophore forms, isolating the components [13]. Nucleation allows
the sequestering of proteins needed for phagophore growth and maturation during elongation.
Fusion between the lysosome, which contains lysosomal enzymes capable of degradation, and
the autophagosome is the final stage in macroautophagy [13]. This process has been described as
either non-selective or cargo specific depending on the components, receptors, and stimuli
involved [14].
A type of macroautophagy that is specific to the organelle it degrades is mitophagy. In this
process, the mitochondria is the specific target via specific outer mitochondrial membrane
proteins [14]. Mitophagy occurs primarily when there is a decline in the demand for metabolic
capacity or when the mitochondria is damaged [15].
This review will primarily focus on macroautophagy (called autophagy from now on) its stages,
key proteins and regulators, and its role in physiology and disease.
Microautophagy and Chaperone Mediated Autophagy
Lysosomal fusion with a pre-formed and matured autophagosome is not the only means by
which cellular components can be degraded. Chaperone-Mediated Autophagy (CMA) is a
selective form of autophagy involving only proteins with a C-terminal pentapeptide KFERQ
motif. The HSP70 cochaperone identifies these proteins in the cytoplasm and delivers them to
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the lysosome (Figure 1b). There, a receptor allows for translocation of the protein into the
lysosomal lumen for degradation [16]. In microautophagy lysosomes directly engulf and digest
cellular components that have formed multi-vesicular bodies (Figure 1c). Microautophagy
interacts with both autophagy and endocytic machinery as well as relies on interactions between
endosomal sorting complexes and heat-shock protein 70 (Hsp70) [14, 17].
Autophagy Machinery and Stages
The autophagy pathway is complex and detailed, involving several different protein complexes
and reactions. The pathway is best explained in four stages, initiation, nucleation, elongation, and
fusion.
Initiation
The primary proteins involved in initiation of autophagy compose the unc51-like autophagy
activating kinase 1 (ULK1) complex and the class III phosphatidylinositol 3-kinase (PI3K)
complex I as seen in Figure 2 [17]. ULK1 is the most important isoform in the family of ULK
kinases in autophagy [18 – 21]. Assembly of the ULK1 complex then leads to phosphorylation of
autophagy and Beclin regulator 1 (AMBRA1) and activation of the PI3K complex [18, 21].
The ULK1 complex is composed of ULK1 and noncatalytic subunits FAK family-interacting
protein of 200 kDa (FIP200), autophagy-related protein 13 (Atg13), and autophagy related
protein 101 (Atg101) [18]. The complex must be activated in three ways, the protein kinase
activity must be actuated, the kinase must then be recruited to the phagophore assembly site
(PAS), and the noncatalytic scaffolding structures must be functioning [21]. Through
autophosphorylation of the protein kinase’s activation loop at Thr180 of ULK1 the first step in
complex activation is achieved. Autophosphorylation is induced by autophagy inducing
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conditions such as starvation, as well as co-assembly with the other subunits which increases the
concentration of ULK1 promoting autophosphorylation [21].
The mechanism by which starvation triggers activation of the ULK1 complex has been
extensively researched yet is still debated. What is understood is that mechanistic target of
rapamycin complex 1 (mTORC1) is a master regulator of metabolism and is known to
phosphorylate Atg13 under normal conditions [22]. Phosphorylation of Atg13 inhibits its
assembly into the ULK1 complex. It is through this pathway that when mTORC1 is inactivated
during amino acid depletion and stress, autophagy is then triggered [7, 22].
Another regulatory mechanism that mediates autophagy via the ULK1 complex is the Adenosine
monophosphate (AMP)–activated protein kinase (AMPK) pathway [19]. Direct phosphorylation
of ULK1 by AMPK at multiple sites leads to its activation and subsequent upregulation of
autophagy [18].
Targeted autophagy involves numerous receptors for the recognition and selection of large
protein aggregates for autophagosome degradation. Among these receptors, sequestosome-1
(SQSTM1/p62) is one of the most important as a regulator of autophagy through its action as a
reporter of and receptor for autophagy activity [23]. SQSTM1 functions through its C-terminal
ubiquitin-binding domain interacting with ubiquitin non-covalently in order to recognize
ubiquitinylated proteins. It also possesses a short LC3-interacting region (LIR) sequence which
interacts with LC3 as a connection to the autophagy machinery and pathway [23]. When
autophagy is inhibited, SQSTM1 will accumulate due to lack of degradation of its targets.
Therefore, SQSTM1 is used as a marker for autophagy flux or activity and can be used as an
indicator of a disruption in normal autophagy pathways [24].
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Nucleation
The process of sequestering small group molecules to the phagophore assembly site is
nucleation. A key protein involved is Atg9 which cycles from peripheral sites to the PAS and has
been speculated to bring lipids to the growing membrane [25 – 26]. Atg9 recruitment requires a
functioning Phosphoinositide 3-kinase (PI3K) complex I [25, 27]. Through their recruitment,
subsequent Atg proteins can be recruited to the PAS such as Atg8-PE conjugate and the Atg512/16L complex which will be discussed in more detail in the next section [21].
Elongation
Two ubiquitin-like conjugation systems are required for elongation of the phagophore,
microtubule-associated protein 1 light chain 3 (LC3) and the Atg5-12/16L1 complex (Figure 2)
[28 – 30].
First, LC3 is cleaved by the cysteine specific protease Atg4 which exposes the C-terminal
cysteine. Atg7 and Atg3 then conjugate LC3 to the membrane lipid phosphatidylethanolamine
(PE) resulting in the transition from the cytosolic LC3 type I (LC3-I) to the membrane bound
LC3 type II (LC3-II) as seen in Figure 2 [31]. The ubiquitin-like protein Atg12 covalently
conjugates to Atg5 in the second ubiquitin like system. This conjugation requires the activity of
Atg7 and Atg10. Once conjugated, noncovalent association with Atg16L1 creates the Atg512/16lI complex which forms the scaffold of the maturing phagophore [32]. This complex also
acts as an E3-like protein during LC3 lipidation by aiding in recruitment and activation of the
Atg7/Atg3 proteins [28, 30]. The Atg5-12/16L1 complex dissociates from the phagophore once
the autophagosome membrane fully forms [21].
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Fusion
Once the autophagosome has fully enclosed, fusion with a lysosome is possible. This fusion
results in an autolysosome that is fully matured. The fusion machinery consists of the RabSNARE (Soluble NSF Attachment Proteins Receptor) system including Ras-related protein Rab7a (Rab7), Vesicle-associated membrane protein 3 (Vamp3), Vacuolar morphogenesis protein 7
(Vam7), and Vesicle transport through interaction with t-SNAREs homolog 1 (Vti1) [33 – 34].
Rab7 is known as a key regulator for autophagosome-lysosome fusion and is essential for the
progression of autophagy as well as being highly conserved in eukaryotic cells. This is achieved
through the regulation of bidirectional transport of autophagosomes along microtubules via the
interaction of Rab7 and specific effectors [35 – 37]. In addition to regulating fusion, the
subsequent maturation of the autolysosome is also partly regulated by Rab7 function under
nutrient rich conditions [37]. The majority of SNARE proteins are tail-anchored transmembrane
proteins allowing vesicular traffic-mediated connection to the source membrane. Fusion is also
regulated via Class C vacuolar protein sorting (Vps) / Homotypic fusion and protein sorting
(HOPS) proteins which contain a tethering protein complex [38 – 39]. The HOPS complex binds
to UV radiation resistance associated (UVRAG) which is, in turn, bound to beclin-1 and studies
have shown Beclin may be involved as a facilitator for fusion [21, 40].
Lysosomal proteins are also regulators of fusion, such as lysosome-associated membrane
glycoprotein 2 (LAMP2). LAMP2 is a key transmembrane protein in chaperone mediated
autophagy by binding with heat shock protein complex but is also required for lysosomal fusion
in macroautophagy [41]. Additionally, LAMP2 acts as a receptor for DNA and RNA degradation
via autophagy [42]. Successful fusion is also dependent on the pH of the compartments within
the cell and regulated via vacuolar-type ATPase (V-ATPase) enzymes [43, 44].
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Roles of Autophagy
Since it’s discovery, autophagy has been implicated in numerous cellular and phenotypic states.
The role autophagy plays in these states depends on numerous factors and stimuli, both internal
and external. The outcome for both the cell or larger organism is also dependent on autophagy’s
role and its ability or inability to carry out that specific role.
Autophagy and the Skeletal System
The development and maintenance of the skeletal system relies on the function and cooperation
of multiple cell types within the bone as well as various stimuli such as growth activation,
mechanical load, and nutritional state. These cell types include the bone-forming osteoblasts,
bone-resorbing osteoclasts, and growth plate chondrocytes. Autophagy has been implicated as
necessary for bone maintenance, homeostasis, and growth as both a cell survival and intracellular
degradation mechanism [45 – 47]. An overview of the roles autophagy plays in bone can be seen
in Figure 3 and will be discussed further in the following sections.
Autophagy has been shown to be key in chondrocyte survival and maturation. When key
autophagy genes Atg5 or Atg7 are knocked out in mice, enhanced caspase-dependent cell death
is seen in isolated chondrocytes as well as reduced growth capacity [48]. This suggests that
autophagy is a key regulator for chondrocyte survival during endochondral ossification within
the growth plate. Similar studies have found that fibroblast growth factor FGF18 through FGFR4
are mediators of chondrocyte autophagy and subsequent function [49]. It is through chondrocyte
differentiation and maturation that longitudinal bone growth is achieved. Therefore, their
survival is key to bone development and growth.
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Another bone cell type affected by autophagy is the osteoclast. Pro-inflammatory cytokine,
interleukin 17A, has been shown to regulate osteoclast differentiation and increase bone
resorption via autophagy activation of bone marrow macrophages [50]. The interplay between
signaling molecules and autophagy activation in the differentiation of bone cell types leads to
alterations in the ratio of bone forming to bone-resorbing cells and therefore can have
pathological consequences.
Under normal conditions, increased rates of autophagy have been observed in differentiating
osteoblasts and suppression of autophagy has been shown to inhibit terminal differentiation [50 –
52]. Autophagy also pays a role in osteoblast mineralization by autophagic vacuoles trafficking
and secreting apatite crystals in bone [51].
The involvement of autophagy in bone development and homeostasis is not surprising given
autophagy’s recycling capabilities and bone’s growth and turn-over. Therefore, a disruption in
the balance of autophagy in bone leads to changes in cell differentiation and ultimately, the
structure and function of bone. Autophagy is also implicated in the aging process, further
demonstrating its significance in maintaining proper cell and tissue function [53 – 54]. Agerelated decline in autophagy has been seen in various tissues, with suppression of autophagy in
osteocytes mimicking skeletal aging [55].
Autophagy and Disease
Skeletal Diseases/Disorders
Autophagy has been implicated in numerous diseases including neurodegenerative diseases, such
as Alzheimer’s disease, gastro-intestinal diseases such as Crohn’s Disease, and skeletal diseases
[56]. In humans, avascular necrosis of the femur head (ANFH) is a result of insufficient blood
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supply and characterized by attrition and reduced bone repair in the early phases, followed by
necrosis. Increased tumor necrosis factor -α (TNF-α) and autophagy markers in ANFH affected
bone as well as increased autophagy and apoptosis in osteoblast cells via TNF-α manipulation
indicate that autophagy also plays a role in osteoblast survival [57].
Glucocorticoids are often used to treat inflammatory and autoimmune diseases; however, this
can lead to glucocorticoid induced osteoporosis (GIO) via autophagy dysregulation [58 – 59]. In
the case of osteoporosis, correlations, both positive and negative, between several autophagyregulatory genes and bone mineral density were determined in a genome-wide association study
[60]. Other bone related diseases in which autophagy dysregulation has been implicated include
Paget disease of the bone, osteopetrosis, osteogenesis imperfects, and osteomyelitis. In the case
of osteomyelitis, the causative bacterial agent has been shown to manipulate the autophagy
pathway leading to persistence within cells and cell death [61]. This pathology could be a
contributing factor to the bone attrition which accompanies necrosis and bacterial colonization in
osteomyelitis.
Bacterial Infection
Autophagy intervention as Cell Survival Mechanism
Autophagy not only degrades pathogens during bacterial infection, but also acts to activate the
immune response. It is in this way that autophagy both directly and indirectly enhances cell
survival by combating infection (Figure 3). When autophagy is employed to degrade intracellular
pathogens such as Salmonella enterica, Serovar typhimurium, Listeria monocytogenes,
and Shigella flexneri it is called xenophagy [62]. Cells unable to exhibit xenophagy through
membrane-associated, cellular and cytoplasmic modulators are more susceptible to infection [61,
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63 – 65]. For example, B-cell lymphoma-extra-large protein (Bcl-xL)-knockout Hela cells are
more susceptible to Streptococcus pyogenes infection [66]. Additionally, internalized bacterial
peptidoglycans are detected by nucleotide-binding oligomerization domain (NOD)-like receptors
(NLRs) which both interact with Atg16L1 and activate an inflammatory response. This type of
intracellular bacterial sensing aids in recruitment of autophagy machinery necessary for
nucleation and elongation around invading bacteria [67 – 69].
The autophagic degradation of pathogens is heavily relied upon in macrophages as they function
in the immune response. Cytoplasmic bacteria such as Listeria monocytogenes have been shown
to be targeted by autophagy and immunolabeled with antibodies to markers for the rough
endoplasmic reticulum in macrophage [70]. This method of removal from the cytoplasm and
following deliverance to the endocytic pathway reveals host mechanisms that utilize the
autophagy pathway as a means of cell survival via defense against pathogens. Another example
of autophagy targeting a cytosolic bacterium is in the case of Salmonella Typhimurium. In both
Caenorhabditis elegans and Dictyostelium discoideum damaged Salmonella-containing vacuoles
are detected and targeted by LC3 and Atg proteins for the purpose of autophagosome formation
and lysosomal degradation [71]. While the exact mechanism by which S. Typhimurium has yet to
be fully elucidated, it is clear that autophagy targeting restricts its growth and protects the cytosol
from bacteria colonization [61, 72].
Similarly, Mycobacterium tuberculosis is also targeted by autophagy but has also been shown to
block phagosome maturation and replicate within it. A study of M. tuberculosis infection found
that approximately 30% of the phagocytized mycobacteria were selectively labeled with LC3 and
Atg12 within 4 hours of infection [73]. It is often the case that particular bacterial secretions are
necessary for further targeting via autophagy and in the case of M. tuberculosis and S.
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typhimurium, damage to the vacuoles containing them via toxins also aids in autophagy targeting
[74 – 76].
Staphylococcus aureus is a Gram-positive bacterium which leads to numerous infections
including sepsis, pneumonia, and osteomyelitis which is found in both humans and other species
such as poultry [77 – 78]. Autophagy has been implicated as a means of cell survival through
enhancing the cell’s tolerance to the bacterial pore forming toxin, α-toxin [79]. This protection is
dependent upon the presence and function of major autophagy proteins including LC3 and
Atg16L. This has been shown via transgenic KO mice for both LC3 and Atg16L being
susceptible to severe S. aureus infection of the lungs and blood to the point of lethal [79]. The
recycling and degradative property of autophagy which makes it so useful in bone homeostasis
also aids in pathogen and pathogen secretion defense. A disruption in this defense system would
not only result in decreased cell survival, but also benefit the invading bacteria.
Bacterial hijacking of Autophagy
Although autophagy is an effective mean of degrading intracellular bacterial pathogens, many
bacteria have evolved mechanisms and weapons to hijack many biological processes, including
the autophagy machinery (Figure 3) [80 – 81]. Multiple mechanisms exist that either enhance or
prevent phagosome formation, subvert autophagy machinery, or prevent autophagosome and
lysosomal fusion. For example, the causative agent of anaplasmosis,
Anaplasma phagocytophilum, can enhance autophagosome formation and consequently procure
nutrients from within the autophagosome [82 – 83]. Shigella flexneri, another bacterial pathogen,
has outer membrane protein IcsA autotransporter (IscA) which promotes actin-based motility
and can bind to Atg5 making it a target for autophagy degradation. However, the bacterial
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protein IscB competitively binds to IscA in place of Atg5, masking the bacteria form the
autophagy pathway [84].
While some bacteria evade autophagy through inhibiting its initiation, others are able to utilize
the autolysosome for replication before inhibiting processes further down the autophagy
pathway. An example of such a bacterium is S. aureus. In fact, it has been shown that S. aureus
will replicate within the LC3+ labeled double-membrane for three to twelve hours before
escaping into the cytosol to continue cell death and infection [85 – 87]. S. aureus avoids
autophagic degradation via inhibition of lysosomal fusion [88]. This was determined by the
accumulation of autophagosomes coupled with changes in autophagy gene and protein
expression over time of infection in bovine epithelial cells. Both the ratio of LC3 type I:II and
the accumulation of p62 were increased, indicating a block of autophagy flux [88]. If autophagy
flux is impaired, it is an indicator of disruption of proper fusion and lysosomal degradation,
which would allow the bacteria to replicate within the double membrane, causing increased
severity of infection [87 – 89]. This type of strategical misuse of autophagy by S. aureus calls
into question its use of such mechanisms in other cell and tissue types. Further research needs to
be done to determine the potential role of autophagy in other diseases caused by S. aureus, such
as osteomyelitis especially given bone’s dependency on autophagy for homeostasis.
Conclusions and Perspectives
Autophagy has far reaching and diverse effects on development, maintenance, and survival at
cellular levels. In bone, it is responsible for homeostasis through facilitating cell differentiation
into the necessary bone-forming and bone-degrading cell types, as well as providing means of
cell survival for chondrocytes in conditions found during longitudinal bone growth.
Dysregulation of the autophagy pathway is associated with decreased bone growth and several
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skeletal diseases involving bone attrition. In bacterial infections, autophagy is pivotal for survival
and also the target of bacterial manipulation for the purpose of infection. One of the most
common agents of bone infection such as osteomyelitis, S. aureus is known to manipulate
autophagy to persist within the cell, leading to intense infection. As of now, the connection
between the delicate balance of functioning autophagy in bone and its manipulation under
bacterial infection has yet to be investigated. However, given the scope and significance of
autophagy’s role in bone maintenance and bacterial infection, future studies are warranted.
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Figure 1: The types of autophagy: a) Macroautophagy characterized by phagophore and
autophagosome formation and the focus of this review; b) Chaperone-mediated autophagy
involving chaperone complex recognition of proteins for future lysosomal degradation; c)
Microautophagy, which involves direct lysosomal engulfment and degradation.
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Figure 2: The stages of autophagy and key molecular regulators involved. Initiation is primarily
regulated by two complexes: ULK1 and PI3K. Elongation is regulated by the cleavage and
alteration of LC3 and the formation of the Atg5-12/16lI complex.
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Figure 3: Autophagy machinery and its current/prospective roles in bone: Homeostasis
characterized by the influence on osteoclast and osteoblast cell differentiation as well as
facilitating osteoblast mineralization during potential disease states and under normal conditions.
Cell survival for osteoblast in hypoxic conditions during endochondral ossification and bacterial
challenge. Cell death via bacterial inhibition or hijacking and subsequent infection of the cell.
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Abstract: Autophagy is a cell survival and homeostasis mechanism involving lysosomal
degradation of cellular components and foreign bodies. It plays a role in bone homeostasis,
skeletal diseases, and bacterial infections as both a cell-survival or cell-death pathway. This
study sought to determine if autophagy played a role in bacterial chondronecrosis with
osteomyelitis (BCO). BCO is a prominent cause of lameness in modern broilers and results from
bacterial infection of mechanically stressed leg bone growth plates. The protein and gene
expression of key autophagy machinery was analyzed in both normal and BCO-affected broilers
using real-time qPCR and immunoblot, respectively. Gene expression showed a significant
downregulation of key target signatures involved in every stage of autophagy in BCO-affected
bone, such as ATG13, SQSTM1 (p62), ATG9B, ATG16L, ATG12, LC3C, and RAB7A.
Additionally, protein expression for LC3 was also significantly lower in BCO. An in vitro study
using hFOB cells challenged with BCO isolate, Staphylococcus agnetis 908, showed a similar
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dysregulation of autophagy machinery along with a significant decrease in cell viability. When
autophagy was inhibited via 3-MA or CQ, comparable decreases in cell viability were seen along
with dysregulation of autophagy machinery. Together, these results are the first to implicate
autophagy machinery dysregulation in the pathology of BCO.
Key words: autophagy, broiler, bacterial chondronecrosis with osteomyelitis, lameness,
osteoblasts, bone
Introduction
Autophagy is a key component of cellular homeostatic, survival, defense, and death. It is a
process by which cells are able to degrade cellular debris, damaged organelles, or foreign bodies,
via membrane isolation and lysosomal fusion and degradation [1, 2]. There are four stages in
autophagy, initiation, nucleation, elongation, and fusion [3]. Initiation involves the activation and
trigger of autophagy machinery. Nucleation is characterized by the sequestering of key proteins
and complexes to the site of autophagosome formation. Elongation occurs as the autophagosome
expands and eventually closes. Fusion refers to the fusion of the mature autophagosome with a
lysosome to undergo lysosomal degradation of its contents [4, 5]. Autophagy aids in cellular
survival through regular maintenance as well as aid in cellular processes and functions. In bone,
functioning autophagy machinery aid in bone growth and homeostasis via promotion of
chondrocyte survival in hypoxic environments, regulation of osteoblast and osteoclast
differentiation, and contribution to osteoblast mineralization [6-9]. Under bacterial challenge,
autophagy’s effectiveness has shown to increase cell survival and decrease bacterial loads [1012]. While its ineffectiveness or inhibition has shown to have damaging effects on cellular
viability and function. For example, some bacteria, such as Staphylococcus aureus, have been
shown to manipulate autophagy via inhibition of fusion in order to persist within the cell under
82

membrane protection while replicating and ultimately lysing within the cell and causing cell
death [13-15]. It is the dynamic nature of autophagy’s involvement in physiological states that
has led it to be increasingly investigated in different diseases and disorders. In the case of BCO,
the involvement of bacterial infection and bone inflammation as well as cellular necrosis make
autophagy a pathway worth investigating given its significance to both the function of bone and
response to bacteria.
BCO, also known as femur head necrosis (FHN), is a common cause of lameness in the modern
broiler affecting fast-growing, higher yielding birds more frequently [16]. It is characterized by
bacterial infection in primarily the proximal head of rapidly-growing leg bones of a broiler,
resulting in chondronecrosis and osteomyelitis [17]. It is theorized that collagen-binding bacteria,
entering the blood stream via the respiratory or gastrointestinal tract, are able to come into
contact with preexisting wound sites within the mechanically-stressed, highly-vascularized
growth plates and colonize [18, 19]. These wound sites also often transect blood supply leading
to hypoxic conditions. As infection persists, inflammation and necrosis lead to bone attrition and
associated lameness can become detectable, although subclinical BCO can also occur [17, 20].
Understanding and combating BCO, and associated lameness, has become a high priority for
both improving both animal welfare and production.
Although it is better understood how bacteria infect the bone and what the end-point symptoms
of BCO are, what is still yet to be fully elucidated is the mechanism by which bacteria cause
BCO. It has been shown the mitochondrial dysfunction exists in BCO affected tissue, but
molecular pathways linking bacterial effects and what is seen in BCO tissue have yet to be
discovered. To that end, this study sought to elucidate the potential involvement of autophagy in
BCO.
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Materials and Methods
Collection of BCO and Normal Bone Samples.
All animal experiments were approved by the University of Arkansas (Fayetteville, AR) Animal
Care and Use Committee (protocol number 15043) and were in accordance with
recommendations in NIH’s Guide for the Care and Use of Laboratory Animals. The BCO model
and healthy counterparts were conducted as previously described [16, 17]. Briefly, animals were
placed on either litter or wire-flooring and had ad libitum access to fresh water and feed (3.9
Mcal metabolizable energy kg-1and 180 g crude protein kg-1) while the experiment took place at
the University of Arkansas Poultry Research Farm. Ambient temperature was lowered gradually
from 32˚C to 25˚C by 21 days of age. A light cycle of 23 hours light/1 hour dark was maintained
along with an approximately 20% relative humidity until 56 days of age. At the end of the 56
days, animals were weighed, humanely euthanized, and immediately necropsied to determine
presence of subclinical lesions in the proximal heads of both the femora and tibiae. Bone was
selected macroscopically based on previously reported scale [16, 17]. Normal bone was taken
from animals raised on litter only and when considered free of any necrosis or lesion and BCOaffected bone was from birds raised on wire- flooring and exhibiting lameness, and consisted of
bone with FHN. Proximal portions of bone, primarily consisting of the growth plate, from both
affected and unaffected animals were snap frozen in liquid nitrogen and stored at -80˚C for later
analysis.
Cell Culture
Human fetal osteoblast (hFOB) 1.19 cells (CRL-11372; ATCC, Manassas, VA) were cultured in
a 1:1 mixture of Ham’s F12 medium/Dulbecco’s modified Eagle’s medium, 10% fetal bovine
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serum, and 0.3 mg/mL G418. Cells were grown at 34ºC in a humidified atmosphere of 95% air
and 5% CO2.
Bacterial Challenge
Staphylococcus agnetis strain 908 (a generous gift from Dr. Douglas Roads) was isolated from
the affected bone of BCO model, and was grown overnight in Luria broth at 37˚C [18]. To
determine cell density, cultures were diluted using phosphate-buffered saline before absorbance
at 650 nm was measured. Bacteria at a multiplicity of 50:1 were added to cell cultures in
antibiotic-free media and left to attach for 1 hour. Cells were washed three times with phosphatebuffer saline and complete media was added. Cells were maintained for an additional 24 hours
and then processed for protein expression (N=3) [21].
Autophagy Inhibitor Treatments
hFOB cells were treated with either 3-Methyladenine at a concentration of 5mM (Sigma Aldrich,
St. Louis, MO), Chloroquine at a dose of 10 µM (InvivoGen, San Diego, CA), or vehicle control
for 24 hours before being lysed (N=3). Pilot studies were used to determine effective inhibitor
dose.
Cell Viability
Cell viability was performed as previously described 22. Briefly, hFOB cells were seeded at 1 ×
104 cells per well of a 96-well plate before being transfected as described above. CellTiter 96
AQueous One Solution CellProliferation Assay (Promega, Madison, WI) was used, according to
manufacturer’s recommendations, and results were obtained using a Synergy HT multimode
microplate reader (BioTek, Winooski, VT). All sample readings were background corrected, and
results were reported relative to control.
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RNA isolation, reverse transcription, and real-time quantitative PCR
From the normal and BCO-affected bone samples (N=6), total RNA was isolated in accordance
with the protocol of [23]. Cellular RNA was isolated using Trizol reagent (Life Technologies,
Carlsbad, CA), based on manufacturer’s instructions. RNA concentrations were determined
using Synergy HT multimode microplate reader and total RNA was reverse transcribed using
qScript cDNA SuperMix (Quanta Biosciences, Gaithsburg, MD). Amplification was achieved
using Power SYBRGreen Master Mix (Life Technologies, Carlsbad, CA) and real-time
quantitative PCR (7500 Real Time System; Applied Biosystems, Foster City, CA). The
sequences for oligonucleotide primers for r18s, Beclin1, ATG7, ATG3, LC3A, LC3B, and LC3C
were previously published [24, 25]. As well as ATG13, ATG9A, ATG14, UVRAG ATG16L,
ATG12, ATG4A, ATG4b, and ATG10 [26]. Additional primers used were ATG2B (forward, 5’CCGTTCTCGGAGTCCATCA -3’; and reverse, 5’- GAGCCGGTGCCCTGGTA -3’), ATG9B
(forward, 5’- TCACCCCTGAAGATGGAGAGA -3’; and reverse, 5’TTTCCAGCATTGGCTCAATC -3’), RAB7A (forward, 5’- GTGCCAAGGAGGCCATTAAC
-3’; and reverse, 5’- AAGTGCATTTCGTGCAATCG -3’), SQSTM1 (p62) (forward, 5’TTACGTGCAGGACGGAGTTTT -3’; and reverse, 5’- CACGCCTGCACTCCTTTTTC -3’),
and LAMP2 (forward, 5’- TCAATAGCTGAAGAATGCTTTGCT -3’; and reverse, 5’TGCCAACTGCGACTGGAATA -3’).
Real-time quantitative PCR cycling conditions were 50˚C for 2 minutes, 95˚C for 10 minutes and
40 cycles of a two-step amplification (95˚C for 15 seconds followed by 58˚C for 1 minute). The
dissociation protocol from the sequence detection system was used for melting curve analysis to
exclude potential contamination of non-specific PCR products. Negative controls that were used
as templates contained no reverse transcription products. Relative expression of target genes was
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determined using the 2-∆∆CT method and healthy bone tissue or untreated cells were used as
calibrators [27].
Western Blot Analysis
Bone samples and cell lysate were homogenized in lysis buffer (10 mmol/L Tris base, pH 7.4;
150 mmol/L NaCl; 1 mmol/L EDTA; 1 mmol/L EGTA; 0.1% Triton X-100; 0.5% Nonidet P-40;
and protease and phosphatase inhibitors) and stainless-steel beads, using the Bullet Blender
Storm (NextAdvance, Averill Park, NY). Cells were homogenized in lysis buffer after being
washed with phosphate-buffered saline. Total protein concentrations were determined using a
Bradford assay kit (Bio-Rad, Hercules, CA), and ran in 4%-12% gradient Bis-Tris gels (Life
Technologies) and then transferred to polyvinylidene difluoride membranes. Once transferred,
membranes were blocked using a Tris-buffered saline (TBS) with 5% nonfat milk and Tween 20
at room temperature for 1 hour. The membranes were washed with TBS and Tween 20 and then
incubated with primary antibodies at a dilution of either 1:500 or 1:1000 overnight at 4˚C.
Primary antibodies used were rabbit anti-Beclin1 (Cell Signaling Technology, Danvers, MA),
rabbit anti-ATG7 (Cell Signaling Technology, Danvers, MA), rabbit anti-ATG16L (Aviva
Systems Biology, San Diego, CA), rabbit anti-ATG12 (Cell Signaling Technology, Danvers,
MA), rabbit anti-ATG3 (Thermo Fisher Scientific, Waltham, MA), rabbit anti-ATG5 (Cell
Signaling Technology, Danvers, MA), rabbit anti-LC3 (Cell Signaling Technology, Danvers,
MA), and rabbit anti-RAB7 (Santa Cruz Biotechnology, Dallas, TX). After another wash,
secondary antibodies diluted to 1:5000 were added to 5% nonfat milk in TBS and Tween 20 and
incubated with the membranes at room temperature for 1 hour. The protein signals were
visualized using chemiluminescence (ECL Plus; GE Healthcare, Pittsburg, PA) and images were
captured using the FluorCHem M MultiFluor System (ProteinSimple, San Jose, CA). Prestained
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molecular weight marker (Precision Plus Protein Dual Color) was used as a standard (Bio-Rad,
Hercules, CA). Protein loading was assessed by immunoblotting using rabbit
antieglyceraldehyde-3-phosphate dehydrogenase (Santa Cruz Biotechnology, Dallas, TX). Image
acquisition and analysis were performed by AlphaView software (version 3.4.0, 1993–2011;
ProteinSimple).
Statistical Analysis
Data were analyzed by Student t-test or One-way ANOVA, as appropriate, using GraphPad
version 7.03 (GraphPad Software, Inc., LaJolla, CA). Results are expressed as means ±SEM,
with P-value < 0.05 set as statistically significant.
Results
Key Autophagy Machinery Expression was Downregulated in BCO affected Tissue
Key autophagy machinery genes, and corresponding protein, involved in initiation were
measured in normal and BCO affected tissue. Both protein and gene expression were analyzed in
normal and BCO affected femurs for Coiled-Coil Myosin-Like BCL2-Interacting Protein
(Beclin1) with no significant difference seen (Figure 1 a, b, c). Autophagy-related protein 13
(ATG13) and Sequestosome I (SQSTM1), also known as Autophagy Receptor P62 (p62), mRNA
expressions were significantly downregulated in BCO affected tissue (Figure 1 d, e) (P < 0.05).
In investigating the nucleation stage of autophagy, Autophagy-related protein 5 (ATG5) protein
expression was measured with no significant difference seen when comparing BCO affected and
normal bone (Figure 2 a, b). However, the mRNA expression of ATG14 and ATG9B were
significantly downregulated in BCO, when compared to normal bone (Figure 2 c, e) (P < 0.05).
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Autophagy-related protein 9A mRNA expression showed no significant differences between
normal and BCO affected bone (Figure 2 d).
The elongation stage of autophagy saw several significant differences in expression of autophagy
molecular signatures. While protein expression of ATG7, ATG16L, ATG12, and ATG3 were not
significantly different between BCO and normal bone, LC3 protein expression was significantly
lower in BCO-affected bone (Figure 3a-f) (P < 0.05). Gene expression of ATG16L, ATG12,
LC3C, ATG2B, ATG4B, and ATG10 were also significantly downregulated in BCO-affected
bone compared to normal (Figure 3h, i, m, n, p, q) (P < 0.05). ATG7, ATG3, LC3A, LC3B, and
ATG4A showed no significant difference between BCO and normal tissue (Figure 3g, j, k, l, o).
Autophagy machinery involved in the fusion stage showed decreased mRNA abundances of
member RAS Oncogene Family (RAB7A) in BCO-affected bone (Figure 4c) (P < 0.05). While
protein expression of RAB7 as well as mRNA expression of Lysosomal Associated Membrane
Protein 2 (LAMP2) and UV Radiation Resistance-Associated Gene (UVRAG) were not
significantly different between normal and BCO (Figure 4a, b, d, e).
S. agnetis 908 Challenge Decreased Viability and Key Autophagy Machinery Expression in
hFOB cells
Exposure to S. agnetis 908 resulted in significant decreased cell viability in hFOB cells (Figure 5
a) (P < 0.05). Protein expression of ATG7, ATG16L, Beclin1, ATG12 and ATG3 were
significantly lower in bacterially challenged cells compared to control (Figure 5b-e, g, h) (P <
0.05). The ratio of LC3 type II to LC3 type I was significantly increased in cells under bacterial
challenge (Figure 5b, j) (P < 0.05). ATG5 and RAB7 protein expression were unaffected by
exposure to S. agnetis 908 (Figure 5 b, f, i).
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Inhibition of Autophagy in hFOB Decreased Cell Viability and Autophagy Machinery
Expression
Treatment of hFOB cells with either 3-methyladenine (3-MA) or Chloroquine (CQ) resulted in
significantly decreased cell viability in hFOB cells (Figure 6 a) (P < 0.05). Protein expression of
ATG7 and Beclin1 was significantly decreased in cells exposed to both inhibitors compared to
control (Figure 6 b - d) (P < 0.05). ATG12 and ATG3 protein levels were lower in cells treated
with CQ compared to control, but not 3-MA (Figure 6 b, e, f) (P < 0.05). The ratio of LC3 type II
to LC3 type I was significantly increased in both 3-MA and CQ treated hFOB cells, with CQ
treatment resulting in the highest ratio (Figure 6 b, g) (P < 0.05).
Discussion
In the pursuit of identifying potential mechanisms responsible for the bacterial infection,
necrosis, and inflammation of the bone in BCO, the autophagy pathway was investigated.
Autophagy has been increasingly implicated in several skeletal disorders such as avascular
necrosis of the femur head, glucocorticoid induced osteoporosis and osteomyelitis [28-32]. In
osteomyelitis, autophagy has been shown to be manipulated by causative agents allowing the
persistence within the cell and subsequent cell death [33, 34]. Its dual role in both cellular
defense and cell death under bacterial challenge as well as its susceptibility to bacterial
manipulation, warrant in depth analysis into autophagy in BCO.
The initiation stage of autophagy has been shown to be both upregulated and inhibited under
bacterial challenge, depending on the bacterium involved [14, 35]. A key component of
autophagy initiation is formation of the ULK1 complex, which requires the involvement of
ATG1 proteins such as ATG13 [36-38]. BCO affected femurs were shown to have significantly
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decreased mRNA expression of ATG13. Phosphorylation of ATG13 by mechanistic target of
rapamycin complex 1 (mTORC1) occurs under normal conditions, inhibiting autophagy [39]. It
is through the inactivation of mTORC1 that stimuli, such as amino acid depletion and stress,
activate the autophagy pathway within a cell [40]. Another key component of autophagy
initiation is the function of SQSTM1, a reporter of and receptor for autophagy activity. SQSTM1
mRNA expression as also significantly decreased in BCO femurs. An accumulation of SQSTM1
protein has been used as an indicator of inhibited autophagy [41, 42]. While the mRNA
expression does not tell us the state or quantity of protein expression in BCO tissue, it does
indicate potential overall decreased SQSTM1 availability. The downregulation of ATG13 and
SQSTM1 in BCO bone could be indicative of a dysregulation of autophagy initiation under BCO
conditions.
Two key machinery involved in autophagy nucleation were significantly downregulated in BCO
affected femurs, ATG14 and ATG9B. ATG9 is believed to be involved in bringing lipids to the
newly forming membrane in the phagophore assembly site (PAS) [43-45]. ATG9 is critical to
survival of mice in the early neonatal starvation period in which functioning autophagy is
essential [46]. In the case of bacterial infection, ATG9 has been shown to be essential in the
formation of the double membrane around Salmonella [47]. ATG14 is a subunit of the
Phosphoinositide 3-kinase (PI3K) complex I which aids in directing the complex to the PAS
where the complex plays a major role in membrane elongation of the forming autophagosome
[48]. Autophagy studies involving yeast and mammals has shown that overexpression of ATG14
increases autophagic activity [49, 50]. Additionally, deletion of ATG14 has been shown to affect
the localization of other key autophagy machinery such as AG8 and the ATG5-ATG12/ATG16L
complex and, therefore, may indirectly regulate autophagosome size [51-53]. Both ATG9 and
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ATG14 dysregulation in BCO bone suggest that the nucleation stage of autophagy may be
affected under BCO conditions.
Elongation involves the expansion and closure of the phagophore to form an autophagosome.
This process begins with the cleavage of LC3 by ATG4. LC3 is then conjugated from LC3 type I
to membrane-bound LC3 type II by ATG7 and ATG3 [54]. The ATG5-12/ATG16L complex
comes into play again during elongation by recruiting ATG7 and ATG3 and forming the scaffold
by which the maturing phagophore elongates and it requires the activity of ATG7 and ATG10
[55]. In BCO affected tissue, there was significant decreased gene expression of ATG12,
ATG16L, LC3C, and ATG4B. In the case of LC3, both LC3 protein and LC3C gene expression
were significantly lower in BCO bone. Additionally, ATG2B and ATG10 were also significantly
decreased. ATG2 ATG2 acts as a tether between the pre-autophagosome membranes and the
endoplasmic reticulum during elongation to aid in expansion and closure [56, 57]. It has been
shown that depletion of ATG2A and ATG2B leads to an accumulation of open and immature
phagophore structures in mammalian cells [58, 59]. The formation of the ATG5-ATG12
conjugation of the ATG5-ATG12/ATG16L complex is dependent on initial formation of an
ATG12-ATG10 thioester intermediate [60]. Indeed, mutations in the ATG10 gene have shown to
lead to dysfunction of the ATG5-ATG12 conjugation and lack of autophagic bodies [61].
Decreased protein and gene expression of key elongation factors could contribute to BCO
pathogenicity through dysregulation of autophagy machinery necessary for cellular homeostasis
and defense.
The fusion of the fully formed autophagosome with the lysosome and subsequent maturation of
the autolysosome involves the Rab-SNARE (Soluble NSF Attachment Proteins Receptor) system
including Ras-related protein Rab-7a (RAB7A) [4, 62, 63]. RAB7A is responsible for the
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transport of autophagosomes along microtubules for proceeding fusion via interaction with
specific effectors [4, 64]. In BCO affected bone, RAB7A mRNA expression was significantly
downregulated indicating potential dysregulation of this key fusion machinery.
Taken as a whole, the in vivo results of this study suggest dysregulation of key machinery in
every stage of autophagy in BCO-affected tissue. In order to determine if this dysregulation was
a direct result of the bacterial component of BCO, an in vitro experiment was conducted with
hFOB cells and known BCO isolate, S. agnetis 908. Not only did challenged cells show
significant decreased viability, but also similar autophagy machinery dysregulation resulting
from bacterial challenge. Key initiation protein Beclin1, as well as elongation machinery, ATG7,
ATG16L, ATG12, and ATG3, were significantly decreased in S. agnetis-infected hFOB cells.
Most notably, the ratio of LC3 type I to LC3 type II significantly increased under bacterial
challenge. LC3 has been used as an indicator of autophagy function with the accumulation of
LC3 type II in relation to LC3 type I occurring due to lack of LC3 type II lysosomal degradation
when autophagy is dysregulated [65, 66]. These results could be indicative of a potential
decrease in autophagic activity in bacterially challenged cells. In bone tissue, autophagy is
essential in osteoblast differentiation with suppression of autophagy also playing a role in
decreased cellular function via reduced autophagic vacuoles containing apatite crystals inhibiting
mineralization [6]. These results present the ability of a known BCO isolate to not only impact
cell viability, but also affect the autophagy machinery within cells in a manner which could
inhibit autophagy.
To elucidate whether inhibition of autophagy could be the mechanism by which the bacterial
exposure decreased cellular viability, two different autophagy inhibitors were used, 3-MA and
CQ. 3-MA inhibits class II PI3Ks thereby inhibiting autophagy, primarily in the nucleation stage
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[67]. While CQ inhibits autophagy via inhibition of lysosomal function and thereby acting on the
fusion stage [68, 69]. Both treatments resulted in significant decreased cell viability and
increased ratio of LC3 type II to type I. Additionally, decreased expression of ATG7 and Beclin1
was also seen in cells treated with 3-MA and cells treated with CQ. ATG12 and ATG3 protein
was significantly lower in CQ treated cells compared to control. These results suggest that
inhibition of autophagy, in either earlier or later stages, results in decreased cell viability
comparable to that seen when cells are challenged with a known BCO isolate. Autophagy
machinery were also significantly affected via these inhibitors comparable to bacterially
challenged cells and BCO tissue.
Taken together, the results from this study are the first to implicate autophagy machinery
dysregulation in the pathogenicity of BCO in modern broilers. While more research into the
exact mechanism and machinery involved in BCO is needed, clearly, autophagy machinery
dysregulation is present in BCO and could be caused by bacterial influence. This dysregulation
has the capacity to reduce cell viability and potentially contribute to the etiology and symptoms
of BCO. These findings give a new perspective into potential targets for treatment and
prevention of BCO via genetics, probiotics, or pharmacological means.
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Figure 1. Autophagy Initiation Machinery in Normal and BCO affected Bone
Protein expression for initiation machinery Beclin1 (a) with corresponding statistical analysis
(b). Gene expression for genes regulating autophagy initiation, Beclin1 (c), ATG13 (d), and
SQSTM1 (p62) (e). Significance was determined using a student t-test with p-value < 0.05. *
indicates significant difference between Normal and BCO.
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Figure 2. Autophagy Nucleation Machinery in Normal and BCO affected Bone
Protein expression for ATG5 (a) and statistical analysis of the Western blot results (b). Gene
expression for key nucleation machinery, ATG14 (c), ATG9A (d), and ATG9B (e). Significance
was determined using a student t-test with p-value < 0.05. * indicates significant difference
between Normal and BCO.
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Figure 3. Autophagy Elongation Machinery in Normal and BCO affected Bone
Protein expression for ATG7, ATG16L, ATG12, ATG3, and LC3 (a) and statistical analysis of
the results as compared to GAPDH (b, c, d, e, f). Gene expression for key elongation machinery,
ATG7 (g), ATG16L (h), ATG12 (i), ATG3 (j), LC3A (k), LC3B (l), LC3C (m), ATG2B (n),
ATG4A (o), ATG4B (p), and ATG10 (q). Significance was determined using a student t-test with
p-value < 0.05. * indicates significant difference between Normal and BCO.
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Figure 4. Autophagy Fusion Machinery in Normal and BCO affected Bone
Protein expression for RAB7 (a) and corresponding statistical analysis (b) as compared to
GAPDH. Gene expression for RAB7A (c), UVRAG (d), and LAMP2 (e), key autophagy fusion
machinery. Significance was determined using a student t-test with p-value < 0.05. * indicates
significant difference between Normal and BCO.
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Figure 5. Effect of S. agnetis 908 Challenge on Cell Viability and Autophagy Machinery in
hFOB cells
MTT assay results from hFOB cells treated with S. agnetis 908 at a MOI of 50:1 or a vehicle
control for 24 hours (a). Western blot results (b) and statistical analysis for ATG7 (c), ATG16L
(d), Beclin1 (e), ATG5 (f), ATG12 (g), ATG3 (h), RAB7 (i), and LC3 type II: type I (j) as
compared to GAPDH. Significance was determined using a student t-test with p-value < 0.05. *
indicates significant difference between control and infected cells.
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Figure 6. Effect of Autophagy Inhibition via 3-MA and CQ on Cell Viability and
Autophagy Machinery in hFOB cells
MTT assay for cell viability presented as percent of control viability under treatment of 3-MA (5
mM), CQ (10 µM), or a vehicle control on hFOB cells for 24 hours (a). Western blot results for
autophagy machinery proteins (b) and statistical analysis for ATG7 (c), Beclin1 (d), ATG12 (e),
ATG3 (f), and LC3 type II: type I (g) as compared to GAPDH. Significance was determined
using One-way ANOVA with p-value < 0.05. Different letters indicate significant differences
between treatments.
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Abstract: Molecular biology has revealed the complex interplay and overlap of molecules across
biological systems such as the immune system and its relation to and influence on the skeletal
system. Cytokines and chemokines are signaling molecules responsible for immune cell function
as well as chemotaxis under inflammatory conditions. It has become clear that these molecules
have influence on processes beyond inflammation, including cellular differentiation and
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maturation, growth, and homeostasis, particularly in bone. In this review, key molecular families
of cytokines and chemokines will be described as well as their function in healthy, growing or
remodeling bone. Additionally, the current understandings of cyto(chemo)kines’ involvement in
inflammation and bacterial infections of bone will be expounded and provide a basis for
considerations of future research.
Introduction
The skeletal system is home to the generation of immune cells as well as the site of intense
growth and constant remodeling. The complexity of bone contributes to its susceptibility to
disease and infection. Notoriously difficult infections to treat, osteomyelitis and periodontitis,
present a unique challenge to researchers to understand the molecular mechanisms behind the
symptoms of necrosis, bone loss, and inflammation to improve treatments and aid in diagnosis.
Key modulators of inflammation as well as influential players in bone growth and remodeling,
cytokines and chemokines represent a link between pathology and physiology within an
organism. The expression pattern of cyto(chemo)kine dictates the immune response, anti- or proinflammatory, as well as the cell types involved under that condition. This requires
cyto(chemo)kines to have systemic influence within a biological system and a unique profile
within circulation of an inflammatory or infectious state. In the skeletal system, these
cyto(chemo)kine profile has far reaching implications on cell differentiation, bone growth, and
the delicate balance of bone resorption and formation in addition to regulating the bacteriallyinduced inflammatory response. Therefore, further research into the role of cyto(chemo)kines in
both local and systemic immunoregulation and the etiology of bone infection is warranted and
could provide novel treatments and means of diagnosis in the fields of human and veterinary
medicine.
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Overview of Cytokines and Chemokines
Cytokines
Inflammation is an immune process modulated via molecules such as cytokines. These
modulators act in a complex network of signaling pathways and interactions resulting in a
spectrum of physiological responses and states. The responses differ depending on the cytokine
involved, the nature of the immune response, and the cell or tissue type within an organism.
Primarily, cytokine driven inflammation involves heating and swelling as well as redness and
subsequent pain or loss of function at the tissue level [1,2]. At the cellular level, inflammation
involves the recruitment, activation, and modulation of the major immune system cells such as
macrophage, neutrophils, monocytes, T-cells and B-cells. Cytokines play a role in the diverse
cellular signaling, modulation, and downstream effects seen in inflammatory states. In addition
to inflammation, cytokines are involved in cellular processes such as growth and survival [3,4].
They exist within certain organs, such as liver and bone, at low concentrations and can act in
polarizing ways with both pro- and anti-inflammatory functions in addition to their influence
over homeostatic processes. Cytokines can be grouped by their prospective molecular family,
their target cell/function, and whether they act in primarily anti- or pro-inflammatory pathways.
In this review, cytokines will be grouped and discussed first by their molecular family and then
further defined by their mode of action and effects.
Types of Cytokines and their functions
There are many different cytokines, but two major types are interleukins and tumor necrosis
factors. Interleukins can be both pro- and anti-inflammatory and are expressed by numerous cell
types such as leukocytes and macrophages [5,6].
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A pro-inflammatory interleukin cytokine is interleukin-1β (IL-1β). It is produced primarily in
response to microbial molecules via pattern recognition receptors [1]. Once synthesized, IL-1β
must then be cleaved to be activated and secreted. Once secreted, IL-1β binds to interleukin-1
receptor 1 (IL-1R1) found on the surface of target cells. This forms a subsequent signaling
complex which then interacts with adaptor molecules leading to the activation of mitogenactivated protein kinases (MAPKs) and the transcription factor nuclear factor kappa B (NF-κB)
[7]. This activation leads to further production of pro-inflammatory cytokines and other
downstream pro-inflammatory effects. Other pro-inflammatory interleukins include those in the
same family as IL-1β, such as IL-18, as well as IL-6 and IL-17 [8,9]. IL-6 can have both pro- and
anti-inflammatory effects and is produced by numerous cell types including endothelial cells,
fibroblasts, and smooth muscle cells, as well as immune cells such as mononuclear phagocytes
and both T- and B-cells. Its production can be induced by other cytokines such as TNFs and IL1s, but also bacterial stimuli such as lipopolysaccharides (LPS) [9,10]. IL-6 has many roles in
host immune response, most notably, it facilitates the final differentiation of B-cells to produce
antibodies and stimulates production of acute phase proteins (APPs) in hepatocytes and other cell
types [11]. IL-6 functions through a cell-surface receptor complex (IL-6R) with both a ligand
binding glycoprotein and a signal transducing component, similarly to IL-1β [12]. IL-6R exists
in both a soluble and membrane bound form. The soluble form creates a dimer with IL-6 that
travels throughout the body while the membrane bound form executes normal physiological
functions in certain cell types mediated via IL-6 [9]. The membrane bound signaling is
considered classical signaling pathway which primarily occurs in leukocytes and liver cells and
is anti-inflammatory in nature. In contrast, the signaling pathway induced by soluble receptor
binding can occur in any cell expressing the soluble receptor within the cytoplasm and elicits
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pro-inflammatory responses [11]. IL-6 has been shown to be detectable in circulation under
experimental conditions such as induced endotoxinaemia as well as in septic conditions at high
concentrations during initial phase. In the case of septic patients, the level of circulating IL-6 has
been shown to correlate with severity of disease [13,14]. The dueling roles of IL-6, anti- and proinflammatory as well as physiological and pathological, regarding the skeletal system and
skeletal diseases is covered in more detail in following sections.
While it is clear cytokines’ roles may include both pro- and anti-inflammatory regulation, some
cytokines tend to perform anti-inflammatory functions more regularly. Anti-inflammatory
interleukins, such as IL-10 and IL-12, act to decrease pro-inflammatory cytokine production and
change certain cellular activation or expression [15,16]. For example, IL-10 acts to shift the
cytokine expression of T-cells to the T helper 2 (Th2) cytokine profile rather than T helper 1
(Th1) profile as well as decrease macrophage production of pro-inflammatory cytokines. The
paradigm of Th2 and Th1 cytokine profiles and their effect on inflammatory and disease states
has been extensively reviewed previously [17-20]. IL-10 is produced by numerous cell types in
both the adaptive and innate immune system. The receptor for IL-10 is IL-10RA and it signals
via the Janus tyrosine kinases (JAKs) and signal transducers and activators of transcription
(STATs) similarly to other cytokines [21]. Ligand binding allows for recruitment of STATs
which form homo- and hetero-dimers capable of nuclear translocation and subsequent
transcription of target genes [22-24]. Within the IL-10 family, there are numerous cytokines and
a diverse array of receptors. It is the unique expression patterns of cytokine-receptor
combinations that result in diverse physiological and pathological responses [15]. So is the case
with IL-12, where within the IL-12 family, distinct ligand-receptor combinations result in a
range of responses including both pro-inflammatory and immunosuppressive effects depending
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on pathological or physiological conditions. The IL-12 cytokine and IL-12R combination
functions similarly to IL-10, using JAK and STAT signaling transduction pathways, but
primarily acting on natural killer (NK) and T cells [25]. In the IL-12/IL12R signaling pathway,
STAT4 and its transcription targets lead to the potentiation of Th1 differentiation. Notably, this
signaling pathway has also bene shown to provide negative feedback queues which eventually
reduce IL-12 signaling [16,23]. Interleukins are cytokines with diverse and sometimes combating
roles which act via a network of receptors and signaling molecules to have both physiological
and pathological effects.
Another major group of cytokines are tumor necrosis factors (TNFs). The TNF superfamily
consists of transmembrane proteins including receptors and ligands with numerous and diverse
functions. Identified in the 1970s, tumor necrosis factor α (TNFα) is a prototypic member of the
TNF super family and an endotoxin-induced, monocyte-derived serum factor responsible for
necrosis of certain tumors. Since its discovery, TNFα has proven to be an essential component of
the innate immune system via its potent pro-inflammatory regulation. Its many roles include
inducing cytokine production, stimulating growth, and activating adhesion molecules [26-28].
TNFα is first synthesized as a transmembrane precursor transported by the rough endoplasmic
reticulum and Golgi complex to the cell surface for secretion. The soluble form of TNFα results
from cleavage by the metalloprotease TNFα converting enzyme (TACE) with the trimers acting
as the potent ligand for TNF receptors on target cells[27]. Further cleavage leads to translocation
to the nucleus where pro-inflammatory cytokine signaling is induced. The more ubiquitously
expressed TNF receptor 1 (TNFR1) is the primary mediator for TNFα pro-inflammatory effects.
In addition to immunoregulatory effects, TNFα has functions related to lipid metabolism, insulin
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resistance, skeletal growth, and coagulation and has been implicated in numerous disease states
[28].
Chemokines
A major tenant of the immune system is its ability to recruit necessary cells to sights of infection
or injury and those cells’ ability to interact [29]. Chemokines are molecules with the specific
function of directing of the circulation of lymphoid cells and recruiting them under necessary
conditions. Like cytokines, they function both physiologically, also known as homeostatic
chemokines, and pathologically, or inflammatory chemokines. Additionally, the distinction
between these two functional groups is not concrete and overlaps in chemokine function exists.
A common way of grouping chemokines is using either CC, CXC, XC, or CX3C to indicate the
spacing of the first two cysteines on the amino terminals of the proteins [7]. Chemokine ligands
are denoted as one of these four groups followed by “L” whereas receptors are denoted as “R”.
This review will focus primarily on CCL and CXCL chemokines.
Homeostatic CC chemokines include CCL20, CCL17, CCL19, and CCL21 [30]. CC chemokine
ligand 20 (CCL20) binds to receptor CCR6 and was one of the first chemokines to be discovered
via bioinformatics-based DNA database searching and sequencing techniques [31]. It was given
three names from three different research groups. The first name was based on its expression in
the liver leading to the name liver and activation-regulated chemokine (LARC) [32]. The second
group cloned the cDNA from an activated human monocyte cDNA library and designated it CC
chemokine macrophage inflammatory protein-3α (MIP-3α) [33]. Now recognized as CCL20, the
protein structure is similar to other chemokines with three-stranded antiparallel β-sheet and a
COOH- terminal α-helix [34]. There is also a loop region believed to be involved in initial
binding of CLL20 with its receptor [33]. CCL20 has been shown to have effects on T- and B-
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lymphocytes and dendritic cells. For dendritic cells, it is clear that CCL20 and tis receptor CCR6
play a role in recruitment of immature dendritic cells and precursors to sites of infection or injury
[35]. It has been shown that LPS as well as some viruses and cytokines, such as TNFα and IL-4,
are able to induce CCL20 expression in several cell types. It has also been shown that CCL20
has constitutive expression in several tissues which contributes to its more homeostatic function
[7]. However, CCL20 follows the same overlapping pattern seen in many chemokines in its
involvement in both homeostatic and pathological processes. In particular, pathologies involving
endothelial surfaces have demonstrated CCL20 involvement including atopic dermatitis,
inflammatory bowel disease, and rheumatoid arthritis [36-38].
Inflammatory CC chemokines include CCL4 and CCL5. CCL4 has a very similar structure to
CCL20 with triple-stranded antiparallel β-sheets and the CCL4 dimer is cylindrical in general
and elongated. It was first found in the medium of LPS-activated macrophages and has been
shown to induce calcium mobilization in several cell types including NK cells, monocytes,
leukocytes, and vascular smooth muscle cells [39,40]. CCR5 is the most widely known receptor
for CCL4 on the cell surface and is a member of the G-protein-coupled receptor family. CCL4
expression has been associated with type 2 diabetes mellitus and CCR5 expression is associated
with inflammatory states and infections in addition to diabetes [29].
CXCL chemokines that are primarily homeostatic include CXCL13 and CXCL14. CXCL14 has
been coined the “Swiss army knife” of chemokines due to its role in homeostatic migration of
dendritic and NK cells as well as its proven antimicrobial activity against certain bacterial
pathogens [41]. For example, decreased constitutive CCL14 expression has been observed in
cases of atopic dermatitis lesions [42]. Its expression has also been seen in circulating blood cells
as well as skin and saliva barriers which all point to its involvement in innate, and potentially
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adaptive, immune response including chemotaxis in addition to its angiogenic and homeostatic
functions.
A major inflammatory chemokine is CXCL8, known as α chemokine or IL-8, with the orthologs
in avian species being CXCLi1 and CXCLi2 [4,43]. Originally discovered due to its role in
chemoattraction of neutrophils, IL-8 also acts on migration and activation of monocytes,
lymphocytes, and other cell types at sites of infection and is considered a key inflammatory
mediator [44]. Beyond inflammation, IL-8 has been shown to be an angiogenic factor on human
microvascular endothelial cells [45]. IL-8 binds to two receptors, CXCR1 and CXCR2 resulting
in a diverse array of intracellular signaling cascades inducing chemotaxis and degranulation. The
chemotactic signaling induced by IL-8 is primarily through binding with CXCR1. These
signaling cascades involve activation of G-proteins which ultimately stimulate enzymes that
activate MAPK signaling. MAPK signaling can induce cell survival, proliferation, and
inflammation via modifying a cell’s gene expression. Some target genes include adhesion
molecules such as integrin for chemotaxis as well as production of 3,4,5-inositol triphosphate
(IP3) stimulating the release of intracellular calcium stores and affecting degranulation [46,47].
Chemokines act as chemotaxis modulators affecting the make-up of the cellular community
involved in inflammation and the function of those cell types. They have diverse effects ranging
from homeostasis to inflammation and adaptive immune responses.
Cyto(Chemo)kines Roles in Physiological and Pathological Responses
Due to their diverse roles and scope of influence, cytokines and chemokines have been
implicated in both injury and infection as well as normal growth and homeostasis within an
organ system, such as the skeletal system[48-50]. Cytokines and chemokines alike have shown
significant involvement in the immune response to bacterial pathogens.
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Cyto(Chemo)kine Signaling in Skeletal Growth/Remodeling
Skeletal growth is a complex process involving primarily endochondral ossification, a process in
which cartilage is an intermediate to bone formation [51]. This process begins in the center of the
bone and is followed by growth plate endochondral ossification from either end. The primary
cells involved in this process are chondrocytes which undergo differentiation, hypertrophy, and
maturation/mineralization, followed by invasion of bone forming osteoblasts and bone absorbing
osteoclasts [52]. Vascularization is needed to simultaneously retreat and remodel within the areas
of bone growth for the process to continue. Even after skeletal growth is complete, bone
remodeling occurs throughout life and relies on a complex network of cell signaling,
differentiation, proliferation, and function [53].
The connection between bone and the immune system starts at the very beginning of cellular
stages. The progenitors of osteoblasts and osteoclasts are located in the bone marrow where they
exist in direct contact with progenitors of immune cells. Osteoclasts themselves are a highly
specialized immune cell as they derive form hematopoietic progenitor cells [54,55].
Additionally, immune cells are known producers of key osteogenic and osteoclastogenic factors
and several inflammatory disorders have shown to have significant effects on bone mass [56,57].
Indeed, several cytokines have shown to promote osteoclastogenesis including TNFα, IL-1, IL17, and IL-6 [48,56]. A major player in bone growth and remodeling is the transmembrane
protein receptor activator of nuclear factor κB (RANK) or RANK ligand (RANKL). RANKL is
key to osteoclast differentiation and therefore bone resorption [58]. IL-17 is known to indirectly
promote osteoclastogenesis via induction of RANKL production in certain immune cells and
osteoblast lineage cells [3,8]. Influencing RANKL within bone acts as a means of shifting the
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balance of bone resorption and bone mineralization and can have effects on bone mass and
growth.
Chemokines have also been implicated in physiological conditions of bone remodeling as well as
pathological conditions. Both CCL20 and CCR6 deficient mice, showed decreased trabecular
bone mass that was attributed to decreased bone formation due to lower numbers of osteoblasts
[59]. The pathological effects of CCL20 in bone will be discussed in a subsequent section.
Another chemokine that has shown to have potential effects on bone remodeling and growth is
IL-8. In vitro studies have shown that both osteoclasts and osteoblasts express IL-8 under
treatment with inflammatory mediators, including IL-1β and TNFα [60,61]. IL-8 has also been
shown to influence the differentiation of circulating monocytes as conditioned media from IL-8
stimulated primary human osteoblasts lead to osteoclast formation of peripheral blood
monocytes [62]. These findings indicate that IL-8 can affect bone resorption via several means.
Notably, it has also been shown that breast cancer patients with bone metastases had elevated
levels of plasma IL-8 which correlated with increased bone resorption [63].
Overall, cytokines and chemokines have an integrated relationship with bone during growth,
remodeling, and homeostasis. This relationship becomes even more complex when the cytokines
and chemokines become involved in an immune response to infection or disease.
Cyto(Chemo)kine and Inflammation of the Skeletal System
Cytokines and chemokines participate in numerous cellular processes and affect an array of cell
types which overlap both physiology and pathology. In regard to the skeletal system, this
complex network of cell signaling, and chemotaxis becomes central to inflammatory response
and disease symptoms.
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Inflammatory states, especially when chronic, coincide with decreased bone mass as well as
potentially decreased longitudinal bone growth [57]. The mechanism by which this association
occurs is activated and regulated by the cytokine and chemokine during inflammation.
Transgenic mice, overexpressing TNFα and IL-6, experience growth retardation resulting from
decreased insulin-like growth factor 1 (IGF1) and IGF1-binding protein (IGFBP3) which are
integral to longitudinal bone growth at the growth plate [64]. It has been shown that cytokines
can have a systemic effect on skeletal growth via suppression of IGF1 [65,66]. Conversely,
TNFα and IL-1β act to suppress growth by decreasing chondrocyte proliferation and hypertrophy
while increasing apoptosis within the growth plate [65]. A common disease involving
inflammation of the growth plate is rheumatoid arthritis (RA). In RA, bone is rapidly degraded
leading to bone erosions due to inflammation [37]. As the main drivers of inflammation,
including mediators and chemotaxis of immune cells, cytokines have been implicated in RA
pathogenesis [67,68]. The mechanism by which cytokine induce bone degradation is via their
influence on differentiation and activity of osteoclasts as previously described. The balance of
bone-forming to bone-resorbing cell types is off-balance under inflammatory conditions leading
to increased bone resorption and overall bone mass loss. IL-17 has also been implicated in RA
inducing bone loss by similar means as other cytokines. Notably, inhibition of IL-17 in animal
models of inflammatory arthritis showed reduced bone loss potentially based on upregulation of
regulatory cytokines including IL-4 and IL12 [69]. While pro-inflammatory molecules clearly
possess primarily osteoclastogenic functions, especially in inflammatory diseases of the bone,
anti-inflammatory cytokines such as IL-10 and IL-4 are negative regulators of osteoclast
formation. These cytokines are involved in the Th2 differentiation of the T-cell lineage and show
to have regulatory effects on the skeletal system in opposition to their pro-inflammatory
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counterparts [70,71]. Under both cancer-induced bone metastasis as well as inflammatory RA,
the chemokine CCL20 was shown to be correlated to bone loss as well as metastasis and patient
survival. Increased CCL20 expression was found in subchondral bone of RA patients while in a
mouse model for breast cancer bone metastasis, treatment with anti-CCL20 inhibited metastasis
and osteolysis [72,73]. In skeletal inflammatory diseases, cytokines and chemokines act by
influencing the ratio of osteoblast to osteoclast and thereby affecting bone mass and homeostasis.
Another cell type affected by inflammatory state of the bone is the chondrocyte. Chondrocytes
are the main cell type of the growth plate and responsible for endochondral ossification in
longitudinal bone growth [74]. Osteoarthritis is an inflammatory degenerative disease affecting
the articular cartilage and the chondrocytes therein. It is characterized by decreased extracellular
matrix formation by chondrocytes as well as increased matrix metalloproteinases and
aggrecanases [75,76]. Both symptoms have been associated with the expression of proinflammatory cytokines such as TNFα and IL-1β. It has been shown that metalloproteinases and
aggrecanases resulting from these cytokines inhibits the expression of cartilage-specific markers,
type II collagen and aggrecan [77]. This shift away from the anabolic processes within the
chondrocytes necessary for endochondral ossification contributes to osteoarthritic cartilage
degradation and shows how inflammatory states have the potential to produce detrimental
cytokine profiles within bone.
The cell types involved in bone growth and remodeling are all influenced by cyto(chemo)kines
under inflammatory states. Consequently, a common symptom of inflammation is bone loss and
degeneration due to lack of bone formation and dysfunctional cellular processes.
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Cyto(Chemo)kines and Bacterial Infection in Bone
In the event of severe bacterial, and even viral, infections, there is a robust production of
cytokines and resultant immunopathology that has been called a “cytokine storm” [78,79]. It has
been shown that morbidity and mortality in infectious states can be linked to the cytokine and
chemokine levels that make up the “storm” [80]. The diverse array of cytokines and chemokines
produced as well as their numerous receptor binding and signaling effects results in complex
immune and inflammatory responses under bacterial challenge or infection.
In bone, bacterial infections often involve bacteria with receptors for collagen or bone
sialoprotein, such as Staphylococcus aureus [81,82]. The means by which bacteria cause
pathological bone loss are still being investigated. However, it is clear that the bone cell type
affected as well as the bacteria involved play a role. Cytokines have been implicated as potential
means of bacteria to induce cellular pathways that promote bone resorption rather than formation
[83,84]. As previously described, certain cytokines influence stages of bone cell differentiation
and maturation. These cytokines are also induced under bacterial infection, resulting in similar
pathways of osteoclastogenic and osteolytic influence. Additionally, surface proteins of S. aureus
have been shown to induce bone loss via potent osteolytic effects which are inhibited by IL-1
receptor or TNF antibodies [85]. Similar trends have been seen under LPS stimulation in bone as
well [85]. This indicates bacterial influence on bone resorption via modulation of cytokines and
their pathways leading to increased osteoclast activity and decreased bone formation. Bone cells
such as osteoblasts have been shown to produce cytokines, such as IL-6, under bacterial infection
such as osteomyelitis conditions, potentially exacerbating the effects of bacterial infection,
inflammation, and bone loss [86,87]. Research using other bacterial species responsible for bone
infections, such as Escherichia coli and Porphyromonas gingivalis, have shown similar effects of
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LPS and surface proteins inducing shifts in bone-resorbing factors and osteolytic factors
including IL-1, IL-6, nitric oxide, and granulocyte-macrophage colony stimulating factors [8895]. In implant-associated osteomyelitis, the gene expression of chemokines CCL3 and CXCL2
were increased in osteolytic sites. It was also shown that osteoblasts produced both CCL3 and
CXCL2 under bacterial challenge and CCL3 induced monocyte differentiation to osteoclasts
[96].
In addition to stimulating bone resorption and osteolytic factors, endotoxin-LPS has also shown
to inhibit bone collagen and non-collagenous protein synthesis [97,98]. Additionally, surfaceassociated proteins from causative agents of periodontitis inhibited bone matrix synthesis [99].
For example, Bordetella bronchiseptica, a bacterium responsible for oral bone lesions exhibiting
impaired osteoblastic function, produces a dermonecrotic toxin which lead to decreased capacity
of murine osteoblasts to produce both alkaline phosphatase and collagen in vitro [100-102].
Notably, exposure to dermonecrotic toxin also resulted in multinucleated osteoblasts indicating
this toxin’s potential ability to inhibit normal cellular division [103]. The mechanism by which
bone matrix synthesis is inhibited, and its relation to potential cell cycle inhibition, is still being
investigated. Studies have shown a range of bacterial proteins interfere with cellular functions
such as protein synthesis, maturation, differentiation, and potentially cellular division. These
effects seem to be carried out in-part by the modulation and activation of the bacterial-induced,
cytokine “storm”.
The effect of the bacterial infection in bone is seen beyond the tissue level as well, with evidence
of shifts in circulating cytokine profiles in osteomyelitis. Indeed, tuberculous osteomyelitis is
associated with elevated circulating IL-6 concentrations [104]. Other studies have found a
distinction between early and late-stage chronic osteomyelitis, with initial increases of IL-4 and
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TNFα in peripheral mononuclear cells followed by increased IL-10, IL-2, and IL-6 [105]. A
similar study involving LPS stimulation of whole blood from patients with chronic osteomyelitis
as well as evaluation of infected bone found increased expression of TNF, IL-6, and IL-8 locally
in the bone with no significant difference in blood after stimulation [106]. Cytokines play an
integral role in bacterial infections in bone, their influence on a systemic level and their detection
continue to be investigated.
The targeting of cytokines and chemokines in bacterial infections has gone beyond human
medicine to reach animal agriculture as well. Bacterial chondronecrosis with osteomyelitis
(BCO), also called femur head necrosis (FHN), poses a significant threat to the poultry industry
as a leading cause of lameness and production loss in modern broilers [107,108]. Recent studies
analyzing the transcriptome of the proximal femur head in broilers with femur head separation, a
perceived indicator early-stage BCO, revealed genes involved in the immune system, including
cytokine response to be differentially expressed [109]. Notably, some cytokines were also
differentially expressed including CCL19 and CCL21 along with their receptor CCR7. These
cytokines have also been implicated in rheumatoid arthritis pathogenesis via upregulation of
osteoclast activity as previously discussed [110]. In an experimental model of FHN using
methylprednisolone intramuscular injections, broilers with FH had increased serum levels of
catabolic cytokines such as IL-1β, which was concluded to contribute to a disruption of
extracellular matrix homeostasis. This disruption could lead to increased susceptibility to
BCO/FHN via a shift to resorption over bone formation [111]. Analysis of BCO affected and
healthy bone revealed the involvement of dsRNA accumulation and NLRP3 inflammasome
activation in the presence of increased IL-1β expression in BCO affected tissue. Of interest, this
inflammasome activation was shown to be induced by IL-1β in an in vitro model [112].More
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research is needed in order to fully elucidate the role cytokines play in BCO and whether their
presence could be used for treatment as well as diagnosis which could improve prevention,
detection, and treatment in modern broilers.
Conclusions and Perspectives
Cytokines and chemokines are biological bridges between physiology and pathology, especially
within the skeletal system. The unique and diverse ligand-receptor combinations among
cytokines and chemokines present a myriad of signaling pathways and functions at the local
tissue and systemic circulation level. Continued research into the overlap of immune response
and homeostasis in which cytokine sand chemokines are involved could shed light on previously
unknown links and mechanisms in bone inflammatory diseases and bacterial infections. These
potential links could provide a foundation for improved diagnosis and treatment of bone related
diseases in both human medicine and animal agriculture.

122

References
1.

Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007, 45, 27.

2.

Ramani T, Auletta CS, Weinstock D, Mounho-Zamora B, Ryan PC, Salcedo TW,
Bannish G. Cytokines: The Good, the Bad, and the Deadly. Int J Toxicol. 2015, 34, 355365.

3.

Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J. Regulation of Osteoclast
Differentiation by Cytokine Networks. Immune Netw. 2018, 18, e8-e8.

4.

Kaiser P, Stäheli P. Chapter 10 - Avian Cytokines and Chemokines. Elsevier. 2014; pp.
189-204.

5.

Cuneo AA, Autieri MV. Expression and Function of Anti-Inflammatory Interleukins: The
Other Side of the Vascular Response to Injury. Curr Vasc Pharmacol. 2009, 7, 267-276.

6.

Sharma J, Bhar S, Devi CS. A review on interleukins: The key manipulators in
rheumatoid arthritis. Mod rheumatol. 2017, 27, 723-746.

7.

Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: At the
crossroads of cell signalling and inflammatory disease. BBA-Mol Cell Res. 2014, 1843,
2563-2582.

8.

Tang M, Lu L, Yu X. Interleukin-17A Interweaves the Skeletal and Immune Systems.
Front Immunol. 2020, 11, 625034-625034.

9.

Kaur S, Bansal Y, Kumar R, Bansal G. A panoramic review of IL-6: Structure,
pathophysiological roles and inhibitors. Bioorg Med Chem. 2020, 28, 115327-115327.

10.

Ogata A, Kato Y, Higa S, Yoshizaki K. IL-6 inhibitor for the treatment of rheumatoid
arthritis: A comprehensive review. Mod rheumatol. 2019, 29, 258-267.

11.

Benihoud K, Salone B, Esselin S, Opolon P, Poli V, Di Giovine M, Perricaudet M,
Saggio I. The role of IL-6 in the inflammatory and humoral response to adenoviral
vectors. J Gene Med. 2000, 2, 194-203.

12.

Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006, 8, S3-S3.

13.

Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP. High circulating levels
of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value,
and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group.
Am J Med. 1991, 91, 23.

14.

Spittler A, Razenberger M, Kupper H, Kaul M, Hackl W, Boltz-Nitulescu G, Függer R,
Roth E. Relationship Between Interleukin-6 Plasma Concentration in Patients with
Sepsis, Monocyte Phenotype, Monocyte Phagocytic Properties, and Cytokine Production.
Clin Infect Dis. 2000, 31, 1338-1342.
123

15.

Wang X, Wong K, Ouyang W, Rutz S. Targeting IL-10 Family Cytokines for the
Treatment of Human Diseases. CSH Prespect Biol. 2019, 11, a028548.

16.

Moschen AR, Tilg H, Raine T. IL-12, IL-23 and IL-17 in IBD: immunobiology and
therapeutic targeting. Nat Rev Gastro Hepat. 2019, 16, 185-196.

17.

Mahlangu T, Dludla PV, Nyambuya TM, Mxinwa V, Mazibuko-Mbeje SE, Cirilli I,
Marcheggiani F, Tiano L, Louw J, Nkambule BB. A systematic review on the functional
role of Th1/Th2 cytokines in type 2 diabetes and related metabolic complications.
Cytokine. 2020, 126, 154892.

18.

Abebe F. Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis
infection: A review of current understanding: The paper discusses the importance of
simultaneous induction of Th1/Th2 responses to design and develop vaccine against TB.
Int Rev Immunol. 2019, 38, 172-179.

19.

Boissier MC, Assier E, Falgarone G, Bessis N. Shifting the imbalance from Th1/Th2 to
Th17/treg: The changing rheumatoid arthritis paradigm. Joint, bone, spine. 2008, 75, 373375.

20.

Romagnani S. The Th1/Th2 paradigm. Immunol Today. 1997, 18, 263-266.

21.

Iyer SS, Cheng G. Role of Interleukin 10 Transcriptional Regulation in Inflammation and
Autoimmune Disease. Crit Rev Immunol. 2012, 32, 23-63.

22.

Jin Y, Wi HJ, Choi MH, Hong ST, Bae YM. Regulation of anti-inflammatory cytokines
IL-10 and TGF-beta in mouse dendritic cells through treatment with Clonorchis sinensis
crude antigen. Exp Mol Med. 2014, 46, e74-e74.

23.

Patin EC, Willcocks S, Orr S, Ward TH, Lang R, Schaible UE. Mincle-mediated antiinflammatory IL-10 response counter-regulates IL-12 in vitro. Innate Immun. 2016, 22,
181-185.

24.

Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of
the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011,
29, 71-109.

25.

Bastian D, Wu Y, Betts BC, Yu XZ. The IL-12 Cytokine and Receptor Family in Graftvs.-Host Disease. Front Immunol. 2019, 10, 988-988.

26.

Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF Receptor Superfamilies:
Integrating Mammalian Biology. Cell. 2001, 104, 487-501.

27.

Rothe J, Gehr G, Loetscher H, Lesslauer W. Tumor Necrosis Factor Receptors - Structure
and Function. Immunol Res. 1992, 11, 81-90.

28.

Smith CA, Farrah T, Goodwin RG. The TNF Receptor Superfamily of Cellular and Viral
Proteins - Activation, Costimulation, and Death. Cell. 1994, 76, 959-962.
124

29.

Chang TT, Chen JW. Emerging role of chemokine CC motif ligand 4 related mechanisms
in diabetes mellitus and cardiovascular disease: friends or foes? Cardiovasc Diabetol.
2016, 15, 117-117.

30.

Chen K, Bao Z, Tang P, Gong W, Yoshimura T, Wang JM. Chemokines in homeostasis
and diseases. Cell Mol Immunol. 2018, 15, 324-334.

31.

Le Y, Zhou Y, Iribarren P, Wang JM. Chemokines and Chemokine Receptors: Their
Manifold Roles in Homeostasis and Disease. Cell Mol Immunol. 2004, 1, 95-104.

32.

Nakayama T, Fujisawa R, Yamada H, Horikawa T, Kawasaki H, Hieshima K, Izawa D,
Fujiie S, Tezuka T, Yoshie O. Inducible expression of a CC chemokine liver- and
activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)3α/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol.
2001, 13, 95-103.

33.

Pérez-Cañadillas JM, Zaballos Á, Gutiérrez J, Varona R, Roncal F, Albar JP, Márquez G,
Bruix M. NMR Solution Structure of Murine CCL20/MIP-3α, a Chemokine That
Specifically Chemoattracts Immature Dendritic Cells and Lymphocytes through Its
Highly Specific Interaction with the β-Chemokine Receptor CCR6. J Biol Chem. 2001,
276, 28372-28379.

34.

Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu WY, Lubkowski J. The
structure of human macrophage inflammatory protein-3 alpha/CCL20 - Linking
antimicrobial and CC chemokine receptor-6-binding activities with human betadefensins. J Biol Chem. 2002, 277, 37647-37654.

35.

Sisirak V, Vey N, Vanbervliet B, Duhen T, Puisieux I, Homey B, Bowman EP, Trinchieri
G, Dubois B, Kaiserlian D, et al. CCR6/CCR10-mediated plasmacytoid dendritic cell
recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood. 2011, 118,
5130-5140.

36.

Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC. Colonic epithelial cells are a
major site of macrophage inflammatory protein 3α (MIP-3α) production in normal colon
and inflammatory bowel disease. Gut. 2002, 51, 818-826.

37.

Chevrel G, Garnero P, Miossec P. Addition of interleukin 1 (IL1) and IL17 soluble
receptors to a tumour necrosis factor α soluble receptor more effectively reduces the
production of IL6 and macrophage inhibitory protein-3α and increases that of collagen in
an in vitro model of rheumatoid synoviocyte activation. Ann Rheum Dis. 2002, 61, 730733.

38.

Matsui T, Akahoshi T, Namai R, Hashimoto A, Kurihara Y, Rana M, Nishimura A, Endo
H, Kitasato H, Kawai S, et al. Selective recruitment of CCR6‐expressing cells by
increased production of MIP‐3α in rheumatoid arthritis. Clin Exp Immunol. 2001, 125,
155-161.

125

39.

Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B. Activation of NK cells by
CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol. 1996,
156, 322-327.

40.

Schecter AD, Calderon TM, Berman AB, McManus CM, Fallon JT, Rossikhina M, Zhao
W, Christ G, Berman JW, Taubman MB. Human Vascular Smooth Muscle Cells Possess
Functional CCR5. J Biol Chem. 2000, 275, 5466-5471.

41.

Benarafa C, Wolf M. CXCL14: the Swiss army knife chemokine. Oncotarget. 2015, 6,
34065-34066.

42.

Maerki C, Meuter S, Liebi M, Muhlemann K, Frederick MJ, Yawalkar N, Moser B, Wolf
M. Potent and Broad-Spectrum Antimicrobial Activity of CXCL14 Suggests an
Immediate Role in Skin Infections. J Immunol. 2009, 182, 507-514.

43.

Long X, Ye Y, Zhang L, Liu P, Yu W, Wei F, Ren X, Yu J. IL-8, a novel messenger to
cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review).
Int J Oncol. 2016, 48, 5-12.

44.

Poh TY, Pease J, Young JR, Bumstead N, Kaiser P. Re-evaluation of chicken CXCR1
determines the true gene structure - CXCLi1 (K60) and CXCLi2 (CAF/interleukin-8) are
ligands for this receptor. J Biol Chem. 2008, 283, 16408-16415.

45.

Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, Otterson MF, Ota
DM, Lugering N, Domschke W, et al. Angiogenic Effects of Interleukin 8 (CXCL8) in
Human Intestinal Microvascular Endothelial Cells Are Mediated by CXCR2. J Biol
Chem. 2003, 278, 8508-8515.

46.

Takami M, Terry V, Petruzzelli L. Signaling Pathways Involved in IL-8-Dependent
Activation of Adhesion Through Mac-1. J Immunol. 2002, 168, 4559-4566.

47.

Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation.
Microbes Infect. 2003, 5, 1317-1327.

48.

Schett G. Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur J
Clin Invest. 2011, 41, 1361-1366.

49.

Galliera E, Locati M, Mantovani A, Corsi MM. Chemokines and Bone Remodeling. Int J
Immunopathol Parmacol. 2008, 21, 485-491.

50.

Brylka LJ, Schinke T. Chemokines in Physiological and Pathological Bone Remodeling.
Front Immunol.2019, 10, 2182-2182.

51.

Berendsen AD, Olsen BR. Bone development. Bone. 2015, 80, 14-18.

52.

Cancedda R, Castagnola P, Cancedda FD, Dozin B, Quarto R. Developmental control of
chondrogenesis and osteogenesis. Int J Dev Biol. 2000, 44, 707-714.

126

53.

Mackie EJ, Tatarczuch L, Mirams M. The skeleton: a multi-functional complex organ:
the growth plate chondrocyte and endochondral ossification. J Endocrinol. 2011, 211.

54.

Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simões MJ, Cerri PS. Biology of Bone
Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int.
2015, 2015, 421746.

55.

Gooch KJ, Tennant CJ. Bone Cells. In Mechanical Forces: Their Effects on Cells and
Tissues, Springer. 1997, 55-77.

56.

Souza PPC, Lerner UH. The role of cytokines in inflammatory bone loss. Immunol
Invest. 2013, 42, 555-622.

57.

Li H, Zhang S, Huo S, Tang H, Nie B, Qu X, Yue B. Effects of staphylococcal infection
and aseptic inflammation on bone mass and biomechanical properties in a rabbit model. J
Orthop Translat. 2020, 21, 66-72.

58.

Tong X, Zhang J, Li J. LPS-induced inflammation disorders bone modeling and
remodeling by inhibiting angiogenesis and disordering osteogenesis in chickens. Inflam
Res. 2020, 69, 765-777.

59.

Doucet M, Jayaraman S, Swenson E, Tusing B, Weber KL, Kominsky SL. CCL20/CCR6
Signaling Regulates Bone Mass Accrual in Mice. J bone Minner Res. 2016, 31, 13811390.

60.

Rothe L, Collin-Osdoby P, Chen Y, Sunyer T, Chaudhary L, Tsay A, Goldring S, Avioli
L, Osdoby P. Human osteoclasts and osteoclast-like cells synthesize and release high
basal and inflammatory stimulated levels of the potent chemokine interleukin-8.
Endocrinology. 1998, 139, 4353-4363.

61.

Chaudhary LR, Avioli LV. Dexamethasone Regulates IL-1-beta and NTF-alpha- Induced
Interleukin-8 Prodution in Human Bone-Marrow Stromal and Osteoblast-like Cells.
Calcif Tissue Int. 1994, 55, 16-20.

62.

Pathak JL, Bakker AD, Verschueren P, Lems WF, Luyten FP, Klein-Nulend J,
Bravenboer N. CXCL8 and CCL20 enhance osteoclastogenesis via modulation of
cytokine production by human primary osteoblasts. PloS one. 2015, 10, e0131041e0131041.

63.

Kamalakar A, Bendre MS, Washam CL, Fowler TW, Carver A, Dilley JD, Bracey JW,
Akel NS, Margulies AG, Skinner RA, et al. Circulating interleukin-8 levels explain breast
cancer osteolysis in mice and humans. Bone. 2014, 61, 176-185.

64.

De Benedetti F, Meazza C, Oliveri M, Pignatti P, Vivarelli M, Alonzi T, Fattori E,
Garrone S, Barreca A, Martini A. Effect of IL-6 on IGF binding protein-3: A study in IL6 transgenic mice and in patients with systemic juvenile idiopathic arthritis.
Endocrinology. 2001, 142, 4818-4826.

127

65.

Mårtensson K, Chrysis D, Sävendahl L. Interleukin‐1β and TNF‐α Act in Synergy to
Inhibit Longitudinal Growth in Fetal Rat Metatarsal Bones. J Bone Miner Res. 2004, 19,
1805-1812.

66.

MacRae VE, Burdon T, Ahmed SF, Farquharson C. Ceramide inhibition of chondrocyte
proliferation and bone growth is IGF-I independent. J Endocrinol.2006, 191, 369-377.

67.

McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nature
reviews. Immunol. 2007, 7, 429-442.

68.

Brzustewicz E, Bryl E. The role of cytokines in the pathogenesis of rheumatoid arthritis –
Practical and potential application of cytokines as biomarkers and targets of personalized
therapy. Cytokine. 2015, 76, 527-536.

69.

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S,
Kodama T, Akira S, Iwakura Y, et al. Th17 functions as an osteoclastogenic helper T cell
subset that links T cell activation and bone destruction. J Exp Med. 2006, 203, 26732682.

70.

Xu LX, Kukita T, Kukita A, Otsuka T, Niho Y, Iijima T. Interleukin-10 Selectively
Inhibits Osteoclast Progenitors Into Preosteoclat-like Cells in Rat Bone-Marrow Culture
System. J Cell Physiol. 1995, 165, 624-629.

71.

Shioi A, Teitelbaum SL, Ross FP, Welgus HG, Suzuki H, Ohara J, Lacey DL. Interleukin
4 inhibits murine osteoclast formation in vitro. J Cell Biol. 1991, 47, 272.

72.

Lisignoli G, Piacentini A, Cristino S, Grassi F, Cavallo C, Cattini L, Tonnarelli B,
Manferdini C, Facchini A. CCL20 chemokine induces both osteoblast proliferation and
osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone
tissue of rheumatoid arthritis patients. J Cell Physiol. 2007, 210, 798-806.

73.

Lee SK, Park KK, Kim HJ, Park J, Son SH, Kim KR, Chung WY. Human antigen Rregulated CCL20 contributes to osteolytic breast cancer bone metastasis. Sci Rep. 2017,
7, 9610-9613.

74.

van Donkelaar CC, Wilson W. Mechanics of chondrocyte hypertrophy. Biomech Model
Mechan. 2012, 11, 655-664.

75.

Rim YA, Nam Y, Ju JH. The Role of Chondrocyte Hypertrophy and Senescence in
Osteoarthritis Initiation and Progression. Int J Mol Sci. 2020, 21.

76.

Young AA, Smith MM, Smith SM, Cake MA, Ghosh P, Read RA, Melrose J, Sonnabend
DH, Roughley PJ, Little CB. Regional assessment of articular cartilage gene expression
and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis Res
Ther. 2005, 7, R852-R861.

77.

Demoor M, Ollitrault D, Gomez-Leduc T, Bouyoucef M, Hervieu M, Fabre H, Lafont J,
Denoix JM, Audigié F, Mallein-Gerin F, et al. Cartilage tissue engineering: Molecular
128

control of chondrocyte differentiation for proper cartilage matrix reconstruction. BBA.
2014, 1840, 2414-2440.
78.

Eloseily EM, Cron RQ. Bacteria-Associated Cytokine Storm Syndrome. Springer. 2019,
307-317.

79.

Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the Eye of the
Cytokine Storm. Microbiol Mol Biol Rev. 2012, 76, 16-32.

80.

Teijaro JR. Cytokine storms in infectious diseases. Semin Immunopathol. 2017, 39, 501503.

81.

Patti JM, Bremell T, Krajewskapietrasik D, Abdelnour A, Tarkowski A, Ryden C, Hook
M. The Staphylococcus aureus collagen adhesin is a virulence determinant in
experimental septic arthritis. Infect Immun. 1994, 62, 152-161.

82.

RydÉN C, Yacoub AI, Maxe I, HeinegÅRd D, Oldberg Å, FranzÉN A, Ljungh Å, Rubin
K. Specific binding of bone sialoprotein to Staphylococcus aureus isolated from patients
with osteomyelitis. Eur J Biochem. 1989, 184, 331-336.

83.

Aragón-Sánche J, Cabrera-Galván JJ. The role of cytokines in diabetic foot osteomyelitis.
Diabetic Med. 2013, 30, 628-629.

84.

Lacey DC, Simmons PJ, Graves SE, Hamilton JA. Proinflammatory cytokines inhibit
osteogenic differentiation from stem cells: implications for bone repair during
inflammation. Osteoarthr Cartil. 2008, 17, 735-742.

85.

Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. Bacterially induced bone
destruction: mechanisms and misconceptions. Infect Immun. 1996, 64, 2371-2380.

86.

Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S,
Matsuda T, Hirano T. IL-6 is produced by osteoblasts and induces bone resorption. J
Immunol. 1990, 145, 3297-3303.

87.

Damoulis PD, Hauschka PV. Cytokines induce nitric oxide production in mouse
osteoblasts. Biochem Biophys Res Commun. 1994, 201, 924-931.

88.

Hanazawa S, Amano S, Nakada K, Ohmori Y, Miyoshi T, Hirose K, Kitano S. Biological
characterization of interleukin-1-like cytokine produced by cultured bone cells from
newborn mouse calvaria. Calcif Tissue Int. 1987, 41, 31.

89.

Keeting PE, Rifas L, Harris SA, Colvard DS, Spelsberg TC, Peck WA, Riggs BL.
Evidence for interleukin-1 beta production by cultured normal human osteoblast-like
cells. J Bone Miner Res. 1991, 6, 827-833.

90.

Littlewood AJ, Russell J, Harvey GR, Hughes DE, Russell RGG, Gowen M. The
modulation of the expression of IL-6 and its receptor in human osteoblasts In vitro.
Endocrinology. 1991, 129, 1513-1520.
129

91.

Horowitz MC, Coleman DL, Flood PM, Kupper TS, Jilka RL. Parathyroid hormone and
lipopolysaccharide induce murine osteoblast-like cells to secrete a cytokine
indistinguishable from granulocyte-macrophage colony-stimulating factor. J Clin Invest.
1989, 83, 149-157.

92.

Brandi ML, Hukkanen M, Umeda T, Moradibidhendi N, Bianchi S, Gross SS, Polak JM.
Bidirectional Regulation of Osteoclast Function by Nitric Oxide Synthase Isoforms. Proc
Natl Acad Sci. 1995, 92, 2954-2958.

93.

Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993, 329,
2002-2012.

94.

Riancho JA, Salas E, Zarrabeitia MT, Olmos JM, Amado JA, Fernandezluna JL,
Gonzalezmacias J. Expression and functional role of nitric oxide synthase in osteoblastlike cells. J Bone Miner Res. 1995, 10, 439-446.

95.

Nishitani K, Bello-Irizarry SN, de Mesy Bentley KL, Daiss JL, Schwarz EM. Chapter 16
- The Role of the Immune System and Bone Cells in Acute and Chronic Osteomyelitis.
Elsevier Inc. 2016, 283-295.

96.

Dapunt U, Maurer S, Giese T, Gaida MM, Hänsch GM. The Macrophage Inflammatory
Proteins MIP1 (CCL3) and MIP2 (CXCL2) in Implant-Associated Osteomyelitis:
Linking Inflammation to Bone Degradation. Mediators Inflamm. 2014.

97.

Millar SJ, Goldstein EG, Levine MJ, Hausmann E. Modulation of bone metabolism by
two chemically distinct lipopolysaccharide fractions from Bacteroides gingivalis. Infect
Immun. 1986, 51, 302-306.

98.

Harvey W, Wilson M, Meghji S. In vitro inhibition of lipopolysaccharide-induced bone
resorption by polymyxin B. Br J Exp Pathol. 1986, 67, 699-705.

99.

Meghji S, Henderson B, Nair S, Wilson M. Inhibition of bone DNA and collagen
production by surface-associated material from bacteria implicated in the pathology of
periodontal disease. J Peridontol. 1992, 63, 736-742.

100.

Silveira D, Edington N, Smith IM. Ultrastructural changes in the nasal turbinate bones of
pigs in early infection with Bordetella bronchiseptica. Res Vet Sci. 1982, 33, 37.

101.

Kimman TG, Lowik CM, Van De Wee-Pals LJA, Thesingh CW, Defize P, Kamp EM,
Bijvoet OLM. Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic
toxin-containing conditioned medium from Pasteurella multocida, and purified
dermonecrotic toxin from P. multocida. Infect Immun. 1987, 55, 2110-2116.

102.

Horiguchi Y, Nakai T, Kume K. Effects of Bordetella bronchiseptica dermonecrotic toxin
on the structure and function of osteoblastic clone MC3T3-E1 cells. Infect Immun. 1991,
59, 1112-1116.

130

103.

Horiguchi Y, Sugimoto N, Matsuda M. Stimulation of DNA synthesis in osteoblast-like
MC3T3-E1 cells by Bordetella bronchiseptica dermonecrotic toxin. Infect Immun. 1993,
61, 3611-3615.

104.

Evans CAW, Jellis J, Hughes SPF, Remick DG, Friedland JS. Tumor Necrosis Factor-α,
Interleukin-6, and Interleukin-8 Secretion and the Acute-Phase Response in Patients with
Bacterial and Tuberculous Osteomyelitis. J Infect Dis. 1998, 177, 1582-1587.

105.

Ferreira GF, Moraes C, Soares da Silveira AM, Correa-Oliveira R, Teixeira-Carvalho A,
Martins-Filho OA, Moreno EC, do Carmo LS, de Oliveira Fraga LA Cotta Malaquias
LC. Distinct cytokine profiles of circulating mononuclear cells stimulated with
Staphylococcus aureus enterotoxin A in vitro during early and late episodes of chronic
osteomyelitis. Mem Inst Oswaldo Cruz. 2012, 107, 348-355.

106.

Fullilove S, Jellis J, Hughes SPF, Remick DG, Friedland JS. Local and systemic
concentrations of tumour necrosis factor-alpha, interleukin-6 and interleukin-8 in
bacterial osteomyelitis. Trans R Soc Trop Med Hyg. 2000, 94, 221-224.

107. Wideman RF. Bacterial chondronecrosis with osteomyelitis and lameness in broilers: a
review. Poult Sci. 2016, 95, 325-344.
108.

McNamee PT, Smyth JA. Bacterial chondronecrosis with osteomyelitis ('femoral head
necrosis') of broiler chickens: a review. Avian Pathol. 2000, 29, 253-270.

109. Peixoto JO, Savoldi IR, Guaratini Ibelli AM, Cantao ME, Ferreira Jaenisch FR, Giachetto
PF, Settles ML, Zanella R, Petroli Marchesi JA, Pandolfi JR, et al. Proximal femoral head
transcriptome reveals novel candidate genes related to epiphysiolysis in broiler
chickens. BMC Genomics. 2019, 20, 1031-1031.
110. Lee J, Park C, Kim HJ, Lee YD, Lee ZH, Song YW, Kim HH. Stimulation of osteoclast
migration and bone resorption by C-C chemokine ligands 19 and 21. Exp Mol
Med. 2017, 49, e358-e358.
111. Yu Y, Wang S, Zhou Z. Cartilage Homeostasis Affects Femoral Head Necrosis Induced by
Methylprednisolone in Broilers. Int J Mol Sci. 2020, 21, 4841.
112. Greene E. Flees J, Dhamad A, Alrubaye A, Hennigan S, Pleimann J, Smeltzer M, Murray S,
Kugel J, Goodrich J, et al. Double-Stranded RNA Is a Novel Molecular Target in
Osteomyelitis Pathogenesis A Translational Avian Model for Human Bacterial
Chondronecrosis with Osteomyelitis. Am J Pathol. 2019, 189, 2077-2089.

131

Chapter 7 –
Title: Local and Systemic Cytokine, Chemokine, and FGF Profile in Bacterial Chondronecrosis
with Osteomyelitis (BCO)-affected Broilers
Authors: Alison Ramser1,2, Elizabeth Greene1, Robert Wideman1 and Sami Dridi1,2
1

University of Arkansas, Center of Excellence for Poultry Science, Fayetteville, Arkansas 72701.

2

University of Arkansas, Cell and Molecular Biology, Fayetteville, Arkansas 72701.

Corresponding author: Sami Dridi
Center of Excellence for Poultry Science, University of Arkansas, 1260 W. Maple Street,
Fayetteville, AR 72701, USA
Phone: (479)-575-2583, Fax: (479)-575-7139
Email address: dridi@uark.edu
Abstract: Complex disease states, like bacterial chondronecrosis with osteomyelitis (BCO), not
only result in physiological symptoms, such as lameness, but also a complex systemic reaction
involving immune and growth factor responses. For the modern broiler (meat-type) chickens,
BCO is an animal welfare, production, and economic concern involving bacterial infection,
inflammation, and bone attrition with a poorly defined etiology. It is, therefore, critical to define
the key inflammatory and bone-related factors involved in BCO. In this study, the local bone and
systemic blood profile of inflammatory modulators, cytokines, and chemokines, was elucidated
along with inflammasome and key FGF genes. BCO-affected bone showed increased expression
of cytokines IL-1β, while BCO-affected blood expressed upregulated TNFα and IL-12.
Chemokine profile revealed increased IL-8 expression in both BCO-affected bone and blood in
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addition to inflammasome NLRC5 being upregulated in circulation. The key FGF receptor,
FGFR1, was significantly downregulated in BCO-affected bone. Exposure of two different bone
cell types, hFOB and chicken primary chondrocytes, to plasma from BCO-affected birds, as well
as recombinant TNFα, resulted in significantly decreased cell viability. These results
demonstrate an expression of pro-inflammatory and bone-resorptive factors and their potential
contribution to BCO etiology through their impact on bone cell viability. This unique profile
could be used for improved, non-invasive detection of BCO and provides potential targets for
treatments.
Keywords: Cytokines; FGF; BCO; FHN; lameness; broilers
Introduction
Modern broiler chickens are characterized by fast growth and high meat yield resulting in a
highly efficient means of producing animal protein. This achievement in performance has been
met with physiological obstacles such as lameness which leads to animal welfare concerns and
production loss [1]. A common cause of lameness is bacterial chondronecrosis with
osteomyelitis (BCO), also known as femur head necrosis (FHN). BCO involves bacterial
infection, bone attrition, and lack of healing in the proximal head of the femur and tibia [2].
These points are known to be key mechanical stress points within the skeletal system resulting in
increased susceptibility to bacterial infection [3]. The highly vascularized avian growth plate
coupled with occurrence of mechanically induced “wound sites” within the highly dynamic
network of cells of the growth plate creates the perfect storm for BCO [3]. The necrosis and
attrition of bone with simultaneous bacterial infection leads to rapid deterioration of animal
welfare which is exacerbated by the inability to detect BCO without necropsy, especially when
subclinical. While it is clear that BCO-affected broilers are under multiple stressors, both
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immune and physiological, it has yet to be investigated whether BCO has systemic effects on
inflammatory pathways which may contribute to the etiology seen locally which could also be
used as a means of detection via a circulating biomarker.
The key characteristics of BCO, infection, inflammation, and lack of healing or regeneration,
provide a roadmap of potential pathways involved. As mediators of the inflammatory response
under both stress and bacterial infections, cytokines and chemokines have been implicated in
numerous skeletal diseases including rheumatoid arthritis, osteoarthritis, periodontitis, and
osteomyelitis [4-9]. Their involvement in inflammasome activation has also been well
documented and links their roles to cell survival and homeostasis [10]. Additionally, these
molecules have key physiological functions in bone development and homeostasis [11,12].
Fibroblast growth factors regulate healing and development as well as immune cell states and
function in both bone and on a systemic level [13,14]. Specifically, FGF23 is a key factor in the
Bone-Kidney-Cardiac-immune axis as well as macrophage transition under inflammatory states
[15]. FGF pathways have also been implicated in healing and bone regeneration which is a major
tenant lacking in BCO-affected bone [13]. Therefore, this study was undertaken to investigate
whether systemic effects of BCO exist as well as profile the local and systemic expression of
cyto(chemo)kines and key FGFs and evaluate their potential role in BCO etiology.
Materials and Methods
Bone and blood sample collection
All animal experiments were approved by the University of Arkansas (Fayetteville, AR) Animal
Care and Use Committee (protocol number 15043) and were in accordance with
recommendations in NIH’s Guide for the Care and Use of Laboratory Animals. The BCO model
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and healthy counterparts were conducted as previously described [16,17]. Briefly, animals were
placed on either litter or wire-flooring and had ad libitum access to fresh water and feed for 56
days. The wire-flooring environment consisted of a raised floor made of wire covered panels to
create unsteady footing. This design has been shown to induce spontaneous BCO in broilers in
addition to increasing the occurrence of lameness [16]. Ambient temperature and lighting
conditions followed industry standards, as previously described [10]. At the end of the 56 days,
animals were assessed for presence or absence of lameness. First, blood was drawn from the
wing vein of lame birds that were reared on wire-flooring and non-lame birds reared on litter.
Next, birds were humanely euthanized and immediately necropsied to determine presence of
subclinical lesions in the proximal heads of both the femora and tibiae. Bone was selected
macroscopically based on a previously reported scale [16]. Normal blood and bone came from
non-lame birds, reared on litter that did not have BCO lesions. BCO-affected blood and bone
were from lame birds reared on wire-flooring with severe BCO lesions in both legs. Proximal
portions of bone, primarily consisting of the growth plate, were snap frozen in liquid nitrogen
and stored at -80˚C for later analysis. Blood was either stored in heparin treated tubes for cell
treatment or Trizol reagent (Life Technologies, Carlsbad, CA) for RNA isolation.
Cell Culture and Treatment
Human fetal osteoblast (hFOB) 1.19 cells (CRL-11372; ATCC, Manassas, VA) were cultured in
a 1:1 mixture of Ham’s F12 medium/Dulbecco’s modified Eagle’s medium (DMEM), 10% fetal
bovine serum (FBS), and 0.3 mg/mL G418. Cells were grown at 34ºC in a humidified
atmosphere of 95% air and 5% CO2. Chicken primary chondrocytes were grown in a media of
DMEM with 4.5g glucose/L, glutamine, HEPES, and sodium pyruvate supplemented with 10
ng/mL ascorbic acid, 10% FBS, and 1% penicillin/streptomycin. Primary chondrocyte cells were
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grown at 37ºC in a humidified atmosphere of 95% air and 5% CO2. At 80% confluence, cells
were synchronized using serum-free media overnight before being treated with human
recombinant IL-1β (100 ng/mL) (PreproTech, East Windsor, NJ), IL-8 (100 ng/mL) (R&D
Systems, Minneapolis, MN), TNFα (10ng/mL) (PreproTech, East Windsor, NJ), or dimethyl
sulfoxide (DMSO) as control for 24 hours (n=3/group). Following treatment, cells were
processed for viability as described below. Additionally, hFOB cells were washed three times
with phosphate-buffer saline (PBS) and treated with media containing either 5% plasma from
healthy or BCO affected birds or PBS (n=3/group). Cells were maintained for an additional 4
hours before being processed for cell viability.
Cell Viability
Cell viability for hFOB cells was performed as previously described [18]. Briefly, cells were
seeded at 1 × 104 cells per well of a 96-well plate before being treated as described above.
CellTiter 96 AQueous One Solution CellProliferation Assay (Promega, Madison, WI) was used,
according to manufacturer’s recommendations, and results were obtained using a Synergy HT
multimode microplate reader (BioTek, Winooski, VT). All sample readings were background
corrected, and results were reported relative to control.
Cell viability for primary chondrocyte cells was conducted using Trypan Blue live-dead stain
(0.4%) (Life Technologies, Carlsbad, CA) and quantified using Countess II FL (Life
Technologies, Carlsbad, CA).
RNA isolation, reverse transcription, and real-time quantitative PCR
From the normal and BCO-affected bone and blood samples (n =4/group), total RNA was
isolated in accordance with the protocol of previous work [19]. Total RNA was isolated using
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Trizol reagent (Life Technologies, Carlsbad, CA), based on manufacturer’s instructions. RNA
concentrations were determined using Synergy HT multimode microplate reader and total RNA
was reverse transcribed using qScript cDNA SuperMix (Quanta Biosciences, Gaithsburg, MD).
Amplification was achieved using Power SYBRGreen Master Mix (Life Technologies, Carlsbad,
CA) and real-time quantitative PCR (7500 Real Time System; Applied Biosystems, Foster City,
CA). The sequences for oligonucleotide primers for r18s, TNFα, IL-1β, IL-18, IL-3, IL-4, IL-10,
IL-6, CRP, CCLL-4, CXCL-14, CCL-4, CCL-20, NLRP3, NLRC5, NLRX1, and NLRC3 were
previously published [10,20,21]. Additional primers used were IL-17 (forward, 5’CCTTGCTCCTGCTTGCTTTC -3’; and reverse, 5’- AACCAATCGCTCCCCATTTT -3’), IL12B (forward 5’ – TGCCCAGTGCCAGAAGGA - 3’; and reverse, 5’ –
TCAGTCGGCTGGTGCTCTT - 3’), and chemokines IL-8L1 (forward 5’ CAGAACCAAACCCAGGTGACA - 3’; and reverse, 5’ - ACAGCCTTGCCCATCATCTT 3’), IL-8L2 (forward 5’ - TCCTGGTTTCAGCTGCTCTGT - 3’; and reverse, 5’ CGCAGCTCATTCCCCATCT - 3’), CCL-5 (forward 5’ - TTTCTACACCAGCAGCAAATGC
- 3’; and reverse, 5’ - GCCCCTTCCTGGTGATGAA - 3’). Also measured were FGF23
(forward 5’ - CTGCTTGTGCTCTGTATCCTGAA - 3’; and reverse, 5’ CAGCAGCGGAGAGGAGTTG - 3’), FGFR1 (forward 5’ - GCCCCGGAGGCTCTGT - 3’;
and reverse, 5’ - CCGAAGGACCAAACATCACTCT - 3’), and Klotho (forward 5’ TGGCGATGTCCCGGTTTAT - 3’; and reverse, 5’ ATATACTCTGAGCTTATCGTGCACCAT - 3’).
Real-time quantitative PCR cycling conditions were 50˚C for 2 minutes, 95˚C for 10 minutes and
40 cycles of a two-step amplification (95˚C for 15 seconds followed by 58˚C for 1 minute). The
dissociation protocol from the sequence detection system was used for melting curve analysis to

137

exclude potential contamination of non-specific PCR products. Negative controls that were used
as templates contained no reverse transcription products. Relative expression of target genes was
determined using the 2-∆∆CT method and healthy bone tissue or untreated cells were used as
calibrators [22].
Statistical Analysis
Data were analyzed by Student t-test or One-way ANOVA, as appropriate, using GraphPad
version 7.03 (GraphPad Software, Inc., LaJolla, CA). Results are expressed as means ±SEM,
with P-value < 0.05 set as statistically significant.
Results
Plasma from BCO-affected broilers significantly decreased hFOB cell viability
hFOB cells were exposed to fresh plasma from bird both lame and affected by BCO as well as
plasma from non-lame and apparently normal bone for 4 hours. Cell viability was significantly
decreased in cells exposed to plasma from BCO affected birds when compared to normal plasma
(Figure 1) (P < 0.05).
Unique expression profile of inflammatory and bone-related cytokines and chemokines in the
bone and blood of BCO-affected broilers
The local cytokine profile was determined through mRNA expression in normal and BCOaffected bone. Only one significant difference was seen between BCO and normal bone with IL1β being significantly upregulated in BCO by approximately 4 times the fold change (Figure 2a)
(P < 0.01). The systemic cytokine profile was determined by determining gene expression of
cytokines within the whole blood and showed significant upregulation of TNFα and IL-12B
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(Figure 2b) (P < 0.05). In both bone and blood, expression of IL-4, IL-18, IL-6, IL-10, and IL-17
were not significantly affected (Figure 2 a, b). In blood, IL-3 was also measured but its
expression remained similar between normal and BCO (Figure 2b).
The chemokine profile was also evaluated in bone and blood of BCO-affected and normal birds.
In bone, IL-8L2 was significantly upregulated in BCO compared to bone without lesions (Figure
3a) (P < 0.05). While expression of IL-8L1 was not significantly different in bone, IL-8L1 was
significantly upregulated in the blood of BCO-affected birds compared to normal group (Figure
3b) (P < 0.05). Additionally, the chemokine CCL-20 was significantly upregulated in blood, but
not locally in the bone. CCL-4, CCLL-4, CXCL-14, CCL-5, and CRP expression was not
significantly different in bone nor blood (Figure 3 a, b) (P > 0.05).
Circulating levels of inflammasome NLRC5 were significantly increased in BCO
While there were no significant differences in inflammasome expression in bone, blood from
BCO-affected birds had significantly higher NLRC5 mRNA expression compared to normal
birds (Figure 4 a, b) (P > 0.05; P < 0.05).
Key receptor in the FGF23 pathway was significantly down regulated in BCO-affected bone
In the local bone, FGFR1 expression was significantly decreased in BCO-affected tissue (Figure
5a) (P< 0.05). No significant differences were seen in blood between the two groups (Figure 5b).
Recombinant IL-1β and TNFα proteins significantly decreased cell viability in both human and
chicken bone cells
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Treatment with human recombinant IL-1β or TNFα significantly reduced cell viability in hFOB
cells by approximately 18% (P = 0.0036 for IL-1β and P = 0.0249 for TNFα, Figure 6). Similar
results were seen in chicken primary chondrocyte cells (data not shown).
Discussion
Modern medical research has revealed intense networks of molecular signaling and action under
disease and infectious states with far-reaching, systemic impacts. In BCO, the suspected delivery
of bacteria to the bone via the high vascularization in the growth plate coupled with the evidence
of chronic inflammation and lack of healing could drive systemic effects within the broiler
detectable within circulation. If true, this could act as a non-invasive biomarker for BCO. Thus,
the potential systemic effects in BCO were first investigated via exposure of hFOB cells to
plasma from normal and BCO-affected birds. The resulting decreased cell viability points to
potential circulating factors which affect bone cellular function and viability.
Under an inflammatory and infectious state, such as BCO, cyto(chemo)kines play an integral
role via their both local and systemic action and stimuli [23]. Cytokines specifically are cell
signaling molecules which drive inflammation via their effects on immune cell activation and
modulation as well as downstream effects within a multitude of cell types [24]. In BCO-affected
bone, there was clear increase in interleukin-1β (IL-1β) mRNA expression while other cytokines
measured were unaffected. This corroborates previous work done in BCO which showed that
increased IL-1β expression was coupled with dysregulation of Dicer 1 Ribonuclease III and
Leucine-rich containing protein 3 (NLRP3) inflammasome activation [10]. IL-1β is a wellstudied pro-inflammatory cytokine with roles in not only inflammasome activation and apoptotic
pathways [24,25]. Additionally, both IL-1β and TNFα have been shown to decrease chondrocyte
proliferation and hypertrophy, necessary steps in endochondral ossification and proper growth
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plate homeostasis [26]. In osteoarthritis, IL-1β expression was shown to increase in conjunction
with decreased extracellular matrix formation by chondrocytes contributing to osteoarthritic
cartilage degradation [27]. Serum levels of IL-1β were increased in broilers with femur head
necrosis in an experimental model involving methylprednisolone intramuscular injections which
also coincided with disruption of extracellular matrix homeostasis [28]. These results support the
finding of increased expression of IL-1β in BCO-affected bone in this study. In BCO, IL-1β
could be acting not only as a pro-inflammatory influencer, but as a contributor to decreased
cartilage stability and maturation increasing susceptibility to mechanical stress and bacterial
infection.
Cytokines upregulated in circulation included tumor necrosis factor α (TNFα) and IL-12B. Like
IL-1β, TNFα is a well-studied, potent pro-inflammatory cytokine of the TNF super family. It acts
via induction of cytokine production, stimulation of growth and activation of adhesion molecules
[29-31]. Additionally, TNFα has roles in metabolism such as insulin resistance and lipid
metabolism as well as skeletal growth [30]. Within bone, TNFα has been shown to induce
osteoclastogenesis thereby impacting the ratio of bone resorbing to bone mineralizing cells.
Indeed, overexpression of TNFα in mice resulted in growth retardation resulting from decreased
insulin-like growth factor 1 (IGF1) and IGF1-binding protein (IGFBP3) [32]. This coupled with
its effects on chondrocytes previously described could have effects on bone healing and growth
plate integrity under BCO conditions. It is well documented that bone healing is driven through a
shift from bone-resorbing pathways and cell types, such as osteoclasts, to bone-mineralizing,
such as osteoblasts. Interestingly, surface proteins of Staphylococcus aureus, one of the most
common causative agents in BCO, have been shown to induce bone loss via potent osteolytic
effects. These effects were inhibited by IL-1 receptors and TNFα antibodies [33]. Both IL-1β and
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TNFα act via catabolic mechanisms within bone and pro-inflammatory mechanisms systemically
which could be contributing to the lack of healing seen in BCO. Other studies investigating these
cytokines in osteomyelitis found increased TNFα in early-stage of chronic osteomyelitis rather
than late stage [34]. Another study involving stimulating blood from patients with osteomyelitis
with lipid polysaccharides (LPS) did not affect the expression of TNFα or other cytokines in the
blood [35].
While the cytokines implicate thus far have been pro-inflammatory, IL-12B is a primarily antiinflammatory cytokine [36]. Anti-inflammatory cytokines act by decreasing pro-inflammatory
cytokine production and changing immune cell activation or expression, such as the T helper 1
and T helper 2 profiles [37-41]. However, in the case of IL-12B, the combination of cytokine
ligand and receptor, as well as the physiological conditions, determines whether its function is
anti- or pro-inflammatory [36,38]. In the case of BCO, further investigation into cytokine
receptor expression as well as protein expression is necessary to fully elucidate the role of IL12B in circulation.
Another key molecule in inflammatory states that have been implicated in disease states is
chemokines. Chemokines act by directing the circulation of lymphoid cells and recruiting them
under conditions such as injury and infection [42,43]. Nomenclature for chemokines involves
denoting the spacing of the first two cysteines on the amino acid terminals of the proteins with
either CC, CXC, XC, or CX3C followed by “L” to indicate it is the ligand [24]. CCL-20 was
significantly upregulated in the blood of BCO-affected broilers and it has been shown to be
induced by TNFα in several cell types [24]. It is primarily a homeostatic chemokine with
constitutive expression in several tissues. However, it has been shown that CCL-20 plays a role
in recruitment of immature dendritic cells and precursors to sites of infection and injury and that
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CCL-20 is involved in pathologies of endothelial surfaces, such as inflammatory bowel disease
and rheumatoid arthritis [44-46]. In rheumatoid arthritis, CCL-20 expression correlated to bone
loss and patient survival [47]. Its presence in circulation of BCO-affected broilers could be due
to the simultaneous increased expression of TNFα leading to downstream effects in both immune
cell recruitment and bone loss.
In both bone and blood of BCO-affected birds, IL-8 was increased. Granted IL-8L2 was
increased in bone and IL-8L1 was increased in blood, the two avian orthologs have shown to
have similar functions and comparable homology to human CXCL8 [48,49]. IL-8 acts primarily
in activation and migration of monocytes, lymphocytes, and other immune cells to sites of
infection and injury [50]. It is considered a key inflammatory mediator and shown to have
angiogenic effects [50,51]. In bone, IL-8 expression by osteoblast and osteoclasts has been
shown to be induced by cytokines IL-1β and TNFα, both shown here to be upregulated in BCO
[52,53]. IL-8 has also been shown to trigger circulating monocytes to undergo osteoclast
formation [54]. Notably, breast cancer patients with bone metastases were shown to have
elevated levels of plasma IL-8 which also correlated with increased bone resorption [55]. The
results of this study corroborate with these studies and suggest further evidence of an imbalance
in bone resorption to bone-forming pathways in BCO.
Given the clear upregulation of certain cyto(chemo)kines both in local bone and systemic blood
circulation of BCO-affected broilers, the inflammasome profile was also evaluated. NLRP3 has
already been shown to be increased in BCO bone [10]. Results showed that NLRC5 was also
significantly increased in the blood of BCO affected broilers. NLRC5 has been shown to have
potential influences on the nuclear factor kappa B (NF-κB) pathway as well as NLRP3
inflammasome activation by working in the complex forming step [56]. Inflammasome
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complexes are a part of the innate immune system initiating inflammation. Their activation leads
to the activation of caspase-1 which is responsible for the cleavage and subsequent activation of
pro-inflammatory cytokines such as IL-1β [57]. Its expression has been seen in the primary cells
of myeloid and lymphoid origin as well as bone marrow and B cells and to be upregulated in
chicken macrophages under inflammatory states [58,59]. Interestingly, NLRC5 is seen to play an
active role in the first stage of inflammation and a diminished role with the process of
inflammation [60]. The upregulation of blood NLRC5 expression in BCO-affected birds could
indicate its involvement in induction of the other pro-inflammatory cytokines upregulated and as
an indicator that BCO represents a persistent inflammatory state.
In addition to inflammasome complexes, cyto(chemo)kines have influences on and are affected
by FGFs [61]. FGFs have far reaching effects on both immune response and healing or
homeostasis of bone [13,62]. Indeed, the role of FGF signaling in skeletal formation has been
demonstrated via gain-of-function mutations in the FGF receptor (FGFR) genes [63].
Expressions of key FGFs involved in bone processes as well as healing and immune response
were evaluated. Notably, FGFR1, which has a diverse and expansive repertoire of ligands and
effects in both bone and immune responses, was significantly down regulated in BCO-affected
bone. FGFR1 is the receptor for FGF23 which is primarily produced by the bone and involved in
immune and homeostasis functions [14]. FGFR1 knock-out mice showed no difference to control
in bone mineral density or soft X-ray imaging of the femur, however, the lack of FGFR1 in the
bone coincided with decreased serum phosphate, serum FGF23, and expression of FGF23 within
the bone in addition to decreased body weight and a shorter lifespan [15]. Extracellular
phosphate is involved in the induction of processes necessary within hypertrophic chondrocytes
for normal endochondral bone development as well as the development of vascular diseases
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[64,65]. Therefore, lack of FGFR1 could be contributing to a loss of bone integrity by disrupting
hypertrophic chondrocyte function. Further research into the protein expression and modification
state of FGFR within BCO-affected bone is needed to fully understand what its down regulation
could mean for BCO etiology. However, this si the first the FGF pathway has been implicate din
BCO in modern broilers and warrants further investigation.
Given the clear profile of pro-inflammatory cytokines and chemokines in BCO, recombinant
proteins were used to determine if these could be the factors within BCO plasma responsible for
the decreased cell viability in hFOB cells. To that end, both hFOB cells and chicken primary
chondrocyte cells were challenged with IL-1β, IL-8, and TNFα. Of the three treatments, TNFα
significantly reduced cell viability in both cell types. Decreased viable osteoblast-type cells due
to the circulating levels of TNFα could be contributing to the etiology of BCO by shifting the
ratio of bone-resorbing and bone-forming cells. Additionally, decreased viability of chondrocytes
within the growth plate could contribute to its susceptibility to infection and mechanical stress.
However, it is unclear if the TNFα expression is the result of or a contributor to the bacterial
infection and bone loss. An essential piece missing in the understanding of BCO is its
progression at both a cellular and systemic level and warrants further research. Identifying the
culpable circulating cell types is also warranted for future research as it could elucidate the
means in which BCO exerts systemic effects.
Conclusions
In this study, plasma from BCO-affected broilers had significant effects on the viability of hFOB
cells demonstrating circulating factors which influence bone cell function and survival. This is
the first study profiling cyto(chemo)kines and key FGFs in BCO bone and blood and
demonstrating that elevated TNFα expression in the blood of BCO-affected birds could be the
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causative agent in bone cell viability. The unique circulating profile of BCO-affected birds
provides a potential means of non-invasive detection and potential targets for treatment.
Additionally, this is the first study to investigate FGFs in relation to BCO and showed decreased
FGFR1 in the BCO-affected bone. Taken together, these results indicate increased expression of
pro-inflammatory and bone-resorptive factors which could be contributing to bone loss and
necrosis seen in BCO. Further research is needed to elucidate the direct mechanisms behind
these factors and their effects.
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Figure 1. Effect of Plasma from Normal and BCO-affected Broilers on hFOB Cell Viability
MTT assay results from hFOB cells treated with media containing 5% plasma form wither
normal (non-lame and no lesions of the bone) or BCO-affected (lame with lesions in both legs)
broilers for 4 hours. Significance was determined using a student t-test with p-value < 0.05. *
indicates significant difference between groups.
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Figure 2. Local and Systemic Cytokine Profile in Normal and BCO-affected broilers
Gene expression for TNFα, IL-4, IL-18, IL-1β, IL-6, IL-10, IL-12B, IL-17, and IL-3 in bone (a)
and blood (b) of normal and BCO-affected broiler chickens. Significance was determined using a
student t-test with p-value < 0.05. * indicates significant difference between Normal and BCO.

Figure 3. Local and Systemic Chemokine Profile in Normal and BCO-affected broilers
Gene expression for CCL-4, CCL-20, CCLL-4, CXCL-14, CCL-5, CRP, and IL-8L1/IL-8L2 in
bone (a) and blood (b) of normal and BCO-affected broiler chickens. Significance was
determined using a student t-test with p-value < 0.05. * indicates significant difference between
Normal and BCO.
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Figure 4. Local and Systemic Inflammasome Profile in Normal and BCO-affected broilers
Gene expression for NLRC3, NLRC5, and NLRX1 in bone (a) and blood (b) of normal and BCOaffected broiler chickens. As well as expression of NLRP3 in blood (b). Significance was
determined using a student t-test with p-value < 0.05. * indicates significant difference between
Normal and BCO.

Figure 5. Local and Systemic Expression of key FGFs in Normal and BCO-affected broilers
Gene expression for FGF23, FGFR1, and Klotho in bone (a) and blood (b) of normal and BCOaffected broiler chickens. Significance was determined using a student t-test with p-value < 0.05.
* indicates significant difference between Normal and BCO.
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Figure 6. Effect of Human Recombinant IL-1β, IL-8, and TNFα on hFOB Cell Viability
MTT assay results from hFOB cells treated with human recombinant IL-1β (100 ng/mL), IL-8
(100 ng/mL), and TNFα (10 ng/mL) for 24 hours. Significance was determined using a student ttest with p-value < 0.05. * indicates significant difference between treated groups and the
control.
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Abstract: Lameness is a leading cause of animal welfare and production concerns for the poultry
industry as fast-growing, high-yielding broilers seem to be more susceptible to bone disease and
infections. A major limitation for functional studies of these disorders is the lack of a chicken
immortalized chondrocyte cell. Primary chondrocyte isolation is a valid and complex method for
establishing a reliable in vitro model for diseases. In this study, isolation and high-density
culturing of primary chondrocytes from 10-day old chicks was followed by confirmation of cell
type, identification of optimal phenotypic expression, and evaluation of cells functionality. By
evaluating mRNA abundances as well as protein expression and secretion of collagen type I
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(COLI), collagen type II (COLII), SRY-Box Transcription Factor 9 (Sox9), aggrecan (ACAN),
and collagen type 10 A1 (COLXA1) on day 3 (d3), d7, d11, d14, d18, and d21 in culture it was
shown that avian growth plate chondrocytes under these conditions exhibit optimal phenotypes
from d3 to d7. This is evident by a shift from COLII dominant expression in early-culture to
COLI dominant expression by late-culture in conjunction with a loss of other chondrocyte
markers such as Sox9, ACAN, and COLXA1. Additionally, morphological changes seen through
live cell imaging coincide with the shift of phenotype in mid- to late-culture periods indicating a
dedifferentiated phenotype. The functionality of the cultured cells was confirmed using
Brefeldin-A treatment which significantly reduced secretion of COLII by d7 chondrocytes.
These results provide a foundation for future research utilizing avian primary chondrocytes with
optimal phenotypes for disease modeling or passaging.
Key Words: broiler, primary chondrocyte, growth plate, chicken, characterize
Introduction
The growth plate is home to intense molecular remodeling from embryonic to early development
and beyond. Longitudinal bone growth is the direct result of endochondral ossification done by
chondrocyte cells within the growth plate. The junction where the dynamic growth plate meets
the harder articular cartilage cap is often the site of infection, disease, and stressors 2, 3. In
addition to mechanical stress from weight bearing and movement, these locations in the skeletal
system are under immense metabolic and conformational stress as cells progress through stages
needed for bone growth to occur 4. In the modern chicken, the growth plate is home to the
leading causes of lameness, bacterial chondronecrosis with osteomyelitis (BCO) and tibial
dyschondroplasia (TD) 5-7. These disorders are the result of weak points within the growth plate
being either exploited by opportunistic bacterium or crippled by hypoxia 8, 9. Either way,
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detection of these two disorders is only possible through necropsy. Additionally, it has been
shown that their presence does not always coincide with visible lameness 10. Regardless of the
clinical status, leg disorders and lameness in general, are a major animal welfare and production
concern to the poultry industry 11, 12. Thus far, studies have shown molecular pathways such as
dsRNA accumulation and mitochondrial dysfunction to be implicated in BCO etiology through
investigation of affected bone tissue and in vitro analysis using a human osteoblast cell line 13, 14.
However, a major limitation in the study of this disease is the lack of a chicken specific and
growth-plate relevant in vitro model. To that end, this study was undertaken to isolate, culture,
and characterize primary growth plate chondrocytes from modern broiler chicks.
In order to evaluate the success and effectiveness of primary cell cultures, it is important to
understand the in vivo environment and cell stages. There are several key stages to the
chondrocyte cell cycle, starting with condensation of the mesenchymal stem cells into
chondroprogenitor cells 15. Condensation is regulated by transcription factors such as Sox9 and
results in increased COLII expression16. Following condensation, chondroprogenitors go through
proliferation and differentiation into chondrocytes exhibiting COLII and ACAN expression and
secretion 17. The final stage chondrocytes undergo is hypertrophy where COL10A1 is a specific
marker 18. Expression of COLI is seen before condensation and in dedifferentiated chondrocytes,
therefore, COLI is commonly used as a negative marker for chondrocytes 19. These markers were
evaluated at different time-points during primary chondrocyte cell culture in order to characterize
the cells and determine the moment of optimal phenotype for utilizing primary chondrocytes as
in vitro models for diseases.
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Materials and Methods
Cell Isolation and Culture
Primary chondrocytes were isolated from the proximal tibia heads of 10-day-old broiler chicks.
The method of isolation was modified from previous work 20. All animal experiments were
approved by the University of Arkansas (Fayetteville, AR) Animal Care and Use Committee
(protocol number 21050) and were in accordance with recommendations in NIH’s Guide for the
Care and Use of Laboratory Animals. Chicks were reared in standard conditions, 32 ºC ambient
temperature and 23 hours light/1-hour dark cycles, for ten days with ad libitum access to food
and fresh water. Leg quarters were aseptically separated from culled chicks before careful
isolation of the proximal tibia head from skin and surrounding muscle. A diagonal cut was made
into the tibia head and the articular cartilage cap was removed, exposing the growth plate. A 5
mm curette was used to shave the top layers of the growth plate and shavings were placed in
serum-free media, DMEM containing 4.5g glucose/L, glutamine, 25 mM HEPES, 1 mM sodium
pyruvate, and 10 ng/mL added ascorbic acid. This process was repeated for all chicks. The
shavings were then transferred to digestion media composing of all aforementioned media with
additional 10% FBS, 1mg/ml hyaluronidase (Sigma Aldrich, St. Louis, MO), and 10mg
collagenase IV (Worthington Biochemical Corporation, Lakewood, NJ) before being incubated
overnight at 37 ̊ C. Cells were then seperated from tissue debris using ficoll gradient of Histopaq1077 density gradient medium and centrifugation separation before being plated at a density of 2
x 105 cells/cm2 in complete media. Complete media contained all components previously
mentioned, except for the hyaluronidase and collagenase. Media was changed every 48 hours
and the cells were maintained in 37 ̊ C and 5% CO2.
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Live Cell Imaging
Cells were imaged at day 3 (d3), d7, d11, d14, d18, and d21 in culture using the Cytation 3 Cel
Imaging Multi-Mode Reader (BioTek, Winooski, VT) at a magnification of 20x.
RNA isolation, reverse transcription, and real-time quantitative PCR
Total RNA was isolated from primary chondrocytes on each time point (n=3/group) in
accordance with the protocol of previous work 22. Cellular RNA was isolated using Trizol
reagent (Life Technologies, Carlsbad, CA), based on manufacturer’s instructions. RNA
concentrations were determined using Synergy HT multimode microplate reader and total RNA
was reverse transcribed using qScript cDNA SuperMix (Quanta Biosciences, Gaithsburg, MD).
Amplification was achieved using Power SYBRGreen Master Mix (Life Technologies, Carlsbad,
CA) and real-time quantitative PCR (7500 Real Time System; Applied Biosystems, Foster City,
CA). The sequences for oligonucleotide primers for r18s was previously published 14. Additional
primers used were COLIA1 (forward, 5’- GTCGCCATCCAACTGACCTT -3’; and reverse, 5’TGCAGTGGTAGGTGACGTTCTG -3’), COLIA2 (forward 5’ - GCAACACAAGGAGTCTGCATGT
- 3’; and reverse, 5’ - AAATCCGCGTATCCACAAAGC - 3’), COLII (forward 5’ ACCTGCCGCGACATCAA - 3’; and reverse, 5’ - GTCAATCCAGTAATCTCCGCTCTT - 3’),
ACAN (forward 5’ - CAGAGCCGTGGAGAATGATTTC - 3’; and reverse, 5’ GGCCGCCAGTTCTCAAATT - 3’), Sox9 (forward 5’ - CCCCTGTGCCGCTTTCT - 3’; and
reverse, 5’ - GTCCTGTTCTTCTGTCATTTTCATGA - 3’), and COL10A1 (forward 5’ CAGCTGCCAAATTCAGAATCC - 3’; and reverse, 5’ GGAAACCTGAGAAAGAAGAATGAACA - 3’).
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Real-time quantitative PCR cycling conditions were 50˚C for 2 minutes, 95˚C for 10 minutes
and 40 cycles of a two-step amplification (95˚C for 15 seconds followed by 58˚C for 1 minute).
The dissociation protocol from the sequence detection system was used for melting curve
analysis to exclude potential contamination of non-specific PCR products. Negative controls that
were used as templates contained no reverse transcription products. Relative expression of target
genes was determined using the 2-∆∆CT method and healthy bone tissue or untreated cells were
used as calibrators 23.
Protein isolation and Western Blot visualization and analysis
Media and cell lysate from each time point (d3, d7, d11, d14, d18, d21) were homogenized in
lysis buffer (10 mmol/L Tris base, pH 7.4; 150 mmol/L NaCl; 1 mmol/L EDTA; 1 mmol/L
EGTA; 0.1% Triton X-100; 0.5% Nonidet P-40; and protease and phosphatase inhibitors) and
sonicated. Total protein concentrations were determined using a Bradford assay kit (Bio-Rad,
Hercules, CA), ran in 4%-12% gradient Bis-Tris gels (Life Technologies, Carlsbad, CA) and
then transferred to polyvinylidene difluoride membranes. Once transferred, membranes were
blocked using a Tris-buffered saline (TBS) with 5% nonfat milk and Tween 20 at room
temperature for 1 hour. Membranes were then washed with TBS and Tween 20 before being
incubated with primary antibodies at a dilution of either 1:500 or 1:1000 overnight at 4˚C.
Primary antibodies used were rabbit anti- COLI (Origene, Rockville, MD), mouse anti-COLII
(Novis Biologicals, Littleton, CO), rabbit anti-ACAN (ABClonal, Woburn, MA), rabbit antiSox9 (ABClonal, Woburn, MA), and rabbit anti-COL10A1 (ABClonal, Woburn, MA). After
another wash, secondary antibodies diluted to 1:5000 were added to 5% nonfat milk in TBS and
Tween 20 and incubated with the membranes at room temperature for 1 hour. The protein signals
were visualized using chemiluminescence (ECL Plus; GE Healthcare, Pittsburg, PA) and images
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were captured using the FluorChem M MultiFluor System (ProteinSimple, San Jose, CA).
Prestained molecular weight marker (Precision Plus Protein Dual Color) was used as a standard
(Bio-Rad, Hercules, CA). Protein loading was assessed by immunoblotting using rabbit
antieglyceraldehyde-3-phosphate dehydrogenase (Santa Cruz Biotechnology, Dallas, TX) or
Ponceau S Stain (G-Biosciences, St. Louis, MO). Image acquisition and analysis were performed
by AlphaView software (version 3.4.0, 1993–2011; ProteinSimple, San Jose, CA).
Immunofluorescence
Primary chondrocytes were plated on gelatin coated Nunc Lab-Tek II chamber slides (Thermo
Fisher Scientific, Waltham, MA) until predetermined time-points in culture.
Immunofluorescence staining was performed as previously described 24. Briefly, cells were fixed
using paraformaldehyde for 10 minutes at room temperature before being permeabilized with
Triton-X 100. The cells were then blocked with serum-free protein block (Dako, Carpinteria,
CA) for 1 hour at room temperature followed by blocking with primary antibodies at a dilution
of 1:200 in antibody diluent (Dako) overnight at 4ºC. the signal was visualized using either
DyLight 488- or 594-conjugated secondary antibodies (Thermo Fisher Scientific). Vectashield
with DAPI (Vector Laboratories, Burlingame, CA) was used as mounting media before slides
were cover slipped. Images were obtained using Zeiss Imager M2 and AxioVision software
version LE2019 (Carl Zeiss Microscopy, Oberkochen, Germany).
Brefeldin-A treatment
Primary chondrocyte cells were maintained until d7 in culture. Complete media was replaced
with media either treated with 1 µg/mL of brefeldin-A (BFA, Sigma Aldrich, St. Louis, MO) or
dimethyl sulfoxide (DMSO) as vehicle control (n=3/group). Cells were maintained for another
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24 hours at 37 ̊ C and 5% CO2 before both media and cell lysate were collected for protein
isolation and analysis.
Statistical Analysis
Data were analyzed by Student t-test or One-way ANOVA, as appropriate, using GraphPad
version 7.03 (GraphPad Software, Inc., LaJolla, CA). Results are expressed as means ±SEM,
with P-value < 0.05 set as statistically significant.
RESULTS
Cell Morphology during Culture Period
Cytation 3 images, taken at 20x magnification, show cell size and shape change throughout the
culture (Figure 1). Most notably, the change from smaller rounded cells to more geometric in
shape, creating a “cobble-stone” appearance visible starting at d7 until d21. Aggregates of cell
scan also be seen more in mid-culture (d11 and d14) as compared to late-culture conditions (d18
and d21) (Figure 1).
Expression profile of chondrocyte phenotype-associated markers
COLIA1 and COL1A2, which are markers for both condensation and dedifferentiation of
chondrocytes, significantly increased during the culture period with and lowest expression on d3
and the highest expression at d18 (P < 0.05) (Figure 2 a, b). Sox9, a marker for the condensation
stage of chondrocyte cell cycle, was significantly upregulated in the early period of isolation and
significantly decreased from d3 to d14, d18, and d21 (P < 0.05) (Figure 2 c). COLII, a
chondrocyte proliferation and dedifferentiation marker, showed the highest mRNA expression in
the beginning of the culture period (d3, d7, and d11) and significant decreases in late-culture
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(d21) (P < 0.05, Figure 2 d). Similarly, ACAN showed highest expression at d3 and d7 in culture
and significantly dropped at d11 (P < 0.05, Figure 2 e). COLX, a marker of hypertrophic
chondrocytes, significantly decreased from d3 to d7 (P < 0.05) and then significantly decreased
again at d11 (P < 0.05) and remained low throughout the duration of the culture period (Figure 2
f).
At the protein levels, immunoblot blot analysis of the cell lysate showed significantly higher
expression of COLI on d18 compared to d3, d7, and d11 (P < 0.05) (Figure 3a, b). Expression of
Sox9 was also significantly higher on d3 compared to d14, d18, and d21 (P < 0.05) (Figure 3a,
b). In media, COLII was significantly higher on d7 compared to d3, d14, d18, and d21 (P < 0.05)
(Figure 3a, c). ACAN was significantly higher on d3 in media of cultured cells compared to all
other time points (P < 0.01) (Figure3 a, c).
In line with the immunoblot data, immunofluorescence staining in chondrocyte monolayer
culture detected spot-like shapes of COL I and COL II on d7 (arrowheads, Figure 3d) and
network-like shapes on d18 (arrows, Figure 3d).
Next, chondrocytes were treated with BFA and showed significantly reduced secretion of COLII
into the media, as evident by western blot analysis of the cell lysate and media from control and
treated cells (P < 0.05) (Figure 4a, b).
DISCUSSION
Inflammatory bone diseases, especially those affecting the growth plates, are notoriously
difficult to detect and treat due to the extensive layers of skin, muscle, and ligaments surrounding
the general region of infection 25, 26. In modern broilers, lameness is a serious and growing threat
to both production and animal welfare. Common causes of lameness include BCO and TD,
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which both primarily affect the proximal growth plates of the long bones 27, 28. As no current
immortalized chicken bone cell line exists, this study sought to successfully isolate, culture, and
characterize primary growth plate chondrocytes from modern broilers for their potential future
use as in vitro models of bone infection and disease.
Primary chondrocytes were seeded in accordance with high density plating methods for retaining
chondrocyte phenotypic expression 29. This is believed to be done through the dense layers of
chondrocyte cells mimicking a 3D culture environment which has been proven to aid in retention
of proper chondrocyte phenotypes as opposed to monolayer culture techniques 29. Under this
environment, the cells presented a commonly seen morphological change starting around d7 and
becoming more prominent by d11 and onward. The change in cell size and shape has been
shown to coincide with shifts in expression of chondrocyte markers and ECM secretions 30, 31.
Our results show that avian growth plate chondrocytes in high density culture exhibit shape
changes accompanied by an early-culture peak in COLII mRNA expression and protein secretion
followed by a decline in COLII and increase in COLI production into late-culture when the
shape change is most prominent. This switch to COLI production is often seen in in vitro
cultures as a monolayer environment results in dedifferentiation of chondrocytes. Indeed, live
cell imaging shows decreased layering of cells by d18 and d21 indicating a loss of high-density,
3D-mimicking culture which is more conducive for retention of chondrocyte phenotype. This
pattern of loss of COLII production is seen in other monolayer primary chondrocyte cultures.
Human articular chondrocytes seeded at a density of 2.5 x 104 cells/cm2 in monolayer showed
decreased COLII and Sox9 mRNA expression after passaging 32. Additionally, the
morphological changes observed in this study corroborate previous work. Embryonic chick
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chondrocytes seeded at 2.5 x 105 cells/cm2 in comparable media showed attachment by d3 and a
“polygonal” shape by d9 of culture, similar to the “cobblestone” shape observed in this study 33.
Within early-culture, Sox9 protein expression was highest compared to mid- and late-culture
periods, which corroborated with mRNA expression as well. Sox9 is a key transcription factor in
chondrogenesis, driving mesenchymal condensation into chondroprogenitors, and therefore was
expectedly undetectable in media from cultured cells 34. Specifically, Sox9 has been shown to
regulate COLII, COL9A1, COL11A1, and ACAN gene expression in murine chondrocytes 16, 35.
Chondroprogenitor cells have been shown to express Sox9 and drive COLII production in mice
36

. The early expression of Sox9 protein within the cells indicates the potential presence of

chondroprogenitor cells and precedes increased expression of COLII in the cultured
chondrocytes and media by d7. Murine growth plate chondrocytes showed high levels of Sox9,
ACAN, COLII mRNA expression and significantly higher expression of COLXA1 on d3 in
culture when compared to costal chondrocytes 31. COLXA1 mRNA expression as also
significantly higher on d3 compared to all later culture time points. CCOLXA1 is a common
product of hypertrophic chondrocytes and its presence in the earliest time point could be the
result of sampling. The scraping of the growth plate results in sections deep enough to include
layers of condensing, proliferating, and hypertrophic chondrocytes within the digestion and
culture. The inclusion of these different staged chondrocytes into the culture could be the
causative factor in COLXA1 mRNA expression in early-culture. Furthermore, ACAN protein
secretion was also highest on d3 which indicates the presence of proliferating chondrocytes
within culture. This further supports the idea that multiple different cell stages are represented in
the first few days of culture. However, the addition of ascorbic acid in the media is noteworthy
as ascorbic acid has been shown to induce chondrocyte proliferation in culture [37, 38]. Its
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inclusion is due to its ability to aid in chondrocyte phenotype retention and ECM secretion while
decreasing oxidative stress [39, 40].
Once an established phenotype was determined, functional analysis of the cells was undertaken
using BFA. BFA acts to inhibit protein secretion at a pre-Golgi apparatus stage through blocking
guanine nucleotide exchange [41]. Chondrocytes at d7 in culture treated with BFA showed
significantly decreased secretion of COLII compared to untreated controls. This indicates the
active secretion of COLII by the cultured cells and further defines their functionality and
phenotypic relevance for in vitro modeling of growth plate diseases and infections.
Taken together, these findings suggest that chondrocyte markers are at their most optimal
between d3 and d7 in culture and that the shape change observed starting on d7 and fully present
on d11 is likely due to dedifferentiation of chondrocytes. This is supported by a clear shift in
collagen type secretion, from COLII dominant to COLI, in addition to loss of chondrocyte
specific ECM markers such as ACAN and COLXA1 (Figure 5). Further research is needed into
whether this phenotype is maintainable through culture or if these cells could act as an in vitro
model for already established molecular pathways involved in bone diseases and infections.
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Figure 1. Live-cell imaging of chondrocytes in culture
Live cells seeded at a density of 2 x 105 cells/cm2 were imaged using Cytation 3 Cell Imaging
Multi-Mode Reader at 6 different time points, d3, d7, d11, d14, d18, and d21 in culture at the
same magnification (20x). The same wells were imaged at each time point.
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Figure 2. mRNA expression of chondrocyte markers within cultured primary cells
throughout the culture period
Gene expression for COLIA1 (a), COLIA2 (b), Sox9 (c), COLII (d), ACAN (e), and COLX (f) in
chondrocyte cells at d3, d7, d11, d14, d18, and d21 in culture. Significance was determined using
a one-way ANOVA with p-value < 0.05. Lowercase letters indicate significant difference
between time points. ACAN, aggrecan; COL, collagen; Sox, SRY-Box.
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Figure 3. Evaluation of protein production and secretion by primary chondrocytes in
culture
Protein expression for COLI, COLII, COLXA1, ACAN, Sox9, and GAPDH in cell lysate and
media in addition to Ponceau S stain of the media blot and subsequent statistical analysis in
culture (a, b, c). Significance was determined using a one-way ANOVA with p-value < 0.05. (b)
$ indicates significant difference between Sox9 expression on d14, d18, and d21 compared to d3.
# indicates significant difference between COLI expression on d18 compared to d3, d7, and d11.
(c) + indicates significant difference between ACAN secretion on d11, d14, d18, and d21
compared to d3. * indicates significant difference in COLII secretion on d7 compared to d3, d14,
d18, and d21. (d) Immunofluorescence staining of COLI (594-conjugated) and COLII (488conjugated), along with DAPI nuclear dye, in chondrocytes d7 and d18 in culture. ACAN,
aggrecan; COL, collagen; Sox, SRY-Box.
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Figure 4. Effect of BFA treatment on d7 chondrocyte COLII secretion
Protein expression of cells and their media secretions treated with either BFA (1 µg/mL) or
vehicle control at d7 in culture (a). Significance was determined using a student t-test with pvalue < 0.05 (b). * indicates significant difference between control and treated cells.

173

Figure 5. Summary of avian primary growth plate chondrocyte cell stages and phenotypes
within culture
Chondrocytes isolated from 10-day-old chicks and cultured at a high-density (2 x 105 cells/cm2)
exhibit a transition of phenotype during early-, mid-, and late-culture indicative of changes in
representative cell stages and a subsequent dedifferentiation of chondrocytes. These shifts can be
visualized through the mRNA expression ad protein production and secretion of the cells.
Chondrocyte markers are the most optimal for growth-plate in vitro models between d3 and d7
of culture.
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Chapter 9 – Perspectives
BCO has clear systemic effects and involves numerous cellular processes and pathways. Indeed,
bone metabolism and homeostasis are linked to immune response as well as hormone and growth
factors [1-3]. Bone density in particular can be affected by lipid metabolism with hyperlipidemia
associated with weaker bone [4]. In humans with osteonecrosis of the femur head,
hyperlipidemia has been identified as an associated factor and serum lipid levels are shown to be
higher in affected patients [5]. Patients with non-traumatic necrosis of the femur head also
showed increased total cholesterol, low-density lipoprotein with decreased high-density
lipoprotein indicating abnormal lipid metabolism is a strong risk factor of necrosis of the femur
head [6].
Recently, research analyzing the lipid profile of broilers with FHN showed hyperlipidemia along
with increased infiltration of lipid within the bone coinciding with increased expression of lipid
metabolism genes within the femur head [7]. A similar study also identified increased apoptosis
and decreased bone metabolic markers in FHN in conjunction with increased fat within the liver
of FHN-affected broilers [8]. These studies suggest a serious implication of fat metabolism in
bone integrity and metabolism, which could contribute to BCO through increasing susceptibility
to mechanical stressors or be the cause of a non-traumatic etiology [9].
A key factor in obesity and insulin resistance, which has been studied extensively in mammals, is
visfatin. Visfatin is an adipokine that has been assigned numerous functions depending on
species and physiological state [10]. It is known to be involved in metabolic disorders through its
regulation of glucose-stimulated insulin secretion [11]. The liver is the main site of lipid
metabolism (lipogenesis) in the broiler [12]. Therefore, the investigation into visfatin’ s
regulation within avian hepatic cells by hormones, cytokines, and other factors was undertaken

178

to first understand how visfatin is regulated within this primary organ for lipid metabolism.
Visfatin levels were also measured in BCO affected bone and found to be significantly
upregulated (Figure 1). Therefore, further research into the potential role of visfatin in the lipid
metabolism seen in BCO is warranted and the current work in hepatic cells provides a foundation
for future studies.
A marker for energy homeostasis and mitochondrial function is UCP [13]. In chapter 3, UCP
was shown to be significantly upregulated in BCO indicating its potential involvement in
mitochondrial dysfunction and ultimately energy homeostasis. The regulation of UCP in avian
muscle cells, where mitochondria are abundant, was undertaken. This research provides deeper
understanding into how UCP specifically is regulated under hormonal and cytokine factors.
Cytokines, such as IL-1β, were shown to be activated in BCO conditions either systemically or
locally in Chapter 7.
These studies provide a basis for future work and specific analysis of gene regulation under
different physiological challenges or states. Given BCO’s systemic effects and complexity,
research into how these genes function within the BCO etiology is warranted.
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Figure 1. Visfatin mRNA expression form BCO-affected bone compared to normal
Visfatin was measured using rt-qPCR in the bone of BCO-affected and normal broilers using the
same experimental conditions as previously reported [14]. * indicates significant difference in
gene expression (P < 0.05).
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Abstract: Visfatin has been extensively studied in mammals and has been shown to play an
important role in obesity and insulin resistance. However, there is a paucity of information on
visfatin regulation in non-mammalian species. After characterization of chicken visfatin gene,
we undertook this study to determine its hormonal regulation in avian (non-mammalian) liver
cells. Addition of 5 ng/mL TNFα, 100 ng/mL leptin, 1, 3, 10 or 100 ng/mL T3 for24 h
upregulated visfatin gene expression by 1.2, 1.8, 1.95, 1.75, 1.80, and 2.45 folds (P< .05),
respectively, compared to untreated LMH cells. Administration of 10 ng/mL of orexin A
significantly down regulated visfatin gene expression by 1.35 folds compared to control cells. In
contrast, treatment with IL-6 or orexin B for 24 h did not influence visfatin mRNA abundance.
These pro-inflammatory cytokines and obesity-related hormones modulate the expression of
CRP, INSIG2, and nuclear orphan receptors. Hepatic CRP gene expression was significantly
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upregulated by IL-6, TNFα, orexin B, and T3 and down regulated by leptin and orexin A. LXR
mRNA abundances were increased by orexin A, decreased by orexin B, and T3, and did not
affected by IL6, TNFα, or leptin. The expression of FXR gene was induced by IL-6, leptin, and
T3, but it was not influenced by TNFα, orexin A or B. CXR gene expression was up regulated by
TNFα, leptin, orexin B, and T3, down regulated by 5 ng/mL orexin A, and was not affected by
IL-6. INSIG2 mRNA levels were increased by TNFα(5 ng/mL), leptin (100 ng/mL), and T3 (1,
3, 10, and 100 ng/mL), decreased by orexin A, and remained unchanged with IL-6 or orexin B
treatment.
Together, this is the first report showing hormonal regulation of visfatin in avian hepatocyte cells
and suggesting a potential role of CRP, INSIG2, and nuclear orphan receptor LXR, FXR, and
CXR in mediating these hormonal effects.
Key words: LMH cells, avian species, visfatin, hormonal regulation
Introduction
Adipocytokines or adipokines are bioactive factors mainly produced and secreted by adipose
tissues. Visfatin or Nampt is among these adipokines and it was originally identified as a growth
factor for early β cells and thereby called pre-β-cell colony-enhancing factor (PBEF) [2,3].
Nampt has an intracellular (iNampt) and extracellular (eNampt) forms. iNampt is a nicotinamide
phosphoribosyl transferase (Nampt), a cytosolic enzyme, involved in nicotinamide adenine
dinucleotide (NAD) biosynthesis [4]. It regulates the activity of NAD-consuming enzymes such
as sirtuins and affects several metabolic and stress processes [5]. Although the physiological
roles of eNampt have been controversial and a matter of debate for decades, several studies have
assigned to eNampt a cytokine function and thereby they named it “visfatin” which plays a key
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role in metabolic disorders (diabetes and obesity) via regulating glucose-stimulated insulin
secretion and signaling [6,7,8,9].
Visfatin was found to be expressed in several mammalian cell types and tissues including
hepatocytes [10] and has been shown to be regulated by various cytokines, hormones, and factors
[11,12,13,14,15]. Such studies are currently lacking in avian (non-mammalian) species.
Avian genetic selection for high growth rate and muscle enhancement has resulted in
hyperphagic broilers that are prone to obesity. Modern broiler (meat-type) chickens consume
over 4 kg of feed to achieve an average slaughter-weight of 2.8 kg in only 42 days. This body
weight increase arises mainly from breast (pectoralis) muscle and abdominal fat [16,17].
Additionally, chickens are hyperglycemic compared to mammals, with their plasma glucose
levels averaging three times that found in human [18]. They require insulin doses greater than
four times that required in mammals to achieve hypoglycemia, and hence they are insulin
resistant [19,20,21]. They are also lacking functional brown adipose tissue and glucose
transporter GLUT4 [22]. Interestingly, the majority (more than 95%) of de novo fatty acid
synthesis (lipogenesis) occurs in the liver in chickens [23,24]. As a follow up to our previous
study where we have shown that visfatin is expressed in chicken liver and is regulated by
nutritional status and leptin administration, we undertook this study to determine the effects of
IL-6, TNFα, leptin, T3, and orexin A/B on the expression of visfatin gene in chicken hepatocytes
(LMH) in culture.
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Materials and Methods
LMH cell culture
LMH cells [25], purchased from American Type Culture Collection (ATCC® CRL-2117,
Manassas, VA), were cultured in McCoy 5A medium supplemented with FBS (10%), chicken
serum (1%), penicillin-streptomycin (100 µg/mL), and amphotericin B (100 µg/mL) at 37°C in a
5% CO2/95% O2 humidified incubator. The medium and reagents were purchased from
ThermoFisher Scientific (Waltham, MA). At exponential phase of growth (~80%), the complete
medium was removed and replaced by a serum-free medium or a culture medium supplemented
with thyroidectomized FBS and chicken serum for the thyroid hormone study [26] overnight to
synchronize the cells. Depletion of thyroid hormones from sera was confirmed by RIA as we
previously described [27]. Cells were then treated with 5 and 10 ng/mL of recombinant human
IL-6, TNFα (ImmunoTools, Friesoythe, Germany), orexin A or orexin B (Alpha Diagnostic
International, San Antonio, TX), and 10 and 100 ng/mL of recombinant ovine leptin (Protein
Laboratories Rehovot, PLR, Ltd, Rehovot, ISR) or triiodothyronine (T3, MyBioSource, San
Diego, CA) for 24h. Untreated cells were used as controls. The doses and duration of treatments
were chosen based on pilot and previous studies [28,29,30,31,32,33,34].
RNA isolation and RT-qPCR analysis
Total RNA was extracted from LMH cells using Trizol® reagent (ThermoFisher Scientific,
Waltham, MA) according to manufacturer’s recommendations. RNA integrity and quality was
assessed using 1% agarose gel electrophoresis and RNA concentrations and purity were
determined for each sample by Take 3 Micro-Volume Plate using Synergy HT multi-mode micro
plate reader (BioTek,Winooski, VT). The RNA samples were RQ1 RNase-free DNase treated
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(Promega, WI) and 1 µg RNA was reverse transcribed using qScript cDNA Synthesis Kit
(Quanta Biosciences, Gaithersburg, MD). The RT reaction was performed at 42°C for 30 min
followed by an incubation at 85°C for 5 min. Real-time quantitative PCR (Applied Biosystems
7500 Real-Time PCR system) was performed using 5 µL of 10X diluted cDNA, 0.5 µM of each
forward and reverse specific primer, and SYBR Green Master Mix (ThermoFisher Scientific,
Waltham, MA) in a total 20 µL reaction. Oligonucleotide primers used for chicken visfatin, Creactive protein (CRP), chicken xenobiotic-sensing orphan nuclear receptor (CXR), liver X
receptor (LXR), farnesoid X receptor (FXR), insulin-induced gene 2 (INSIG2) and r18S and
beta-actin (ACTN) as housekeeping genes are summarized in Table 1. The qPCR cycling
conditions were 50°C for 2 min, 95°C for 10 min followed by 40 cycles of a two-step
amplification program (95°C for 15 s and 58°C for 1 min). At the end of the amplification,
melting curve analysis was applied using the dissociation protocol from the Sequence Detection
system to exclude contamination with unspecific PCR products. The PCR products were also
confirmed by 2% agarose gel and showed only one specific band of the predicted size. For
negative controls, no cDNA templates were used in the qPCR and verified by the absence of geldetected bands. Relative expressions of target genes were normalized to the expression of 18S
rRNA and calculated by the 2–ΔΔCt method [35]. The untreated cells were used as a calibrator.
Statistical analysis
Data were subjected to one-way ANOVA with hormonal treatments (doses) as the fixed effects.
If ANOVA revealed significant effects, the means were compared by Tukey multiple range test
using the Graph Pad Prism version 6.00 for Windows (Graph Pad Software, La Jolla California,
USA), and differences were considered significant at P < 0.05.
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Results and Discussion
Visfatin is expressed in several peripheral tissues including visceral adipose tissue, muscle, and
hepatocytes [36,37,38] and its plasma concentrations correlated strongly with the amount of
human visceral fat indicating its potential implication in the development of obesity-associated
insulin resistance and diabetes mellitus. Furthermore, a number of cytokines and adipokines have
been reported to regulate visfatin, however the bulk of these accumulated data so far originated
from mammalian species. Here we used avian (non-mammalian) hepatocyte (LMH) cell line
where the majority (>95%) of de novo fatty acid synthesis occurs [23], and thereby constitutes a
unique and an appropriate model to determine the effect of insulin resistance- and obesityassociated hormones on the expression of this adipokine. First, we showed that visfatin is highly
expressed in LMH cells with a low Ct value compared to other cell lines (data not shown).
Treatment with IL-6 or orexin B for 24h did not influence visfatin mRNA abundance (Fig. 1a
and Fig. 5a). In contrast, addition of 5 ng/mL TNFα, 100 ng/mL leptin, 10 or 100 ng/mL T3 for
24h upregulated visfatin gene expression by 20%, 85%, 13%, and 11% (P < 0.05), respectively,
compared to untreated cells (Fig. 2a, Fig. 3a, and Fig. 6a). Administration of 10 ng/mL of orexinA significantly down regulated visfatin gene expression by 26 % compared to control cells (Fig.
4a). Due to the controversial results in the literature, our data corroborated several studies and
disagreed with others. For instance, Kralisch and coworkers [39] have shown that TNFα
administration decreased visfatin mRNA levels in 3T3-L1 adipocytes; however, Hector et al.
[12] and Wang et al. [40] have reported that TNFα treatment increased visfatin gene expression
in a time-dependent manner in human visceral adipose tissue and coronary arterial endothelial
cells, respectively. Similarly, experimental studies have revealed controversial results, indicating
that IL-6 treatment could increase visfatin gene expression in rheumatoid arthritic synovial
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fibroblasts [41] and in human abdominal subcutaneous. However, Kralisch et al. [43] and Zhang
et al. [11] have shown down regulation of visfatin gene expression by IL-6 in 3T3-L1 and BeWo
cells, respectively. In vivo and ex vivo studies conducted by Tan et al. [13] supported leptininduced visfatin expression and secretion in 3T3-L1 cells and humane/murine adipose tissue
explants. Functional studies using pharmacological inhibitors and genetic manipulations showed
that these effects of leptin were mediated by mitogen-activated protein kinase (MAPK) and
phosphatidylinositol 3-kinase (PI3K) signaling pathways [13].
Visfatin levels in hypo-and hyperthyroidism patients as well as the effects of T3 on the
expression of visfatin system have been reported with controversial results. In patients with
Graves’ disease, circulating visfatin levels were found to be elevated and positively correlated
with serum T3 [44]. On the other side, MacLaren et al. [15] demonstrated that T3 treatment
down regulated visfatin gene expression in 3T3-L1 adipocytes. Han et al. [45] reported that both
hyper- and hypothyroidism were associated with higher plasma visfatin levels compared to
euthyroid subjects, and they showed that T3 administration induced a remarkable increase in
visfatin mRNA abundance in 3T3-L1 adipocytes at low concentrations followed by a sharp
decrease at higher concentrations.
Interestingly, only orexin A but not orexin B affected visfatin gene expression in our
experimental conditions. This differential effect might be explained by the differential affinities
of the orexin receptors. Indeed, orexin A triggers orexin receptor 1, while orexin receptor 2 is
used by both orexins A and B [46]. Administration of orexin A has been reported to reduce
plasma visfatin levels in obese and T2DM animals [47]. However, whether this effect of orexin
in these animals is direct or indirect remains unclear.
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The reported discrepancies between these studies might be due to differences in species, tissues,
cell lines, hormone dosage, treatment duration, and/or methodological factors. Overall, chicken
visfatin is expressed in hepatocyte cells and is directly regulated by pro-inflammatory cytokines
(IL-6, TNFα), and obesity-related hormones (orexins, leptin, and T3).
As the pro-inflammatory cytokines and obesity-related hormones are associated with high levels
of CRP and orphan receptors, which all have been shown to control visfatin regulation, we
sought to determine the expression of CRP, LXR, FXR, CXR, and INSIG2 in this study.
Treatment with IL6 (10 ng/mL), TNFα (5 and 10 ng/mL), or orexin B (10 ng/mL) significantly
upregulated CRP gene expression compared to untreated LMH cells (Figs. 1b, 2b, and 5b),
corroborating previous studies [48,49,50]. In contrast, administration of leptin (100 ng/mL),
orexin A (5 and 10 ng/mL), or T3 (10 and 100 ng/mL) significantly down regulated CRP mRNA
levels compared to control cells (Figs. 3b, 4b, and 6b). In mammals, T3 has been shown to
reduce CRP expression via inhibition of hepatic IL-6 and STAT3 signaling [51]. In disaccord
with our present results, plasma mammalian leptin and CRP were found to have a positive
correlation in both normal weight and obese subjects [52,53]. Leptin has been shown to induce
CRP expression in vascular endothelial (HCAEC) cells [54].
Administration of IL-6 did not elicit any change to the hepatic expression of LXR, CXR, or
INSIG2; however, at the high dose of 10 ng/mL it induced the expression of FXR (Fig. 1c-f).
TNFα did not influence LXR or FXR expression, but it up regulated the expression of CXR and
INSIG2 (Fig. 2c-f). Leptin (100 ng/mL) treatment increased FXR, CXR and INSIG2 but not
LXR mRNA abundances (Fig. 3c-f). Orexin A upregulated LXR gene expression and down
regulated that of CXR and INSIG2 without affecting FXR (Fig. 4c-f). Orexin B, however,
decreased the mRNA levels of LXR, and increased CXR gene expression without affecting FXR
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and INSIG2 mRNA levels (Fig. 5c-f). T3 treatment down regulated LXR gene expression and
increased FXR, CXR, and INSIG2 mRNA levels (Fig. 6b-e). Although it is not known whether
chicken CRP and/or visfatin promoters harbor putative LXR-responsive elements, LXR ligands
have been shown to be negative regulators of CRP and visfatin gene expression [55,56]. This
suggest that the effects of orexin A and T3 on visfatin in our experimental conditions were
probably mediated through LXR. Similarly, as FXR and CXR are probably presents in the
visfatin promoter [57], the effects of obesity-associated hormones observed in our study might be
mediated via these nuclear orphan receptors, however further functional studies are warranted to
establish these interactions. It is also plausible that these hormones regulate visfatin gene
expression via modulation of INSIG2 which blocks proteolytic activation of SREBPs by SREBP
cleavage-activating protein (SCAP) [58,59].
In conclusion, this is the first report showing regulation of visfatin by pro-inflammatory
cytokines and obesity-related hormones in avian (non-mammalian) hepatocytes and suggesting
that these effects were mediated via nuclear orphan receptors (LXR, FXR, CXR), CRP, and
INSIG2.
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Table 1. Oligonucleotide real-time qPCR primers
Gene

Accession

Primer sequence (5’ → 3’)

Orientation

numbera

size (bp)

Visfatin NM_001030728 GCTTCAGCCCATTTGGTGA
ATCCCGGAACTGGATCTTTTG
CRP

LXR

FXR

Forward

Forward

CGCGGAAGGTGACGTATTTC

Reverse

ACGATCAGGCACGGACAGTC

Forward

GCCTTGCTTCGCGGTTATTAG

Reverse

AF492497

AAAGCCTAGACTGGGCCACTC Forward
CATGTCCATCTCACAGTTGCC

Reverse

GGTCATCAAATTCGCCAAGG

Forward

TGGCTCCAGGTAGATCTGCTG

Reverse

INSIG2 NM_001031261 CAGCGCTAAAGTGGATTTTGC

Forward

CXR

NM_204702

97

Reverse

NM_001039564 TCTCCTACGCCACCAAAGCT

AF492498

Product

102

201

190

211

65

CAATTGACAGGGCTGCTAACG Reverse
18S

ACTB

AF173612

NM_205518

TCCCCTCCCGTTACTTGGAT

Forward

GCGCTCGTCGGCATGTA

Reverse

CTGGCACCTAGCACAATGAA

Forward

CTGCTTGCTGATCCACATCT

Reverse

60

123

Accession number refer to Genbank (NCBI).
ACTB, beta-actin; CRP, C-reactive protein; CXR, chicken xenobiotic-sensing orphan nuclear
receptor; FXR, farnesoid X receptor; INSIG2, insulin-induced gene 2; LXR, liver X receptor.
a
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Figure 1. Effect of recombinant IL-6 on visfatin gene expression and its related regulators
in LMH cells.
LMH cells were treated with 5 or 10 ng/mL of IL6 for 24h. Untreated cells were used as
controls. Relative expression of visfatin, CRP, LXR, FXR, CXR, and INSIG2 mRNA was
determined by qPCR using 2-ΔΔCt methods [35]. Data are presented as mean ± SEM (n=8).
Different letters indicate a significant difference at P < 0.05.
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Figure 2. Effect of recombinant TNFα on visfatin gene expression and its related regulators
in LMH cells.
LMH cells were treated with 5 or 10 ng/mL of TNFα for 24h. Untreated cells were used as
controls. Relative expression of visfatin, CRP, LXR, FXR, CXR, and INSIG2 mRNA was
determined by qPCR using 2-ΔΔCt methods [35]. Data are presented as mean ± SEM (n=8).
Different letters indicate a significant difference at P < 0.05.
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Figure 3. Effect of recombinant leptin on visfatin gene expression and its related regulators
in LMH cells.
LMH cells were treated with 10 or 100 ng/mL of leptin for 24h. Untreated cells were used as
controls. Relative expression of visfatin, CRP, LXR, FXR, CXR, and INSIG2 mRNA was
determined by qPCR using 2-ΔΔCt methods [35]. Data are presented as mean ± SEM (n=8).
Different letters indicate a significant difference at P < 0.05.
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Figure 4. Effect of recombinant orexin-A on visfatin gene expression and its related
regulators in LMH cells.
LMH cells were treated with 5 or 10 ng/mL of orexin A for 24h. Untreated cells were used as
controls. Relative expression of visfatin, CRP, LXR, FXR, CXR, and INSIG2 mRNA was
determined by qPCR using 2-ΔΔCt methods [35]. Data are presented as mean ± SEM (n=8).
Different letters indicate a significant difference at P < 0.05.

195

Figure 5. Effect of recombinant orexin-B on visfatin gene expression and its related
regulators in LMH cells.
LMH cells were treated with 5 or 10 ng/mL of orexin B for 24h. Untreated cells were used as
controls. Relative expression of visfatin, CRP, LXR, FXR, CXR, and INSIG2 mRNA was
determined by qPCR using 2-ΔΔCt methods [35]. Data are presented as mean ± SEM (n=8).
Different letters indicate a significant difference at P < 0.05.
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Figure 6. Effect of recombinant T3 on visfatin gene expression and its related regulators in
LMH cells.
LMH cells were treated with 10 or 100 ng/mL of T3 for 24h. Untreated cells were used as
controls. Relative expression of visfatin, CRP, LXR, FXR, CXR, and INSIG2 mRNA was
determined by qPCR using 2-ΔΔCt methods [35]. Data are presented as mean ± SEM (n=8).
Different letters indicate a significant difference at P < 0.05.
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Abstract: Uncoupling proteins (UCPs), mitochondrial inner membrane transport proteins, have
several functions including thermogenesis and fatty acid oxidation. There have been extensive
studies of mammalian UCPs demonstrating their regulation by not only extreme metabolic states,
but pro-inflammatory cytokines and energy homeostasis-related hormones. However, little is
known regarding the regulation of avian-UCP (av-UCP), a homolog to mammalian UCP3. We
undertook this study to determine av-UCP hormonal regulation in quail muscle (QM7) cells.
Treatment of IL-6 (5 and 10 ng/mL), TNFα (5 and 10 ng/mL0, and T3 (3ng/mL) upregulated avUCP expression compared to untreated QM7 cells. Administration of leptin (10 and 100 ng/mL)
downregulated av-UCP expression compared to controls. Orexin-A and Orexin-B had no
significant effect on av-UCP mRNA levels. Transcription factors PGC-1α, PPARα, and PPARγ
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were upregulated by TNFα (5 ng/mL) and PPARα and PPARγ were both upregulated by IL-6 (5
ng/mL), TNFα (5 and 10 ng/mL), and T3 (1 ng/mL). PPARβ was upregulated by Orexin-B (5
ng/mL), however, Orexin-A (10 ng/mL) had no significant effect on all other transcription
factors other than downregulation of PPARβ. Taken together, this report demonstrates hormonal
regulation of av-UCP by both energy homeostasis-related hormones and pro-inflammatory
cytokines with potential mediation of hormonal effects on av-UCP by peroxisome proliferator‐
activated receptor transcription factors.
Key words: QM7 cells, avian species, uncoupling protein gene, hormonal regulation
Introduction
Uncoupling proteins are transporter proteins found in the inner membrane of the mitochondria
and are responsible for dissipating the proton gradient generated through the mitochondrial
respiration pathway. The movement of protons by UCP is not coupled with ATP synthesis which
prompts the uncoupling of respiration and thermogenesis. The uncoupling of respiration is
stimulated by increased reactive oxidative species (ROS) and works to reduce their production
while also maintaining redox balance by preventing over production of ATP which would inhibit
respiration [1-3]. In addition to mitochondrial respiration, UCP homologs mediate and catalyze
the export of fatty acids and fatty-acid peroxides. This increases the fatty acid oxidation rate and
prevents lipotoxicity, as well as mediates insulin signaling and regulation of energy expenditure
and intake in differing environmental and stress conditions [4-6].
The diverse functions of uncoupling proteins are partly due to the number of homologs,
including, but not limited to, UCP1, UCP2, UCP3, UCP4, brain mitochondrial carrier protein-1
(BMCP-1), and avian UCP (av-UCP). UCP1 was first found in brown adipose tissue of
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mammals and is the primary homolog responsible for thermogenesis through respiration
uncoupling [7-10]. UCP2 and UCP3 have mild uncoupling capacity in the presence of activators,
such as ROS, and differing tissue distribution in mammals with UCP2 being ubiquitous and
UCP3 mainly in skeletal muscle [4, 11]. The physiological roles of UCP2 and UCP3 have been
speculated to include lipid utilization for the purpose of energy homeostasis in muscle and
evidence suggests their mild uncoupling reduces mitochondrial ROS production and protects
against cellular damage [6, 12, 13]. UCP3 knock-out mice have impaired fatty acid oxidation and
UCP3 is known to increase in fasting states for both mammals and avian species [14]. While
UCP1-4 and BMCP-1 are mammalian homologs, avian species only have one homolog called
av-UCP, which was cloned and characterized in 2001 [15]. av-UCP gene is a nuclear gene whose
amino acid sequence is closer to that of mammalian UCP2 and UCP3 than UCP1 [16]. Its
expression is primarily in skeletal muscle; however, levels have been found ubiquitously in 8week-old-broilers and it has since been found in heart, liver, adipose tissue, spleen, brain, and
lung [12, 17, 18]. Studies have shown up-regulation of av-UCP during fasting, cold-and heat
exposure and metabolic stress [15, 19, 20]. In addition, av-UCP has been correlated with
increased fatty-acid oxidation in skeletal muscle and shown to reduce mitochondrial superoxide
production in chicken skeletal muscle during fasted states [21-23]. This suggests that av-UCP
functions similarly to mammalian homologs, including fatty-acid oxidation, mild thermogenesis,
and attenuation of ROS.
In chickens, hormonal regulation of av-UCP in differing metabolic states and ages has often
conflicted with mammalian models [15, 18, 24, 25]. Mammalian models have shown hormonal
regulation of UCPs by energy-homeostasis-regulating and obesity-related hormones such as
leptin, triiodothyronine (T3), insulin, and glucagon [26-29]. A previous study demonstrated
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upregulation of hepatic leptin and muscle UCP in both acute cold- and chronic heat- exposed
broilers suggesting a potential mechanism between hormonal regulation of UCP to mediate
energy expenditure and intake during extreme environmental conditions [19]. However, the
mechanism behind the regulation of av-UCPs potential involvement in energy metabolism in
differing metabolic conditions has yet to be uncovered. Additionally, there has yet to be a cellmodel investigation into the regulation of av-UCP by hormones involved in energy homeostasis
and stress-response pathways. The goal of the present study is to determine the effects of
Interleukin-6 (IL-6), tumor necrosis factor- alpha (TNFα), leptin, T3, and orexin A/B on av-UCP
in quail muscle (QM7) cells in culture.
Materials and Methods
QM7 cell culture
QM7 cells, purchased from American Type Culture Collection (ATCC® CRL-1962, Manassas,
VA), were cultured in M199 medium supplemented with FBS (10%), penicillin-streptomycin
(100 µg/mL), and tryptose phosphate broth (10%) at 37°C in a 5% CO2/95% O2 humidified
incubator [30]. The medium and reagents were purchased from ThermoFisher Scientific
(Waltham, MA). At exponential phase of growth (~80%), the complete medium was removed
and replaced by a serum-free medium or a culture medium supplemented with thyroidectomized
FBS and chicken serum for the thyroid hormone study overnight to synchronize the cells [31].
Depletion of thyroid hormones from sera was confirmed by RIA as was previously described
[32]. Cells were then treated with 5 or 10 ng/mL of recombinant human IL-6, TNFα
(ImmunoTools, Friesoythe, Germany), orexin A or orexin B (Alpha Diagnostic International,
San Antonio, TX), or 10 or 100 ng/mL of recombinant ovine leptin (Protein Laboratories
Rehovot, PLR, Ltd, Rehovot, ISR) or 1, 3, 10, 30, or 100 mg/mL of triiodothyronine (T3,
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MyBioSource, San Diego, CA) for 24h. Untreated cells were used as controls. The doses and
duration of treatments were chosen based on initial pilot and several previous studies [33-38].
RNA isolation and RT-qPCR analysis
Total RNA was extracted from QM7 cells using Trizol® reagent (ThermoFisher Scientific,
Waltham, MA) according to manufacturer’s recommendations. RNA integrity and quality were
assessed using 1% agarose gel electrophoresis and RNA concentrations and purity were
determined for each sample by Take 3 Micro-Volume Plate using Synergy HT multi-mode micro
plate reader (BioTek,Winooski, VT). The RNA samples were RQ1 RNase-free DNase treated
(Promega, WI) and 1 µg RNA was reverse transcribed using qScript cDNA Synthesis Kit
(Quanta Biosciences, Gaithersburg, MD). The RT reaction was performed at 42°C for 30 min
followed by an incubation at 85°C for 5 min. Real-time quantitative PCR (Applied Biosystems
7500 Real-Time PCR system) was performed using 5 µL of 10X diluted cDNA, 0.5 µM of each
forward and reverse specific primer, and SYBR Green Master Mix (ThermoFisher Scientific,
Waltham, MA) in a total 20 µL reaction. Oligonucleotide primers used for chicken UCP,
peroxisome proliferator-activated receptor gamma coactivator (PGC-1α), chicken peroxisome
proliferator-activated receptor alpha (PPARα), peroxisome proliferator-activated receptor
gamma (PPARγ), and peroxisome proliferator-activated receptor beta (PPARβ) and r18S and
beta-actin (ACTN) as housekeeping genes are summarized in Table 1. The qPCR cycling
conditions were 50°C for 2 min, 95°C for 10 min followed by 40 cycles of a two-step
amplification program (95°C for 15 s and 58°C for 1 min). At the end of the amplification,
melting curve analysis was applied using the dissociation protocol from the Sequence Detection
system to exclude contamination with unspecific PCR products. The PCR products were also
confirmed by 2% agarose gel and showed only one specific band of the predicted size. For
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negative controls, no cDNA templates were used in the qPCR and verified by the absence of geldetected bands. Relative expressions of target genes were normalized to the expression of 18S
rRNA and calculated by the 2–ΔΔCt method [39]. The untreated QM7 cells were used as a
calibrator.
Statistical analysis
Data were subjected to one-way ANOVA with hormonal treatments (doses) as the fixed effects.
If ANOVA revealed significant effects, means were compared by Tukey multiple range test using
the Graph Pad Prism version 6.00 for Windows (Graph Pad Software, La Jolla California, USA),
and differences were considered significant at P < 0.05.
Results and Discussion
UCP was first found in brown adipose tissue as a key contributor to non-shivering thermogenesis
[9]. Its homologs, UCP2 and UCP3, are involved in fatty-acid oxidation and movement as well
as insulin signaling. The avian homolog, av-UCP, is closer to mammalian UCP2 and UCP3 and
is upregulated by not only acute-cold and chronic-heat stress, but differing metabolic states such
as fasting and high fat diets [19, 21, 22, 40]. This points to the potential involvement of av-UCP
in key metabolic pathways regulating energy homeostasis as well as environmental stress
responses. Although mammalian models have shown hormonal regulation of UCP, there has yet
to be a similar avian cell model of av-UCP. Avian skeletal muscle has high expression of avUCP and is rich in mitochondria. It is also the site of lipid utilization for energy homeostasis in
extreme conditions [18, 41]. For these reasons, QM7 cells constitute an appropriate model to
determine the effects of energy-homeostasis-related-, and pro-inflammatory hormones on avUCP.
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Treatment with Orexin-B did not affect UCP mRNA expression. However, treatment with IL-6
(5 and 10 ng/mL), TNFα (5 and 10 ng/mL0, and T3 (3ng/mL) significantly increased UCP
expression compared to untreated cells (Figures 3, 4, and 2). In contrast, treatment of leptin (10
and 100 ng/mL) significantly down regulated UCP mRNA expression when compared to
untreated control (Figure 1). Interestingly, administration of 5 ng/mL of Orexin-A did not have a
significant impact on UCP expression, while 10 ng/mL resulted in slight down-regulation. The
data showed both consistencies and inconsistencies with other avian models. In mouse brown
adipose tissue, leptin treatment increased UCP expression [42-44]. The inconsistency between
results could be due to the different cell type and the fact that chicken lacks functional brown
adipose tissue. However, the down regulation of av-UCP under leptin treatment also conflicts
with a previous study showing increased hepatic leptin and UCP in response to acute cold and
chronic heat stress in broilers [19]. This could be because both leptin and UCP are activated
during these extreme environmental conditions, but leptin is not responsible or needed for UCP
activation and another pathway during these stress conditions results in increased UCP
expression.
Treatment with IL-6 resulted in increased UCP expression compared to the control. IL-6 has
been shown to increase UCP1 expression in mammals and to be necessary for cold-induced UCP
upregulation, but not always coincide with UCP protein levels [45, 46]. IL-6 is both a proinflammatory cytokine and anti-inflammatory myokine induced by exercise and in response to
low glycogen levels or metabolic demand [47]. High levels of IL-6 result in increased lipolytic
rate through the AMPK or PI3-kinase pathway in muscle and adipose tissue resulting in
oxidation of fatty acids and increased energy supply [48, 49]. In addition to being obese, IL-6
knock-out mice had reduced levels of UCP-3, hypertriglyceridemia, and were glucose intolerant
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by 9 months of age [50]. The results coincide with mammalian studies and suggest potential
involvement of IL-6 in av-UCP expression for the purpose of mediating lipid utilization in
muscle and potentially as part of both the IL-6 anti-inflammatory and pro-inflammatory
pathway. Treatment of TNFα strongly up-regulated av-UCP. Tumor necrosis factor-α (TNFα) is
a pro-inflammatory cytokine involved in inflammation and non-shivering thermogenesis in
brown adipose tissue in mammals [51]. Mammalian models have shown differentially and tissue
dependent up-regulation of UCP homologs after TNFα treatment, with UCP3 and UCP2 being
upregulated in muscle [52, 53]. Upregulation of av-UCP by TNFα indicates a potential role of
UCP in TNFα regulated inflammation or thermogenesis mechanism. Further studies are
warranted to investigate connections involving the TNFα pathway. T3 has been shown to
upregulate UCP3 in mammalian skeletal muscle and in mice without functional brown adipose
tissue (BAT), UCP3 was upregulated by administration of T3 in skeletal muscle suggesting that
in the absence of BAT thermogenesis, T3 actions in skeletal muscle are sufficient to rescue cold
tolerance [43, 54, 55]. Chickens lack BAT and are prone to obesity due to fast growth [56].
Studies have shown physiological normal levels of T3 to be between 2 to 4 ng/mL and that
thyroid status affects avian UCP levels [25, 57]. Analysis of the promoter region of av-UCP has
shown potential binding sites for thyroid hormone receptors [58]. T3 dosage of 3 ng/mL resulted
in significant increased UCP mRNA expression and further supports regulation of UCP by T3
for the both energy metabolism and thermogenic purposes. Orexins are neuropeptides which
regulate energy homeostasis, wakefulness, lipid metabolism, neuroendocrine stress response, and
feeding behaviors in mammals [59]. Orexin receptors have been found in avian muscle and
orexins are known to regulate mitochondrial dynamics within avian species [38]. Orexin-A had
slight but insignificant upregulation of av-UCP (5 ng/mL) but a slight, insignificant drop in av-
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UCP at 10 ng/mL. Orexin-B did not have any significant impact on av-UCP expression. This
conflicts with other avian studies that saw decreased av-UCP expression in QM7 cells treated
with Orexin A and B, however the doses were different with 10 and 100 ng/mL in that study and
5 and 10 ng/mL in this study [60]. A slight but insignificant drop in av-UCP is visible at 10
ng/mL of Orexin-A.
The differences between these studies could be due to a number of factors such as, differences in
tissues, species, cell lines, dosage of hormones, duration of treatments and/or methodological
factors. Overall, av-UCP is expressed in muscle and directly regulated by energy-homeostasis
related hormones (leptin and T3) as well as pro-inflammatory cytokines and thermogenesis
related hormones (IL-6 and TNFα).
In the present study, we sought to determine the expression of PGC-1α, PPARα, PPARβ, and
PPARγ as potential transcription factors regulating av-UCP expression. As a mediator of
mitochondrial ROS and fatty acid metabolism in mammals and a known player in avian
thermoregulation and lipid utilization, the beta-adrenergic system has been shown to regulate
UCP expression in both adipose tissue and muscle cells [24, 58]. Analysis of the av-UCP
promoter region suggested potential PPAR and thyroid hormone receptor binding sites [58].
PGC-1α was upregulated by treatment with leptin (10 and 100 ng/mL) and TNFα (5 ng/mL).
Interestingly, treatment with 5 ng/mL of Orexin-A increased relative PGC-1α mRNA levels
while 10 ng/mL resulted in downregulation. Orexin-B (10 ng/mL) and T3 (1, 2, 10, 30, and 100
ng/mL) also downregulated PGC-1α mRNA expression. IL-6 had no significant impact on PGC1α. PGC-1α is a transcription factor that is induced by exercise as well as adrenergic stimulation
and lower temperatures in mammalian skeletal muscle for the purpose of thermogenesis and
mitochondrial biogenesis [61]. In cold-exposed chickens, PGC-1α expression preceded increases
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in av-UCP and av-ANT within skeletal muscle [62]. PGC-1α knock-out mice showed decreased
capacity for UCP1 upregulation in cold exposure [63]. These studies in conjunction with our
results indicate PGC-1α as a potential regulator for av-UCP in muscle. As a transcription factor,
PGC-1α targets other transcription factors involved in fatty acid oxidation and UCP1/GyK
induction such as PPARα, PPARβ, and PPARγ [62]. PPARγ has been shown to increase UCP1
expression in adipose tissue through cold exposure and β-adrenergic agonist induced PGC-1α
expression [64]. IL-6 (5ng/mL), TNFα (5 and 10 ng/mL) and T3 (1 ng/mL) increased both avUCP and PPARγ mRNA expression relative to untreated controls. However, this increase was
not always coupled with a simultaneous increase in PGC-1α mRNA expression except in the
case of TNFα. This suggests the effects of TNFα, and possibly IL-6 and T3, on av-UCP seen in
our experimental conditions could be mediated through PPARγ, and potentially PGC-1α further
upstream. PPARα was also upregulated by TNFα (5 and 10 ng/mL), IL-6 (5 and 10 ng/mL), and
T3 (1 ng/mL). PPARα is expressed in mammalian tissues with high oxidative energy demands
that depend on mitochondrial fatty acid oxidation and in the heart of rodents, it has been shown
to directly regulate UCP3 expression [65, 66]. These studies, along with our results support the
potential mediation of UCP expression by the transcription factor PPARα. Interestingly, IL-6,
TNFα, leptin, and orexin-B did not have a significant effect on PPARβ mRNA expression when
compared to controls. A recent study demonstrated that activation of UCP3 by the PGC1α/PPARβ axis was induced by fatty acid induced metabolic stress in skeletal muscle [67]. The
observed lack of increased PPARβ mRNA expression could be due to differing stimuli necessary
for that pathway, outside of hormonal regulation alone.
In conclusion, this is the first report of regulation of av-UCP by energy-homeostasis-related
hormones and pro-inflammatory cytokines in avian muscle and mediation of av-UCP expression
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through peroxisome proliferator‐activated receptor transcription factors (PGC-1α, PPARα,
PPARβ, and PPARγ).
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Figure 1. Effect of recombinant leptin on av-UCP gene expression and its related
transcription factors in QM7 cells
QM7 cells were treated with 10 or 100 ng/mL of recombinant ovine leptin for 24 h. Untreated
cells were used as controls. Relative expression of av-UCP (a), PGC-1α(b), PPARα(c),
PPARβ(d), and PPARγ(e) mRNA was determined by qPCR using 2-ΔΔCtmethods. Data are
presented as mean ± SEM (n= 9). Different letters indicate a significant difference at P< .05. av-

215

UCP, avian uncoupling protein; PGC-1α, peroxisome proliferator-activated receptor gamma
coactivator-1 alpha; PPAR, peroxisome proliferator-activated receptor; QM7, quail myoblast 7.

Figure 2. Effect of triiodothyronine (T3) on av-UCP gene expression and its related
transcription factors in QM7 cells
QM7 cells were treated with different doses (1, 3,10, 30, and 100 ng/mL) of T3 for 24 h.
Untreated cells were used as controls. Relative expression of av-UCP (a), PGC-1α(b), PPARα(c),
and PPARγ(d) mRNA was determined by qPCR using 2-ΔΔCtmethods (Schmittgen and Livak,
2008). Data are presented as mean ± SEM (n = 9). Different letters indicate a significant
difference at P< .05. av-UCP, avian uncoupling protein; PGC-1α, peroxisome proliferatoractivated receptor gamma coactivator-1 alpha; PPAR, peroxisome proliferator-activated
receptor; QM7, quail myoblast 7.
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Figure 3. Effect of recombinant IL-6 on av-UCP gene expression and its related
transcription factors in QM7 cells
QM7 cells were treated with 5 or 10 ng/mL) of IL-6 for24 h. Untreated cells were used as
controls. Relative expression of av-UCP (a), PGC-1α(b), PPARα(c), PPARβ(d), and PPARγ(e)
mRNA was determined by qPCR using 2-ΔΔCtmethods (Schmittgen and Livak, 2008). Data are
presented as mean ± SEM (n = 9). Different letters indicate a significant difference at P< .05. av-
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UCP, avian uncoupling protein; PGC-1α, peroxisome proliferator-activated receptor gamma
coactivator-1 alpha; PPAR, peroxisome proliferator-activated receptor;QM7, quail myoblast 7.

Figure 4. Effect of recombinant TNFα on av-UCP gene expression and its related
regulators in QM7 cells
QM7 cells were treated with 5 or 10 ng/mL) of TNFαfor 24 h. Untreated cells were used as
controls. Relative expression of av-UCP (a), PGC-1α(b), PPARα(c), PPARβ(d), and PPARγ(e)
mRNA was determined by qPCR using 2-ΔΔCtmethods (Schmittgen and Livak, 2008). Data are
presented as mean ± SEM (n = 9). Different letters indicate a significant difference atP< .05. avUCP, avian uncoupling protein; PGC-1α, peroxisome proliferator-activated receptor gamma
coactivator-1 alpha; PPAR, peroxisome proliferator-activated receptor; QM7, quail myoblast 7.
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Chapter 12 – Overall Conclusion
BCO has proven to be a complex and multifaceted disorder, opening questions of the role
bacteria play within a larger system and how cellular processes affect overall skeletal integrity
and susceptibility. Overall, the modern broiler has proven to be an effective and high-yielding
organism that, under the right conditions, can fall prey to BCO leading to bone attrition,
inflammation, and bacterial infection. Mitochondrial dysfunction is evident based on gene
expression of key mitochondrial regulators and machinery. Autophagy manipulation by known
BCO isolates can affect the viability of bone cells and therefore alter cellular functions and
potentially the balance of bone cell types within the growing bone. There is a clear, unique
cyto(chemo)kine signature within the circulation and the local bone which points to proinflammatory pathways that can contribute to bone loss and have the ability to alter cellular
viability. This profile also is the first to provide a potential non-invasive biomarker for BCO.
Additionally, primary chondrocytes from modern broilers exhibit optimal phenotypes within a
high-density culture around d3 to d7 and could offer a promising alternative to human cell line
models currently used for in vitro modeling of BCO and other lameness issues. Visfatin and avUCP are not only significantly upregulated in BCO-affected bone but are clearly hormonally
regulated within avian cells. They provide a starting point to elucidate the mechanism behind
abnormal lipid metabolism within BCO-affected bone. The molecular pathways involved in
BCO etiology demonstrate the complex nature of skeletal homeostasis and its susceptibility to
disease and infection. Through future investigations, the larger picture of systemic effects of or
contributions to BCO could be defined leading to even more practical understandings of this
animal welfare and production concern.
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